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Abstract  
Antimicrobial resistance (AMR) is defined as the ability of microorganisms to withstand the 
effects of antibiotics. It is considered to be a universal threat to humans, animals and the 
environment. The resistance mechanisms developed by bacteria originate from the 
overuse of antibiotics in medical care and animal farming, or from the spread of resistance 
genes among microorganisms. Worldwide, 700 000 people die annually from resistant 
infections. Therefore, unless action is taken, the estimated annual deaths attributable to 
AMR will be 10 million by 2050.  
The aim of this report is to discuss the mechanisms of antibiotic action and antibiotic 
resistance, focusing on potential effects in water. Waterbodies have been recognised as a 
significant reservoir of antibiotics and antibiotic resistance genes (ARG). They facilitate the 
interchange of resistance genes between pathogenic and non-pathogenic bacteria and may 
contribute to the maintenance of antimicrobial resistance in the environment.  
In this report, a review of the global scientific literature was conducted to show the levels 
of antibiotics in wastewater treatment plants (WWTP), surface waters, agricultural runoff 
and drinking waters. The most frequently monitored antibiotics in WWTP were found to be 
sulfamethoxazole, ciprofloxacin and trimethoprim, while the most important substances in 
surface waters were erythromycin, sulfamethoxazole and trimethoprim.  
The antibiotics monitored in inland surface waters are identified, and the co-occurrence of 
heavy metals and antibiotic resistance in bacteria is discussed. The chemical 
environmental pollution caused by heavy metals such as silver (Ag), copper (Cu) and zinc 
(Zn) can co-select for antibiotic resistance. Antibiotics have been frequently detected in 
different aquatic environments within urban water cycles (in waste, surface and drinking 
water). Even though the detected levels of such antibiotics are low (in the range of ng/L 
to µg/L), they could promote antimicrobial resistance through gene transfer between 
bacteria.  
General safety measures to improve the effectiveness of wastewater treatment processes 
and to control the use of antibiotics in animal husbandry and in human medical practices 
could help constrain the spread of AMR. New research should also be conducted to 
understand the relationship between antibiotics’ concentration and the selection of 
resistance determinants in order to define the minimal concentration of antibiotics 
(separately and combined) that induces resistance in bacteria. This should also be 
considered in the evaluation of the risk assessment of antibiotics in water in order to define 
their environmental impact. 
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1. Introduction  
Antibiotics are chemical agents that kill or inhibit the growth of microorganisms and are 
widely used in the treatment of bacterial diseases. Most of the antibiotics were discovered 
during the “antibiotic golden age”, a period that began in 1941 with the production of 
Penicillin, the first antibacterial agent extracted in 1928 from the fungus Penicillium 
notatum by Alexander Fleming. Starting from 1941, many other antibiotics have been 
discovered and currently they are mainly obtained semi-synthetically or synthetically by 
chemical variations of pre-existing natural antibiotics in order to improve their 
effectiveness.  
The discovery of antibiotics is considered one of the most important event s in the history 
of medicine. Their use in human health care and in animal health management has indeed 
assured the treatment of many bacterial infections for years. However, they are now 
becoming less efficient due to the apparent overuse in medical and veterinary applications  
and high concern has been expressed worldwide due to the increasing development and 
spread of antimicrobial resistance (AMR), which occurs when bacteria resist the effects of 
antimicrobial treatments. In Europe, about 25000 people die of resistant infections every 
year. Unfortunately, resistance has been reported for almost all the available antibiotics 
but, despite the increase of AMR, the development of new antimicrobial agents is declining. 
The decreasing interest in the discovery of new antibiotics has principally economic and 
regulatory reasons. Most pharmaceutical companies are not interested in developing a 
product which requires a huge investment to be commercialised and then placed on the 
market at a low price1,2. In addition, antibiotics are used for a short period of time, 
differently from the drugs prescribed to treat chronic diseases that guarantee a high return 
on investment. The result is that the number of new antibiotics developed and approved 
has reduced progressively over the past 30 years, increasing the problem to treat resistant 
bacteria1.  
In 2014, a review published in the United Kingdom (UK) recommended actions to address 
the growing global problem of drug-resistant infections. Amongst these recommendations, 
the UK report proposed new alternative approaches for treating bacterial infections in order 
to cut the unnecessary use of antibiotics and improve a global surveillance of drug 
resistance and antimicrobial consumption in humans and animals3. The European 
Commission (EC) recognised early the importance in addressing the AMR issue in humans 
and animals with the publication of the “Action Plan” in 20114. The “One Health” approach 
published in 2017 reinforced the previous Plan since it encompasses also the 
environmental contribution to the spread of AMR5,6. 
The European attention towards the environmental problems posed by antibiotics in water 
was also shown by the inclusion of three antibiotics (azithromycin, clarithromycin and 
erythromycin) in the first surface water Watch List (WL) of the European Water Framework 
Directive (WFD) (in 2015) (EU, 2015/495)7, a list of substances potentially harmful for the 
aquatic environment but for which monitoring data were not sufficient to establish their 
environmental risk. The WL mechanism should provide high-quality monitoring data on 
the concentrations of the substances in the aquatic environment and other two antibiotics, 
ciprofloxacin and amoxicillin have been added in the next WL exercise (in 2018) (EU, 
2018/840)8.  
So far, many scientific publications reported the antibiotic concentrations in waterbodies 
and more recently, several papers aimed to focus on genes involved in AMR, however still 
missing the mechanism leading to the selection of resistance determinants in bacteria.  
Nowadays, the greatest concern about the antibiotics in waterbodies is their potential role 
in disseminating and maintaining AMR in the environment and their contribution to the 
spreading of the resistance from environmental microbes to human or animal pathogens.  
Antibiotics can enter the aquatic environment as a result of inadequate wastewater 
treatment, the disposal of unused medicines or through agricultural runoff9. Once in the 
environment, antibiotics can be easily degraded or can persist and therefore accumulate. 
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Antibiotics are only partially removed during the conventional water treatments and 
although their concentrations in many wastewater treatment plant (WWTP) effluents and 
surface waters are low (usually at levels of ng/L to µg/L), such concentrations could 
promote the acquisition of new resistances.  
Considering the relevance of the AMR issue at global level and the key role played by water 
in the AMR spread and persistence, this report aimes at collecting the environmental 
concentration levels of antibiotics reported in the scientific literature for WWTP, surface 
waters, agricultural runoff, aquacultures and drinking waters. Due to the extensive 
scientific data available, the collected information is not exhaustive but is merely meant  
to give an overview on this topic. A database including the antibiotics' measurements at 
European level was also consulted to extract the number of countries and sites where 
antibiotics were measured by competent authorities. The co-occurrence of heavy metals 
and antibiotic resistance was then discussed to assess the potential role of metals as a 
selective force in propagating the antibiotic resistance genes.  
 
2. Mode of action of antibiotics   
Antibiotics are commonly classified as bactericidal when they kill the infecting bacteria or 
as bacteriostatic when they inhibit the growth without killing bacteria10. They can be 
grouped in different classes such as aminoglycosides, β-lactams, tetracyclines and 
quinolones according to their chemical structure and mode of action (Figure 1 and Table 
1). Antibiotics can have different bacterial targets or act on the same target. They can 
disrupt the bacterial cell membrane, inhibit the cell wall synthesis, the nucleic acids, the 
protein synthesis or the metabolic pathways (Figure 1)11. All these mechanisms impair the 
multiplication and growth of bacteria. For example, the antibiotics of the sulphonamides 
class can inhibit the folate metabolism required for purine and pyrimidine biosynthesis and 
hence nucleic acid synthesis which is essential for survival and replication of bacteria. 
Indeed, as shown in Figure 1, sulfonamides act as competitive antagonists of para-
aminobenzoic acid (PABA), a molecule needed to form dihydrofolic acid (DHF) and 
tetrahydrofolic acid (THF), two precursors of folic acid. Examples of antibiotics involved in 
each mechanism are shown in Figure 1.   
Antibiotics are extensively applied in human and veterinary medicine and, as shown in 
Figure 2, there are no antibiotics in Europe which, among those considered, are specific 
for veterinary medicine applications only, meaning that they are also used for treatments 
in humans. The broad use of antibiotics has contributed to spread these compounds in the 
environment and the different routes of antibiotic exposure to the natural ecosystem, 
including waterbodies, are described below in the following paragraph.   
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Figure 1. Mode of action of antibiotics. Antibiotics can inhibit the growth of bacteria 
by targeting the bacterial cell wall or the cell membrane. Other targets are the nucleic acid 
synthesis and the protein synthesis. The latter is a process performed by ribosomes, 
nucleoprotein complexes which consist of a small and large subunit (30S and 50S in 
bacteria, as shown in the figure). Antibiotics can also act as antimetabolites by inhibit ing 
the folate metabolism (and consequently the DNA synthesis) in a pathway involving para-
aminobenzoic acid (PABA) and two precursors of folic acid, dihydrofolic acid (DHF) and 
tetrahydrofolic acid (THF). Antibiotics can inhibit DNA gyrase, an enzyme which modifies 
the DNA conformation, playing a role in replication and transcription. Class of antibiotics 
involved in each mechanism are shown in grey.  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. List of Antibiotics. List of the most common antibiotics. Each box includes a list of antibiotics 
belonging to different classes (in bold). Carbapenems are a subclass of β-lactams antibiotics. 
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Figure 2. Classes of antibiotics used in human and veterinary medicine in Europe.  
The Venn diagram shows representative classes of antibiotics and their uses in human or 
veterinary medicine in Europe. Among the classes listed in the figure, none of them is 
specific for veterinary medicine while there are classes of antibitics (carbapenem, 
streptpgramins and glycopeptides) that are only used for treatments in humans. 
(*) Carbapenems are a sub-class of β-lactam antibiotics. 
Sources: “ECDC/EFSA/EMA second joint report on the integrated analysis of the 
consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria 
from humans and food-producing animals. European Centre for Disease Prevention and 
Control (ECDC), European Food Safety Authority (EFSA) and European Medicines Agency 
(EMA). 28 June 2017;  
http://www.agenziafarmaco.gov.it/; http://www.ema.europa.eu/ema/  
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3. Routes of exposure to aquatic ecosystem  
Antibiotics can enter into the environment by different routes12 including urban and 
industrial waste or agricultural runoff, as shown in Figure 3.  
Antibiotics used in human medicine are mainly discharged into the environment from 
wastewater treatment plants (WWTP). Indeed, after ingestion, a large amount of 
antibiotics is only partially metabolised and the metabolites might retain their antibiotic 
activity13,14. For some antibiotics such as β-lactams, quinolones, tetracyclines, phenicols 
and trimethoprim, the excretion generally exceeds the 50% of the administrated dose, 
while only around 19% of ciprofloxacin dose is excreted as active metabolites 
(sulfociprofloxacin, oxociprofloxacin, desethylene ciprofloxacin and formyl-
ciprofloxacin)15. Therefore, a mixture of antibiotics and their metabolites travel through 
the sewage system to the WWTP where their complete elimination is not possible so that 
the antibiotics can reach the natural aquatic systems (surface waters and soils and the 
sewage sludge)16.  
The impact of veterinary antibiotics discharged in water depends on the farm practices 
and it mainly occurs via excretion. As in humans, after the administration in livestock, 
both metabolised and unmetabolised antibiotics end up in the manure or slurry. The direct 
entry of antibiotics in the environment takes place when cattle are out door or manure is 
used as fertilizer. Once in the soil, antibiotics may enter aquatic systems indirectly via 
surface runoff to surface water and/or by leaching to groundwater12. Antibiotics from 
veterinary use can be also introduced directly into aquatic systems due to their use in 
aquaculture12,17.     
 
Figure 3. Schematic representation of the environmental routes for antibiotics 
from human and veterinary uses. This figure shows the environmental compartments 
where antibiotics from veterinary and human uses are mobilised and transported. The 
arrows show the connection among the compartments and the aquatic ecosystems. The 
presence of veterinary antibiotics in soil and in the aquatic system is mainly due to their 
use in aquaculture or in farms. Administered antibiotics are excreted from animals and the 
application of animal manure for soil fertilisation purposes represents a route to spread 
antibiotics in the environment. Antibiotics used in human medicine can enter the natural 
ecosystem mainly due to the insufficient removal of these compounds in the wastewater 
treatment plants (WWTP). Humans and animals are exposed to antibiotics also through 
the food chain. Besides the excretion, other possible routes that should be considered are 
via accidental spills and discharges during their manufacture, as well as the disposal of 
the unused or expired antibiotics that are not recycled.  
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As pharmaceuticals are constantly released into the environment, organisms could be 
exposed to many of these compounds for long time periods. Antibiotics have highly 
differentiated structures and their behaviour, fate, transport and persistence in the 
environment may depend on their partial transformation, bioaccumulation and deposition 
in sediment, soil, surface water and groundwater18. Depending on their mobility and 
persistence in the environment, antibiotics and their metabolites can reach surface and 
groundwater, and potentially drinking water12. It has been reported that quinolones, 
sulphonamides and trimethoprim are the most detected antibiotics in the environment  
because of their high use in human and veterinary medicine and their persistence in 
aquatic systems12. Compounds that have high sorption coefficients tend to interact with 
solid particles and accumulate in sediments and/or sludge, while the compounds with low 
sorption coefficients tend to remain in aqueous phase favouring their mobility. A study 
reported that tetracycline binds to particulate matter due to its high sorption coefficient 
and therefore will be primarily found on suspended particles and sediments/sludge19.   
 
3.1 Concentration of antibiotics in wastewater treatment plants  
Antibiotics are widely used in human and animal healthcare but, once in the body, these 
drugs are not completely metabolised or eliminated and a percentage ranging from 30% 
to 90% is excreted unchanged into the wastewater system. The traditional water 
treatment systems partly degrade or leave the antibiotics unchanged. The derived 
degradation products can sometimes be as toxic as their parents or having even a higher 
ecotoxicity20.  
Antibiotics can be detected in surface and wastewaters at concentrations from ng/L to 
µg/L21,22. The occurrence of antibiotics in the water cycle is well documented and the 
wastewater treatment plants (WWTP) represent one of the most important sources of 
pharmaceuticals in waterbodies23. The traditional WWTP follow specific processes 
consisting of physico-chemical and biological water treatments to eliminate contaminants 
like organic matter, solids and nutrients. Pharmaceuticals, like antibiotics, are only 
partially removed in WWTP and these compounds can therefore be consistently present in 
waterbodies. One of the stages in water treatment process is disinfection, which is applied 
to remove microbial population in order to protect humans from exposure to pathogenic 
microorganisms, like for example Escherichia coli, whose recommended concentration in 
Italy needs to be below 5000 colony-forming unit (CFU)/100 ml according to the limit s 
established by the local authorities for wastewater. A study comparing two disinfection 
processes, chlorination and ultraviolet (UV) light, found that concentrations of antibiotics 
were significantly lower in the chlorination effluent than in the UV disinfection effluent24. 
However, additional data are necessary to confirm this evidence. 
The most frequently detected pharmaceuticals in wastewaters and surface waters are 
usually antibiotics, anti-inflammatory, analgesics/antipyretics, lipid regulators, beta 
blockers (cardiovascular drugs), radiocontrast agents, hormones, psychotropic drugs 
(antidepressants) and anticonvulsants25,26. A research performed in a Portuguese WWTP 
identified the antibiotics sulfamethoxazole, ciprofloxacin, erythromycin and sulfapyridine 
in wastewater influents. Their average concentrations were in the range of 0.28-0.69 µg/L 
and the removal efficiency following the traditional water treatments was lower or equal 
to 50%. The seasonality did not impact this trend but the removal efficiency observed at 
the end of all the treatment steps was higher during spring than in autumn and winter25.  
Even when the removal of ciprofloxacin in WWTP is high (90%) due to the sorption of the 
antibiotic to sewage sludge, the poor biological degradation of this compound results in its 
accumulation. If the sludge is used as fertilizer, antibiotic residues can be transferred to 
crops and soil where ciprofloxacin can persist for more than 90 days wit h only minima l 
transformations13,27. 
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In the United States (USA) the presence of ciprofloxacin, ofloxacin, sulfamethoxazole and 
trimethoprim was reported in wastewaters at respective concentrations of 0.130, 0.255, 
0.485 and 0.373 µg/L24. Another confirmation of the removal inefficiency of antibiotics in 
WWTP is given by the concentrations of sulfamethoxazole, trimethoprim, ciprofloxacin, 
tetracycline, and clindamycin detected in the receiving water at levels ranging from 0.090 
to 6.0 µg/L28. It has been reported that antibiotics like ciprofloxacin and ofloxacin were 
detected at higher concentrations in hospital effluents discharging into the Ter River, in 
Spain29. Similar results were found in Portugal where ciprofloxacin was frequently detected 
during the analysis of influents and effluents of 15 different WWTP30. In Italy, eight 
antibiotics were detected at concentrations between 0.008 and 1.1 µg/L in samples 
collected from effluents of different treatment plants31. In Brisbane, Australia, the 
application of two different wastewater treatment processes (conventional activated 
sludge treatment and advanced microfiltration/reverse osmosis) showed that both plants 
were efficient in reducing the antibiotic concentrations even if the effluents still contained 
these compounds at low to mid ng/L level32. The importance of checking the occurrence 
and removal of antibiotics in samples collected at different points within the WWTP and 
during different times of the year is crucial to evaluate the efficiency of the current 
treatments and to start thinking about new strategies to minimise the impact of antibiotics 
in the water environment. The improvement of treatment plant methods will enhance 
water quality and can significantly reduce the diffusion of antibiotics in the environment 18.  
 
3.1.1 Data analysis of global antibiotics’ concentrations in wastewater 
treatment plants effluents  
The collected literature data for antibiotics measured worldwide in effluents of wastewater 
treatment plants (WWTP) include 267 samples. The considered publications are listed in 
Table A in the Annex I, and a general statistical overview of the collected data is presented 
in Figure 4. It shows the number of total samples collected for each antibiotic and indicates 
the number of countries where antibiotics were measured (numbers at the bottom of each 
box). The most frequently observed antibiotics in WWTP effluents are sulfamethoxazole 
(31 samples in 13 countries), ciprofloxacin (26 samples in 11 countries), and trimethoprim 
(26 samples in 10 countries) followed by clarithromycin (17 samples in 7 countries), 
erythromycin (15 samples in 7 countries), clindamycin (13 samples in 6 countires) and 
azithromycin (13 samples in 6 countries).  
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Figure 4. Number of collected samples for antibiotics in wastewater treatment 
plants (WWTP) effluents all over the world (literature data). Numbers of collected 
samples are reported in logarithmic scale. The reported monitoring data are for 45 
antibiotics and the numbers at the bottom of each box indicate in how many countries 
each antibiotic was measured. Sulfamethoxazole, ciprofloxacin and trimethoprim are the 
most frequently monitored antibiotics. 
 
The range of antibiotics’ concentrations measured globally in WWTP effluents according to 
the scientific literature review (see Table A in the Annex I) is shown as boxplot in Figure 
5. The boxes were built by using minimal and maximal concentrations and the figure also 
shows the average (mean) concentrations (red bars in the boxes) for each compound. For 
several antibiotics, the minimal, mean and maximal concentrations overlap since only a 
single measurement was available for them. According to the collected data, the maxima l 
concentrations in WWTP effluents for the majority of antibiotics (18 out of 45) are between 
0.1 µg/L and 1 µg/L. Thirteen antibiotics have maximal concentrations between 1 and 10 
µg/L, however, 3 amongst them (ciprofloxac in, ofloxacin, and sulfamethoxazole) have 
max concentrations approaching or equal to 10 µg/L (for the others the max is below 4 
µg/L). The remaining 14 antibiotics showed max concentrations below 0.1 µg/L.  
Regarding the average concentrations, 10 out of 45 antibiotics showed values higher than 
0.5 µg/L while all the other substances (35 out of 45) have mean concentrations below 
0.5 µg/L.  
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Figure 5. Antibiotics’ concentrations in wastewater treatment plants (WWTP) 
effluents all over the world (literature data). The antibiotics’ concentrations are 
reported in logarithmic scale. Boxes were built by using minimal and maximal values and 
mean concentrations are indicated by red bars in each box. The figure shows that the 
maximal concentrations for the majority of antibiotics in WWTP effluents are in the range 
of 0.1-1 µg/L. For thirteen antibiotics, the maximal concentration is between 1 and 10 
µg/L, and only for three antibiotics (c iprofloxacin, ofloxacin, and sulfamethoxazole) it is 
around or equal to 10 µg/L. The remaining 14 substances showed max concentrations 
below 0.1 µg/L (for 5 of them the max is lower than 0.01 µg/L). 
 
About 57% of the data reported in Table A (see Annex I) and represented in Figure 4 and 
Figure 5 refer to the maximal concentrations of the antibiotics detected in WWTP effluents; 
36% are median or mean value concentrations, while the remaining 8% represent minima l 
concentrations. The reported monitoring data are for 45 antibiotics from 13 countries all 
over the world but 79% of effluent samples come from European countries while the 
remaining data are from Australia, China, and United States (USA). The quality of reported 
data is difficult to check since the publications sometimes lack information about the 
analytical methods and limits of quantification for the measurements.  
 
3.2 Antibiotics in surface water 
Inland surface waters refer to waterbodies like rivers or lakes and represent an important  
source for community water needs, such as urban water supply and irrigation. These 
waterbodies can also be used for drinking water (DW) production but only when 
treatments based on filtration and disinfection are correctly applied to assure good DW 
quality. Antibiotics detected in surface waters can derive from industrial sources, from 
households or from hospitals. Indeed, as described in section 3.1, the wastewater 
treatment plants (WWTP) may not completely remove antibiotics leading to their release 
into the freshwater environment33. In addition, antibiotics are also washed away and may 
accumulate in biosolids, nutrient-rich organic materials generated by WWTP that can be 
later used on farms as fertilizers. This practice can cause the release of pharmaceuticals 
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or antibiotics in surface waters by direct leaching into the river bed, biosolid runoff or from 
sewer overflow34.  
When antibiotics are detected in surface water, their concentrations are usually lower than 
the levels found in WWTP effluents. Potential factors responsible for this reduction in 
concentration include the dilution of antibiotics in surface water, the bioaccumulation, 
biodegradation, photodegradation as well as their ability to be absorbed on solids, colloids 
or dissolved organic matters. 
 
3.2.1 Data analysis of global antibiotics’ concentration in surface water 
Antibiotics’ concentrations measured worldwide in inland surface waters (including Europe) 
were gathered from literature sources; the considered publications are listed in Table B in 
the Annex II. 
These collected surface water data contain 728 samples for 43 antibiotics from 24 
countries. However, about 66% of these records refers only to 5 c ountries (Spain, China, 
Italy, United States (USA) and Germany).   
A general overview of the collected literature data is given in Figure 6, showing the number 
of samples and the number of countries (given at the bottom of each box) where 
antibiotics were measured. The top three most frequently monitored antibiotics were 
erythromycin, sulfamethoxazole and trimethoprim, which were measured in more than 10 
countries.  
The range of antibiotics’ concentrations measured in inland surface water is presented in 
Figure 7. The boxes were built by using minimal and maximal concentrations and the 
figure also shows the average (mean) concentrations (red bars in the boxes) for each 
compound. The reported maximal concentrations for the majority of antibiotics (19 out of 
43) are between 0.1 µg/L and 1 µg/L. Sixteen compounds have max concentrations 
exceeding 1 µg/L, however, four antibiotics (azithromycin, ciprofloxacin, 
sulfamethoxazole, and sulfapyridine) have the maximal concentrations slightly higher than 
10 µg/L (these records coming from one single country in Europe). The remaining 8 
substances showed max concentrations below 0.1 µg/L.  
Considering the average concentrations, only 4 out of 43 antibiotics (azithromycin, 
sulfamethoxypyridazine, sulfapyridine, and sulfamethazine) showed values higher than 
0.5 µg/L while all other compounds have mean values under this threshold (sometimes 
considerably below).  
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Figure 6. Number of collected samples for antibiotics in inland surface water all 
over the world (literature data). Numbers of collected samples are reported in 
logarithmic scale. The reported monitoring data are for 43 antibiotics from 24 countries 
and the numbers at the bottom of each box indicate in how many countries each antibiotic 
was measured. As shown in the figure, the most frequently monitored antibiotics in inland 
surface water are erythromycin, sulfamethoxazole and trimethoprim which were also 
measured in more than 10 countries. 
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Figure 7. Antibiotics’ concentrations in inland surface water all over the world 
(literature data). Antibiotics’ concentrations are reported in logarithmic scale. The 
maximal concentrations for the majority of antibiotics are in the range of 0.1-1 µg/L. For 
16 of them, the highest concentrations exceed 1 µg/L. Azithromycin, ciprofloxacin, 
sulfamethoxazole, and sulfapyridine have the maximal concentrations slightly higher than 
10 µg/L. The remaining 8 substances showed max concentrations below 0.1 µg/L. 
 
3.3 Comparison between wastewater treatment plants and surface 
water 
A comparison of the concentrations of the 267 wastewater treatment plants (WWTP) 
samples with the 728 surface water samples collected from the literature is difficult 
because in most cases maximal, median or mean concentrations but no disaggregated 
data are given in scientific publications. At first glance, the values of both the maxima l 
and the average concentrations in surface waters appear to be similar to those reported 
for the WWTP effluents. However, the surface water levels in Figure 7 clearly show for 
most of the substances a higher distribution at lower concentrations below 0.1 or 0.01 
µg/L than for WWTP in Figure 5. Examples are sulfamethoxazole or clarithromycin. 
The concentrations in surface waters should certainly be lower considering the water 
dilution factor which assumes a level of dilution of antibiotics in the receiving water. The 
antibiotic concentration in water is also dependent on the distance from the WWTP (higher 
is the distance, lower is the concentration) and considering that the place of sampling was 
not indicated in the articles, it was not clear if the water was collected close to or far away 
from WWTP effluents, explaining why the values we have reported for WWTP and surface 
waters are comparable.  
 
3.4 Antibiotics’ concentration in European inland surface water 
To examine if recent measurements for antibiotics are available from European inland 
surface waters, a starting list of more than 700 antibiotics taken from the United States 
(USA) National Library of Medicine (https://chem.nlm.nih.gov/chemidplus/) was matched 
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against the European monitoring data set collected by the JRC during the last prioritisation 
exercise of the Water Framework Directive (WFD)35, coming mainly from the European 
national competent authorities. This data set contains more than 16.6 million records for 
1390 individual substances measured in inland surface waters during 2006-2014 time 
period.  
Thirty-five antibiotics were identified and Figure 8 shows the amount of samples collected 
in the period 2006-2014, including the number of European countries which performed 
measurements. However, the EU dataset didn’t distinguish between measurements 
performed close to or away from effluents of wastewater treatment plant (WWTP). 
The statistical analysis showed that only two antibiotics are widely monitored in Europe by 
the national monitoring authorities; sulfamethoxazole was measured in 14 Member States 
(MS) with 11684 samples, and sulfamethazine in 11 MS with 3798 samples. All other 
antibiotics were found to be monitored only in a few European countries. For instance, the 
three antibiotics azithromycin, roxithromycin and trimethoprim were measured in only four 
countries (660, 2094 and 4613 samples, respectively). Six other antibiotics (ciprofloxacin, 
clarithromycin, erythromycin, norfloxacin, ofloxacin and spiramycin) were monitored in 
three countries. The remaining twenty-four antibiotics were monitored occasionally in one 
or two countries and only few samples are available for them (in most cases between 10 
and 100).  
Three of the above-mentioned antibiotics (azithromycin, clarithromycin and erythromycin) 
are included in the Watch List (WL) program (EU, 2015/495)7, and two more (ciprofloxacin 
and amoxicillin) have been added in the updated WL (EU, 2018/840)8. The substances in 
the WL are selected from amongst those that may pose a significant risk at Union level 
but for which monitoring data are insufficient to come to a conclusion on the potential risk 
they may pose. Thus, the monitoring of antibiotics in the WL should generate high quality 
data on their concentrations introduced to or via the aquatic environment. 
Thereby, the statistical analysis of the official European surface water monitoring data 
from the national competent authorities suggests that except for some antibiotics (e.g. 
sulfamethoxazole and sulfamethazine), very few measurements are available for the 
European aquatic environment. 
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Figure 8. Number of collected samples for antibiotics in inland surface water in 
Europe. Total number of samples for antibiotics (logarithmic scale) with measurements 
reported in the official European inland surface water dataset for the period 2006-2014. 
The reported monitoring data are for 35 antibiotics and for each of them, the number at 
the bottom of the boxes indicates in how many countries they were measured. As shown 
in the figure, the most frequently and widely monitored antibiotics in Europe are 
sulfamethoxazole and sulfamethazine. 
 
Then, Figure 9 shows the range of measured environmental concentrations for the 
antibiotics found in the European inland surface water (official) dataset (measured close 
to or away from WWTP effluents) during the period 2006-2014. The boxes were built by 
using minimal and maximal concentrations. The figure also shows the average (mean) 
concentrations (red bars in the boxes) in Europe for each single antibiotic. For some 
antibiotics (amoxicillin, cloxacillin, enoxacin, flumequine, oleandomycin, tetracycline and 
virginiamycin) the minimal, mean and maximal concentrations are overlapping because 
identical or repeating measurements were reported (suggesting the reporting of non-
quantified samples due to a low sensitivity of the analytical methods used in the monitoring 
process). Therefore, the available measured environmental concentrations for them could 
not be considered as reliable. 
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Figure 9. Antibiotics’ concentration in European inland surface water. Range of 
measured environmental concentrations (boxes are built only by using minimal and 
maximal values) and mean concentrations (red bars in each box) of the antibiotics 
reported in the European inland surface water dataset (measuremens close to or away 
from effluents of wastewater treatment plants - WWTP) during the period 2006-2014. For 
some antibiotics (amoxicillin, cloxacillin, enoxacin, flumequine, oleandomycin, tetracycline 
and virginiamycin), the minimal, mean and maximal concentrations overlap suggesting a 
low sensitivity of the analytical methods used in their monitoring process.  
 
In addition, Figure 9 shows that across Europe, the inland surface water concentrations of 
some antibiotics could span several orders of magnitude. For instance, sulfamethoxazole 
showed a minimal concentration equal to 0.5 ng/L and a maximal concentration of 17 µg/L 
while for clarithromycin the range was between 0.5 ng/L and 16 µg/L. Besides, four other 
antibiotics (ofloxacin, roxithromycin, sulfadiazine and trimethoprim) had maxima l 
concentrations between 2 and 5 µg/L. The remaining 29 antibiotics showed max values 
below 1 µg/L (amongst them 24 with max under 0.1 µg/L).  
The average concentrations of antibiotics in European inland surface waters for the 
considered thirty-five compounds showed a range of 0.0006–0.548 µg/L. Only two 
substances have average concentrations higher than 0.1 µg/l; these are clarithromyc in 
(0.193 µg/L) and sulfamethoxazole (0.548 µg/L). Sixteen antibiotics showed a mean 
concentration ≤ 0.01 µg/L and seventeen antibiotics have average concentrations in the 
range of 0.01-0.06 µg/L. 
 
3.5 Antibiotics’ concentration in drinking water 
The antibiotic profile in waterbodies may change in different countries because of the 
differences in the treatment habits and in the prevalence of diseases. The amount of 
antibiotics in drinking water (DW) depends on several factors including the traditional 
water treatment systems used to remove microorganisms and their property to be easily 
degraded or persistent in water. 
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Safe DW is needed to assure the public health and well-being. The Drinking Water Directive 
(DWD) 2015/1787/EC36 should guarantee good quality of DW consumed in Europe and its 
basic purpose is “to protect human health from the adverse effects of any contamination 
of water intended for human consumption by ensuring that it is wholesome and clean”37. 
Antibiotics are not included in the list of parameters usually checked for testing the quality 
of DW in Europe. Indeed, the contamination of antibiotics in tap water is usually low, 
generally in the low ng/L range, but the presence of low antibiotic concentrations detected 
in natural environments are highly relevant because of their potential ability to select for 
new bacterial mutants38.  
The antibiotics amoxicillin, lincomycin, erythromycin and tylosin were detected in Italian 
DW at concentration in the ng/L range which is unlikely to pose a risk to humans following 
an acute exposure to the drugs. Instead, possible negative effects due to a chronic low-
level exposure to antibiotics over a lifetime could not be excluded39. An American study 
has also shown the presence of macrolides (1-5 ng/L), and quinolones (3-4 ng/L) in 
drinking waters40. In addition, traces of the antibiotic oxytetracycline (1 ng/L) were 
detected in tap water by a survey performed in Tai Po (Hong Kong), and the veterinary 
antibiotics florfenicol and thiamphenicol were identified in tap water samples in Shanghai 
(China) with respective median concentrations of 12 and 11 ng/L41,42. A small number and 
amounts of antibiotics have been also detected in DW in North Carolina (United States of 
America, USA). The levels have been compared to those reported in source water 
indicating the incomplete removal of some antibiotics like ciprofloxacin, norfloxacin, 
lincomycin, doxycycline and tylosin during physico-chemical water treatment processes40. 
A different scenario has been instead observed in south-east Queensland, Australia, where 
antibiotics have been detected in surface water in the low ng/L to few µg/L concentration 
range but no antibiotics were observed in any of the DW samples43. The non-detection of 
antibiotics in finished water has also been reported in water samples collected from a 
drinking-water-treatment facility in the USA, indicating that the concentrations were under 
the analytical detection limits or that antibiotics were degraded during the conventional 
treatment process44.  
So far, there is little research available reporting the occurrence of antibiotics in DW (see 
Table 2) and the potential health consequences related to the long-period exposure 
through DW are not known. It is therefore important to check the antibiotics’ 
concentrations in DW even if according to a World Health Organisation (WHO) report, the 
low levels of pharmaceuticals in DW are unlikely to be considered as a potential risk to 
human health45. 
 
Table 2. Antibiotics in drinking water (DW) or sources of DW 
Substance Country Source of monitoring data MEC (µg/L) Reference 
Azithromycin 
 
USA 
Ground- (n=25) and surface-
water (n=49) sources of DW 0.029 (max) 
Focazio et al., 
200846 
Spain DW in Barcelona 0.017 (max) 
López-Serna et al., 
201047 
Chlortetracycline Japan 
Source water of DW 
purification plants (n=6) 0.012 (max) 
Simazaki et al., 
201548 
Ciprofloxacin 
Finland Raw drinking water 0.036 (max) Vieno et al., 200749 
Switzerland Raw DW from Lake Geneva 
0.032 
(median) 
Morasch et al., 
201050 
China Tap water in Macao (n=12) 0.002-0.008 
Yiruhan et al., 
201051 
China 
Tap water in Guangzhou 
(n=10) 0.006-0.680 
Yiruhan et al., 
201051 
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Spain Llobregat River Aquifer (GW) 0.014-0.324 
Cabeza et al., 
201252 
Spain DW in Barcelona 0.013 (max) 
López-Serna et al., 
201047 
Clarithromycin 
Switzerland Raw DW from Lake Geneva 
0.014 
(median) 
Morasch et al., 
201050 
Spain DW in Barcelona 0.004 (max) 
López-Serna et al., 
201047 
Switzerland GW in Switzerland 0.004 (max) 
Huntscha et al., 
201253 
Clindamycin Switzerland Raw DW from Lake Geneva 
0.004 
(median) 
Morasch et al., 
201050 
Enoxacin Spain DW in Barcelona 0.016 (max) 
López-Serna et al., 
201047 
Enrofloxacin 
USA 
Ground- (n=25) and surface-
water (n=49) sources of DW 0.040 (max) 
Focazio et al., 
200846 
China Tap water in Macao (n=12) 0.003-0.005 
Yiruhan et al., 
201051 
China 
Tap water in Guangzhou 
(n=10) 0.008 (max) 
Yiruhan et al., 
201051 
Spain DW in Barcelona 0.019 (max) 
López-Serna et al., 
201047 
Erythromycin 
USA Finished DW in North Carolina  0.005 (max) Ye et al., 200740 
USA 
Ground- (n=25) and surface-
water (n=49) sources of DW 0.040 (max) 
Focazio et al., 
200846 
Portugal GW, Lisbon 0.004 (max) 
de Jesus Gaffney et 
al., 201554 
Portugal DW, Lisbon 0.005 (max) 
de Jesus Gaffney et 
al., 201554 
Spain Llobregat River Aquifer (GW) 0.154 (max) 
Cabeza et al., 
201252 
Florfenicol China Tap water in Shanghai 
0.00082-
0.024 Wang et al., 201642 
Flumequine USA Finished DW in North Carolina  0.003 (max) Ye et al., 200740 
Josamycin Spain DW in Barcelona 0.001 (max) 
López-Serna et al., 
201047 
Lincomycin Netherlands 
DW produced from Rhine, 
Meuse or Polder River 0.001 (max) 
Houtman et al., 
201455 
Lomefloxacin 
China Tap water in Macao (n=12) 0.009-0.037 
Yiruhan et al., 
201051 
China 
Tap water in Guangzhou 
(n=10) 0.179 (max) 
Yiruhan et al., 
201051 
Norfloxacin 
China Tap water in Macao (n=12) 0.007-0.017 
Yiruhan et al., 
201051 
China 
Tap water in Guangzhou 
(n=10) 0.083 (max) 
Yiruhan et al., 
201051 
Spain DW in Barcelona 0.033 (max) 
López-Serna et al., 
201047 
Ofloxacin 
Switzerland Raw DW from Lake Geneva 
0.006 
(median) 
Morasch et al., 
201050 
Spain Llobregat River Aquifer (GW) 0.006 (max) 
Cabeza et al., 
201252 
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Spain DW in Barcelona 0.015 (max) 
López-Serna et al., 
201047 
Oxolinic acid USA Finished DW in North Carolina  0.004 (max) Ye et al., 200740 
Oxytetracycline China Tap water in Hong Kong 0.001 Li et al., 201741 
Roxithromycin USA Finished DW in North Carolina  0.001 (max) Ye et al., 200740 
Sarafloxacin USA 
Ground- (n=25) and surface-
water (n=49) sources of DW 0.020 (max) 
Focazio et al., 
200846 
Spiramycin Spain DW in Barcelona 0.021 (max) 
López-Serna et al., 
201047 
Sulfabenzamide Spain GW in Catalonia 0.002 (max) 
García-Galán et al., 
201056 
Sulfadiazine 
Portugal GW, Lisbon 0.002 (max) 
de Jesus Gaffney et 
al., 201554 
Portugal DW, Lisbon 0.001 (max) 
de Jesus Gaffney et 
al., 201554 
Spain GW in Catalonia 0.001 (max) 
García-Galán et al., 
201056 
Sulfadimethoxine 
Switzerland Raw DW from Lake Geneva 
0.002 
(median) 
Morasch et al., 
201050 
Spain GW in Catalonia 0.002 (max) 
García-Galán et al., 
201056 
Sulfadoxine Spain GW in Catalonia 0.004 (max) 
García-Galán et al., 
201056 
Sulfamerazine Spain GW in Catalonia 0.003 (max) 
García-Galán et al., 
201056 
Sulfamethazine 
Portugal GW, Lisbon 0.001 (max) 
de Jesus Gaffney et 
al., 201554 
Portugal DW, Lisbon 0.001 (max) 
de Jesus Gaffney et 
al., 201554 
Spain Llobregat River Aquifer (GW) 0.023-0.084 
Cabeza et al., 
201252 
Spain GW in Catalonia 0.004 (max) 
García-Galán et al., 
201056 
Spain DW in Barcelona 0.004 (max) 
López-Serna et al., 
201047 
Switzerland GW in Switzerland 0.006 (max) 
Huntscha et al., 
201253 
Sulfamethoxazole 
USA Finished drinking water 0.003 (max) Benotti et al., 200957 
Switzerland Raw DW from Lake Geneva 
0.014 
(median) 
Morasch et al., 
201050 
Europe 164 GW from 23 countries 
0.002 
(mean) Loos et al., 201058  
Netherlands 
DW produced from Rhine, 
Meuse or Polder River 0.013 (max) 
Houtman et al., 
201455 
Japan 
Source water of DW 
purification plants (n=6) 0.019 (max) 
Simazaki et al., 
201548 
USA 
DW samples from 29 DWTPs 
0.008 (max) 
Glassmeyer et al., 
201759 
Portugal GW, Lisbon 0.002 (max) 
de Jesus Gaffney et 
al., 201554 
Portugal DW, Lisbon 0.001 (max) 
de Jesus Gaffney et 
al., 201554 
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Spain Llobregat River Aquifer (GW) 0.009-0.046 
Cabeza et al., 
201252 
Spain GW in Catalonia 0.064 (max) 
García-Galán et al., 
201056 
Switzerland GW in Switzerland 0.015 (max) 
Huntscha et al., 
201253 
Sulfamethoxypyridazine Spain GW in Catalonia 0.001 (max) 
García-Galán et al., 
201056 
Sulfapyridine 
Portugal GW, Lisbon 0.007 (max) 
de Jesus Gaffney et 
al., 201554 
Portugal DW, Lisbon 0.002 (max) 
de Jesus Gaffney et 
al., 201554 
Spain Llobregat River Aquifer (GW) 0.016-0.021 
Cabeza et al., 
201252 
Spain GW in Catalonia 0.001 (max) 
García-Galán et al., 
201056 
Sulfaquinoxaline 
Netherlands 
DW produced from Rhine, 
Meuse or Polder River 0.026 (max) 
Houtman et al., 
201455 
Spain GW in Catalonia 0.001 (max) 
García-Galán et al., 
201056  
Sulfathiazole USA 
Finished water in DW 
purification plant 0.01 (max) 
Stackelberg et al., 
200760 
Sulfisoxazole sodium Japan 
Source water of DW 
purification plants (n=6) 0.013 (max) 
Simazaki et al., 
201548 
Tiamulin Netherlands 
DW produced from Rhine, 
Meuse or Polder River 0.055 (max) 
Houtman et al., 
201455 
Thiamphenicol China Tap water in Shanghai 
0.00084-
0.022 Wang et al., 201642 
Trimethoprim 
USA 
Ground- (n=25) and surface-
water (n=49) sources of DW 0.020 (max) 
Focazio et al., 
200846 
Switzerland Raw DW from Lake Geneva 
0.009 
(median) 
Morasch et al., 
201050 
Netherlands 
DW produced from Rhine, 
Meuse or Polder River 0.056 (max) 
Houtman et al., 
201455 
Spain DW in Barcelona 0.001 (max) 
López-Serna et al., 
201047 
Tylosin USA Finished DW in North Carolina  0.004 (max) Ye et al., 200740 
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3.6 Antibiotics’ concentration in aquaculture 
Aquaculture is the farming of aquatic animals and plants in fresh, marine and brackish 
water. The first aquaculture farms were small in size with low stock density and minima l 
additional treatments to promote food production. The rapid population growth during the 
20th century and the parallel increased demand for high-quality proteins supplied by 
finfish and shellfish has determined a subsequent strong diffusion of aquaculture practices. 
In 2009, almost 50% of the world’s consumed seafood was produced by aquaculture and 
in 2011, the aquaculture’s revenue has been estimated at around €3 billion per year in 
Europe, with greater gains than the catching sector61,62. Among the species primarily 
reared in aquaculture farms, the seabass, the trout, the salmon and mussels are the most  
representative in Europe, where the five Member States (MS), United Kingdom, Italy, 
France, Greece and Spain, are the main producers of aquaculture products, accounting for 
almost 70% of the total European production62. The aquaculture industry has contributed 
to increase the seafood production and to meet their demand on the market since 1970. 
Due to the growing request for seafood, aquaculture methods have increasingly shifted 
from extensive systems (where no feeding activity are provided) to semi-intensive (where 
food is supplemented) or intensive systems (where all nutritional requirements are 
provided by commercial feeds) in order to boost the production. Increases in 
industrialisation of aquacultures has been followed by the intensification of fish density, 
stressful conditions and nutrient pollution, resulting in poor water quality and the growing 
use of antibiotics to avoid the spread of diseases that would cause serious losses in 
production and sales. One of the examples of environmental sustainability in aquaculture 
is given by the reduction in use of antibiotics in aquaculture in favour of vaccines. 
Currently, the situation in Europe does not seem to be a cause for concern. Indeed a 
European Report published in 2015 shows that only 0.32% of the total samples (1,546) 
derived from aquaculture environments and analysed in 28 MS for the presence of 
antibacterials (which also include antibiotics), were considered non-compliant samples63.   
Regarding vaccines, this practice is one of the factors which has fostered the development 
of the salmonid aquaculture industry in countries such as Norway. Nowadays, most of the 
fish vaccines are administered by intra-peritoneal injection, but other methods include the 
immersion of the fish for a few second in a vaccine solution and the oral vaccination 
obtained by mixing the antigens into the feed64,65. Several licensed vaccines are today 
available for the Atlantic salmon, one of the most representative salmonid species in global 
aquaculture, whose worldwide production in 2011 was 1.619.200 tonnes66. In Norway, 
salmons are prevalently vaccinated against diseases like furunculosis, vibriosis, cold-water 
vibriosis and winter ulcer, contributing to the decrease in antibiotic use without causing 
negative effects for the industry65,66.  
Although the large industrial scale vaccination was initially developed for salmonid species 
including Atlantic salmon, coho salmon, rainbow trout and ayu, vaccines are today 
available for 17 species of fish and target more than 28 diseases caused by viruses or 
bacteria66. Efforts are now focused on creating more oral vaccines due to their simple 
delivery and low-cost production or using expression systems like yeast to get round the 
problem of producing vaccines for viruses not easily culturable in the laboratory. The final 
goal is to develop alternative methods to reduce the cost of vaccination and produce 
vaccines with a strong and long-lasting protection for most of the fish species.  
There are very few studies on antibiotic residues in aquacultures and considering the 
increasing human consumption of aquaculture products, more investigations should be 
carried out and data from farmers and institutions should be made public to be aware of 
antibiotic concentrations in aquacultures. 
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3.7 Antibiotic use in farms 
The ever-increasing demand of food animal production has been the main reason for the 
intensification of antibiotic use in livestocks not only as a therapy but also as metaphylaxis. 
The metaphylaxis involves the administration of high doses of antibiotics to the whole flock 
for a short period of time even if the clinical symptoms are exhibited only in a few animals. 
The aim of this mass medication is to eliminate or decrease the outbreak of diseases that 
could harm the livestock, preventing health problems and economic losses at the 
subproductive level.  
Subtherapeutic levels of antibiotics have been extensively used as growth promoters in 
animal farming. The growth promotion refers to the administration of antibiotics in healthy 
animals to increase the growth rates and food efficiency. The exact mechanism of 
antimicrobial growth promoters is still unclear but it seems that it is related to interactions 
between antibiotics with intestinal microbial population67.  
These above-mentioned livestock antibiotic use practices have promoted a selective 
pressure for bacteria that are resistant to antibiotics, resulting in an increasing awareness 
of the effects of antimicrobial drug use in animal’s commensal flora. In Sweden, the use 
of antibiotics for growth promotion in animal farming was banned in 1986, while in 
Denmark, the addition of the two antibiotics avoparcin and virginiamycin to animal feeds 
was outlawed in 199568. In the European Union (EU), avoparcin was banned as growth 
promoter in 1997 and two years later the use of bacitracin, spiramycin, tylosin and 
virginiamycin was also prohibited68. The general use of antimicrobial drugs for growth 
promotion was definitively banned in Europe since January 2006 and their use was phased 
out in the United States (USA) in 201769. As of today, antibiotics can be used in the USA 
and in Europe to treat, control or prevent infections in livestocks. In 2011, the European 
Commission has published a report stating the importance of the “Introduction of the new 
Animal Health Law, which will focus on prevention of diseases, reducing the use of 
antibiotics and replacing current Animal Health provisions based on disease control”70. A 
recent joint opinion has been published by the European Medicines Agency (EMA) and the 
European Food Safety Authority (EFSA) on measures to reduce the antimicrobial use in 
animal husbandry and the impacts on food safety in Europe71. In this document is 
underlined the need to phase out the preventive use of antimicrobials at national level and 
to reduce metaphylaxis by adopting recognised alternative measures71. Outlawing the use 
of antibiotics for prevention or growth promotion purposes represents an important step 
to assure a responsible use of antimicrobial drugs. This approach will surely contribute to 
reduce the phenomena of resistance as well as the spreading of the resistant strains in 
the environment. 
The ongoing broad use of antibiotics by livestock industry results in their constant 
introduction into the environment besides being a risk to public health due to human 
consumption of meat and animal derivatives. However, in Italy, only 53 of 159.543 bovine 
milk samples analysed during routine quality control in 2001 were found positive for some 
antibiotics like penicillin G, amoxicillin and cephalosporin. Penicillin G was detected in 26 
samples at concentrations ranging from 3.7±0.4 µg/l to 6240±550 µg/l; amoxicillin was 
found in 3 samples at concentrations ranging from 8.5±0.1 µg/l to 53.7±2.3 µg/l and 
cephapirin was identified in 2 samples at the concentration of 5.7±0.1 µg/l and 6.4±0.3 
µg/l72. The antibiotic concentrations were high respect to the Maximum Residue Limit  
(MRL) set by the European Union (EU) Regulation 2377/9073 but the total number of milk 
samples found positive at the microbial test was very low and not worrying in terms of 
human health. In 2015, a European report summarised the monitoring data on the 
detection of veterinary medical product residues and other substances in live animals and 
animal products in the EU. The total number of samples analysed by 28 Member States 
(MS) for antibacterial detection was 114.485. For the antibacterial category, which also 
includes antibiotics, a percentage of 0.20% of the samples analysed under the Directive 
96/23/European Commission (EC) and including bovines, pigs, sheep/goat s, horses, 
poultry, aquaculture, milk, eggs, rabbits and honey, were non-compliant samples. The 
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highest percentage of non-compliant samples was reported for honey (0.95%) and in 
general, the percentage of non-compliant samples (0.20%) was comparable to the 
previous eight years (0.18-0.29%)74. 
It should be mentioned that when livestocks are treated with antibiotics, the application 
of manure as organic fertilizer in agriculture can mediate the contamination of soil and 
surface waters. A tetracycline concentration equivalent to 23 mg/kg has been detected in 
pig manure samples from Austria, while in China, the antibiotics norfloxacin and 
enrofloxacin were found in chicken manure at concentrations of 225 and 1420 mg/kg, 
respectively75,76. In addition, accumulation of antibiotics was observed in crops under 
manure fertilisation77,78. This means that antibiotics may be transferred into the 
environment through the cyclic application of manure, thus causing potential ecological 
risks from exposure to these contaminants. 
Agricultural runoff is also considered a source of antibiotics. It refers to the water leaving 
farms that runs over agricultural land and then flows in surface water rather than being 
absorbed into groundwater or evaporating. Agricultural runoff can be caused by 
meteorological factors (e.g. type of precipitations, rainfall intensity) or can be influenced 
by agricultural activities which are not well-managed (e.g overgrazing). Concentrations of 
antibiotics detected in agricultural runoff are listed in the Table 3. 
 
Table 3. Antibiotics in agricultural runoff 
Substance Country Source of monitoring data MEC (µg/L) Reference 
Ampicillin 
France Cojeul River (agricultural livestock impact) 0.001 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.006 Tlili et al., 201679 
Chlortetracycline 
France Cojeul River (agricultural livestock impact) 0.004 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.017 Tlili et al., 201679 
Ciprofloxacin 
France Cojeul River (agricultural livestock impact) 0.007 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.006 Tlili et al., 201679 
Clarithromycin USA 
Agricultural runoff at the coastline of Maumee Bay 
(Lake Erie) 0.072 (max) Wu et al., 200980 
Clindamycin USA 
Agricultural runoff at the coastline of Maumee Bay 
(Lake Erie) 0.011 (max) Wu et al., 200980 
Danofloxacin 
France Cojeul River (agricultural livestock impact) 0.085 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.05 Tlili et al., 201679 
Difloxacin 
France Cojeul River (agricultural livestock impact) 0.036 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.026 Tlili et al., 201679 
Doxycycline 
Poland 
Water from water supply systems of 25 food-producing 
animal farms 1650 (max) 
Gbylik-Sikorska et al., 
201581 
France Cojeul River (agricultural livestock impact) 0.005 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.012 Tlili et al., 201679 
Enrofloxacin 
Poland 
Water from water supply systems of 25 food-producing 
animal farms 1670 (max) 
Gbylik-Sikorska et al., 
201581 
France Cojeul River (agricultural livestock impact) 0.04 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.025 Tlili et al., 201679 
Erythromycin USA 
Agricultural runoff at the coastline of Maumee Bay 
(Lake Erie) 0.438 (max) Wu et al., 200980 
Flumequine Poland 
Water from water supply systems of 25 food-producing 
animal farms 3.48 (max) 
Gbylik-Sikorska et al., 
201581 
Lincomycin 
USA 
Agricultural runoff at the coastline of Maumee Bay 
(Lake Erie) 0.005 (max) Wu et al., 200980 
Poland 
Water from water supply systems of 25 food-producing 
animal farms 304 (max) 
Gbylik-Sikorska et al., 
201581 
Monensin 
France Cojeul River (agricultural livestock impact) 0.018 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.017 Tlili et al., 201679 
Neomycin Poland 
Water from water supply systems of 25 food-producing 
animal farms 32 (max) 
Gbylik-Sikorska et al., 
201581 
Norfloxacin 
France Cojeul River (agricultural livestock impact) 0.008 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.008 Tlili et al., 201679 
Ofloxacin 
France Cojeul River (agricultural livestock impact) 0.008 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.007 Tlili et al., 201679 
Orbifloxacin France Cojeul River (agricultural livestock impact) 0.033 Tlili et al., 201679 
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France Fresnoy Lagoon (agricultural livestock impact) 0.028 Tlili et al., 201679 
Oxytetracycline 
France Cojeul River (agricultural livestock impact) 0.001 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.001 Tlili et al., 201679 
Sulfadiazine 
France Cojeul River (agricultural livestock impact) 0.018 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.02 Tlili et al., 201679 
Sulfadimethoxine 
France Cojeul River (agricultural livestock impact) 0.021 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.023 Tlili et al., 201679 
Sulfamerazine 
France Cojeul River (agricultural livestock impact) 0.011 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.02 Tlili et al., 201679 
Sulfamethazine USA 
Agricultural runoff at the coastline of Maumee Bay 
(Lake Erie) 0.010 (max) Wu et al., 200980 
Sulfamethoxazole 
USA 
Agricultural runoff at the coastline of Maumee Bay 
(Lake Erie) 0.112 (max) Wu et al., 200980 
Poland 
Water from water supply systems of 25 food-producing 
animal farms 58.7 (max) 
Gbylik-Sikorska et al., 
201581 
France Cojeul River (agricultural livestock impact) 0.014 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.013 Tlili et al., 201679 
Sulfathiazole 
France Cojeul River (agricultural livestock impact) 0.008 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.013 Tlili et al., 201679 
Tetracycline 
France Cojeul River (agricultural livestock impact) 0.011 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.01 Tlili et al., 201679 
Tiamulin Poland 
Water from water supply systems of 25 food-producing 
animal farms 66.8 (max) 
Gbylik-Sikorska et al., 
201581 
Tilmicosin Poland 
Water from water supply systems of 25 food-producing 
animal farms 1.73 (max) 
Gbylik-Sikorska et al., 
201581 
Trimethoprim 
USA 
Agricultural runoff at the coastline of Maumee Bay 
(Lake Erie) 0.252 (max) Wu et al., 200980 
Poland 
Water from water supply systems of 25 food-producing 
animal farms 17.8 (max) 
Gbylik-Sikorska et al., 
201581 
France Cojeul River (agricultural livestock impact) 0.026 Tlili et al., 201679 
France Fresnoy Lagoon (agricultural livestock impact) 0.028 Tlili et al., 201679 
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4. Antibiotic Resistance 
The antimicrobial resistance (AMR) is defined as the ability of microorganisms to resist the 
effects of antimicrobial treatments, especially antibiotics. However, since the advent of 
the antimicrobial medicine, the increasing use and misuse of antibiotics have contributed 
to the spread of resistant bacteria. The antibiotic resistance (ABR) results in the 
ineffectiveness of medical treatment for bacterial diseases thus increasing the 
morbidity/mortality rates of affected patients.  
ABR is a natural process in bacteria. The intrinsic or natural resistance is a mechanism 
attributed to an innate inability of responding to certain antibiotic agents in order to 
guarantee the normal cell functions. The Gram-negative bacteria are for example 
intrinsically resistant to the antibiotic vancomycin, the large molecular size of which does 
not allow the penetration through the outer bacterial membrane82. Another example is 
Pseudomonas aeruginosa, whose innate resistance to many antibiotics is likely to be due 
to its low membrane permeability83. Bacteria can also acquire resistance to antibiotics. 
The acquired or active resistance implies genetic modifications in microorganisms so that 
a particular antibiotic agent that was once effective against the organism, becomes 
ineffective. The acquired resistance is the major mechanism of antimicrobial resistance.  
Resistance mutations may confer a significant fitness cost for bacteria. Bacterial fitness is 
defined as the ability to replicate in a given environment and when bacteria become 
resistant to an antibiotic, their growth rate decreases hence compromising their virulence 
and transmissibility. However, the fitness cost may be reduced or eliminated as a result 
of additional genetic modifications that increase fitness without compromising resistance.  
This is of particular concern because it may cause the stabilisation of the resistance in a 
bacterial population84.  
A recent European report published in 2017 underlines the relationship between the 
consumption of antibiotics and the occurrence of antimicrobial resistance in bacteria from 
humans and food-producing animals85. The analysis was made by antimicrobial classes 
including fluoroquinolones, cephalosponins, polymixins and macrolides and suggests the 
prudent use of antibiotics for both humans and veterinary purposes. 
 
4.1 Mechanisms of Antibiotic Resistance 
Bacteria are characterised by a genetic plasticity that allows them to adapt to different 
environmental threats including the presence of antibiotic molecules that may compromise 
their survival. Antibiotic resistance (ABR), developed as a strategy to respond to the 
antibiotic occurrence, can be genetically mediated through either the acquisition of 
resistance genes from other bacteria or through the occurrence of spontaneous resistance 
mechanisms which favour the survival of microorganisms86. While some bacterial strains 
display intrinsic resistance, a bacterial population can gain resistance to antibiotics by the 
recombination of foreign DNA into the chromosome or via the mutation in key genes during 
replication. This mutation can then be passed to the subsequent generations leading to a 
population of resistant bacteria (vertical transmission), as shown in Figure 10A. More 
commonly, resistance genes can be acquired from other strains and species (horizontal 
transmission) through different mechanisms (Figure 10B): transformation (uptake of the 
free DNA from the environment), transduction (transfer of DNA from a virus to bacteria) 
and conjugation (transfer of DNA between bacteria by direct cell-to-cell contact) (Figure 
10B)87.  
  
 30 
 
 
Figure 10. Mechanism of vertical and horizontal transmission in bacteria.                               
A. During replication, the bacteria can transfer a resistance gene contained in a plasmid 
from a parent cell to the next generation (vertical transmission). B. The horizontal 
transmission in bacteria can be mediated by three principal mechanisms: transformation 
(uptake of the free DNA), transduction (virus-mediated gene transfer) and conjugation 
(transfer of DNA through a close contact between donor and recipient bacteria).  
 
The reported increasing prevalence of ABR may be in large part caused by the misuse of 
antibiotics and by other factors including the use of antibiotics in agriculture, animal 
husbandry and household chores or by the prolonged hospitalisation and the ineffective 
infection-control practices in ill patients. The spread of ABR in humans is therefore 
influenced by the development of resistant organisms as a result of selective pressure of 
antimicrobial use and by their transmission from person to person. In this scenario, when 
resistant bacteria emerge following mutational events, the antibiotic acts on the 
susceptible bacteria and leaves the resistant population unchanged, making the treatment 
ineffective. Conjugation is the main strategy through which the resistance spreads. As 
shown in Figure 10, conjugation involves transfer of genetic material by cell-to-cell contact 
and the main mobile genetic elements (MGE) taking part in this mechanism are plasmids, 
transposons and integrons which ensure a genetic interchange in bacteria and play a 
crucial role in the dissemination of antimicrobial resistance87. The role of the environment  
and in particular of waterbodies like lakes, rivers or wastewater effluents in the spread of 
antimicrobial resistance is a matter of growing relevance. Indeed, waterbodies receive 
bacteria from different sources (e.g. hospitals, industries, farms) where specific strains 
have been probably selected by intensive antibiotic usage, and could promote a genetic 
exchange among environmental strains and allochthonous bacteria, leading to acquisition 
of new antibiotic resistances. The horizontal gene transfer favours the spread of antibiotic 
resistance in waterbodies because the resistance genes in bacteria can be localised on the 
bacterial chromosome as well as on the extrachromosomal elements like transposons and 
plasmids88. Bacteriophages, the viruses that infect bacteria, may also represent an 
efficient vector for the acquisition and dissemination of ant ibiotic resistance genes (ARG) 
and they could be an important source of ARG for their high survival capacity and their 
abundance in waterbodies89-91. Discharge of antibiotics into waterbodies could also have 
an impact on the introduction of new resistance genes in the environmental bacteria, which 
in turn can transfer their intrinsic resistance genes to humans, and therefore linking ABR 
in the environment with the resistance observed in clinic. In order to survive in the 
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presence of antibiotics, bacteria have evolved different resistance mechanisms. The most  
relevant are described in the following paragraphs (4.1.1 to 4.1.3).  
 
4.1.1 Inactivation of antibiotics 
One of the main mechanisms of antibiotic resistance is the bacterial ability to produce 
enzymes capable to inactivate the drug by hydrolysis or chemical modifications (Figure 
11). The biochemical reactions catalysed by the enzymes include: acetylation, 
phosphorylation and adenylation.  
Aminoglycoside modifying enzymes (AME) are an example giving resistance through 
biochemical modification of the aminoglycosides, antibiotics that inhibit  protein synthesis. 
The AME covalently modify the OH and NH2 groups of the substrate, and three cases can 
be distinguished: i) the aminoglycoside acetyltransferases which modify the target 
antibiotics by transferring the acetyl group from acetyl-CoA; ii) the aminoglycoside 
phosphatases which transfer the phosphoryl group from adenosine triphosphate (ATP) to 
the substrate; and finally iii) the aminoglycoside adenylyltransferases which catalyse the 
transfer of the adenosine monophosphate (AMP) group from ATP92. All these enzymatic  
modifications have the final effect of lowering the affinity of the drug for the target so that 
antibiotics are not able anymore to exert their antibacterial properties.  
The chloramphenicol acetyltransferases (CAT) represent another class of enzymes capable 
to modify chemically the substrate. They transfer the acetyl group from acetyl-CoA to 
chloramphenicol and as for the AME, the enzymatic inactivation of the drug catalysed by 
CAT results in the reduced binding between the antibiotic and the target 83.  
One of the best examples of resistance via hydrolysis is represented by the well-
characterised enzymes β- lactamases. The β-lactam antibiotics including penicillin and 
cephalosporin contain a chemical structure named β-lactam ring. This structure is capable 
of binding to the enzymes Penicillin Binding Proteins (PBP) that help build the 
peptidoglycan layer. The β-lactams interfere with the crosslinking of the peptidoglycan by 
binding the PBP and thus preventing the bacterial cell wall synthesis. By inhibiting the cell 
wall synthesis, the bacterial cell is damaged due to osmotic instability or autolysis. The 
enzymes β-lactamases hydrolyse the β-lactam ring and prevent the binding between 
antibiotics and PBP, thus rendering the antimicrobial ineffective86.  
To date, many different types of β-lactamases have been described and classified 
according to their biochemical functions (Bush-Jacob classification) or their structural 
characteristics (Ambler classification) (Table 4). As shown in Table 4, the Ambler 
classification suggests four different molecular classes: A, B, C and D93. Class A enzymes 
include penicillinases, carbapenemases, cephalosporinases and extended-spectrum β-
lactamases (ESBL). These enzymes are inhibited by sulbactam, tazobactam and clavulanic 
acid including monobactams but not cephamycins. Cefotaximase-M (CTX-M) type enzymes 
belong to the ESBL and they were probably acquired from Kluyvera, a bacterial genus 
found in the soil. The genes coding for CTX-M enzymes have been found associated to 
transposons or insertion sequences and they have been isolated especially in 
cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae. Class B enzymes 
include metallo-β-lactamases, so called because they utilise zinc2+ (Zn2+) as a cofactor for 
the hydrolysis of the β-lactam ring (Table 4). One example of metallo-β-lactamases is 
represented by the New Delhi metallo-beta-lactamase-1 (NMD-1). The blaNMD gene has 
been found located on plasmids and on the host chromosome and it is characterised by a 
high mobility in a short span of time. This enzyme is particularly found in Gram-negative 
bacteria including Escherichia coli and Klebsiella pneumoniae worldwide. In addition, its 
discovery in soil and drinking water (DW) suggests a potential threat to human health.  
Finally, Class C and Class D β-lactamases are enzymes like AmpC and oxacillin hydrolysing 
enzymes (OXA), respectively (Table 4). The AmpC β-lactamase is a cephalosporinase and 
the gene blaAmpC is located both on the chromosome and on plasmids. The OXA enzymes 
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have the ability to hydrolyse oxacillin and are often associated to mobile gene elements 
(MGE). They are now widely spread in Acinetobacter baumannii but also in other bacteria 
like Escherichia coli and Klebsiella pneumoniae.    
 
 
Figure 11. Mechanisms of antimicrobial resistance: inactivation of antibiotics.  A. 
When the antibiotics enter the bacteria, they exert their activity by binding to a specific 
target. B. Bacteria can acquire or develop resistance to antibiotics through the activity of 
enzymes which hydrolyse or chemically modify the antibiotics preventing their binding to 
the target (e.g. β-lactamases, aminoglycosides, glycopeptides, tetracyclines). 
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Table 4. Ambler classification of β-lactamases  
 
CTX-M: cefotaximase-M, SHV: sulfhydryl variable enzymes, KPC: Klebsiella pneumoniae  
carbapenemases, IMP: imipenemase metallo-β-lactamases, VIM: Verona integron 
encoded metallo-β-lactamases, NDM-1: New Delhi metallo-β-lactamase-1, OXA: oxacillin 
hydrolyzing enzymes. 
4.1.2 Decrease of antibiotic penetration and pumping of antibiotics out of 
cells 
The susceptibility of bacteria to a specific antibiotic is determined by their ability to reduce 
the cellular internalisation of the drug, or on the contrary, to favour antibiotic extrusion 
mechanisms as shown in Figure 12 and 13. Bacteria have therefore developed strategies 
to reduce the quantity of antibiotics able to cross the cell membrane to survive in their 
presence. Mechanisms used by bacteria to reduce the intracellular antibiotic accumulation 
include either the downregulation of protein channels (porins) localised on the outer 
membrane to reduce the drug influx into the cells (Figure 12 and Figure 14), or the 
expression of efflux pumps to remove the antibiotics already present within the cells 
(Figure 13 and Figure 14)94. The amount of porins is particularly relevant for Gram-
negative bacteria whose outer membrane is an important barrier that provides protection 
against toxic compounds and that must be overcome to allow antibiotics to penetrate the 
bacteria cell envelope and reach their intracellular targets. Bacteria can regulate outer 
membrane permeability by modulating the expression of porins (Figure 14). The 
downregulation of these proteins or their replacement with selective channels, implies a 
limited access of antibiotics into the cells. This intrinsic mechanism of antibiotic resistance 
can be achieved by two main processes: a) a modulation of porins expression; and b) an 
impairment of porins functions. All these mechanisms result in a decreased antibiotic 
penetration in bacteria and they mainly affect molecules such as β-lactams and 
tetracyclines which often use porins to pass through the cell membrane. As observed in 
clinical isolates, the low susceptibility of Pseudomonas aeruginosa to imipenem is due to 
the downregulation of the porin protein OprD and the reduced number of specific porins is 
responsible for resistance of Pseudomonas spp. and Acinetobacter baumanii to β-
lactams95,96. An important contribution to the intrinsic antibiotic resistance is also given by 
the overexpression of efflux pumps, membrane proteins capable of extruding antibiotics 
from both the periplasm and cytoplasm of bacteria (Figure 14). Efflux pumps are able to 
export a wide range of substances so that the antibacterial concentration into the cells is 
so low that the drug cannot exert its function. Most efflux pumps have a broad substrate 
specificity but they can also be substrate-specific like the tetracycline (Tet) efflux pump, 
a membrane protein involved in the extrusion of tetracycline97. The ability of some efflux 
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pumps to interact with a wide range of antibiotics is explained by the formation of 
hydrophobic and electrostatic interactions between substrates and the central cavity of 
the membrane proteins. Up to date, there are five different families of efflux pumps, 
grouped according to their mechanisms and structural conformation, as shown in Figure 
14: a) the major facilitator superfamily (MFS); b) the resistance-nodulation-cell division 
family (RND); c) the small multidrug resistance family (SMR); d) the multidrug and toxic 
compounds extrusion family (MATE); and e) the ATP-binding cassette superfamily (ABC)87.  
 
 
Figure 12. Mechanisms of antimicrobial resistance: decreasing antibiotic 
penetration. Bacteria can acquire or develop resistance to antibiotics by reducing the 
antibiotic intracellular concentration as a result of their low penetration into the bacteria 
(e.g. β-lactams, aminoglycosides, quinolones).  
 
 
 
 
 
 
  
 35 
 
 
 
Figure 13. Mechanisms of antimicrobial resistance: pumping of antibiotics out of 
bacteria. Bacteria can acquire or develop resistance to antibiotics by reducing the 
antibiotic intracellular concentration as a result of their extrusion by efflux pumps (e.g. β-
lactams, aminoglycosides, macrolides, quinolones). 
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Figure 14. Porins and efflux pumps. Schematic representation of porins and efflux 
pumps in bacteria. Porins are membrane proteins allowing the uptake and extrusion of 
molecules while efflux pumps are transport proteins involved in mechanisms of drug 
extrusion. The main families of efflux transporters are: 1) resistance-nodulation-cell 
division family (RND), 2) small multidrug resistance family (SMR), 3) major facilitator 
superfamily (MFS), 4) multidrug and toxic compounds extrusion family (MATE), and 5) 
ATP-binding cassette superfamily (ABC). As shown in the figure, the drugs are pumped 
out of the cell by efflux pumps while H+ or Na+ are pumped into the cell. In the ABC family, 
the pumps are powered by adenosine triphosphate (ATP) which is hydrolysed to adenosine 
diphosphate (ADP) and inorganic phosphate. 
 
Efflux pumps are encoded by genes located in mobile genetic elements (MGE) or on the 
chromosome. Efflux pumps included in the first four groups (Figure 14) use proton 
exchange as source of energy while the ABC family necessitates the energy generated by 
adenosine triphosphate (ATP) hydrolysis. Among these groups, the efflux pumps belonging 
to the RND superfamily are associated with resistance to a wide range of antibiotics (e.g. 
tetracycline, some β-lactams, fluoroquinolones) and other toxic compounds like dyes, bile 
salts and disinfectants98. In particular, the efflux pumps MexAB-OprM and MexCD-OprJ 
play a role in resistance to carbapenems, fluoroquinolones and aminoglycosides, thus 
contributing to the multidrug resistance (MDR) in bacteria99. Moreover, MexCD-OprJ has 
been found in many clinical isolates of Pseudomonas aeruginosa100. Sometimes, the 
conjunct modulated expression of porins and efflux pumps can result in the resistance to 
different antibiotics as in the case of imipenem and carbapenems in Pseudomonas 
aeruginosa clinical strains101. The expression of efflux proteins is controlled by specific 
transcription factors and by mutations localised in genes encoding these proteins or their 
molecular regulators. A deeper comprehension of molecular basis of the expression of 
efflux pumps could be helpful in preventing antibiotic efflux mechanisms and in designing 
novel therapeutics to prevent the overexpression of these proteins.  
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4.1.3 Change in target site 
The target alteration is one of the mechanisms used by bacteria to induce antibiotic 
resistance. Indeed, most antibiotics exert their activities by binding to a specific target, 
preventing its function and consequently killing the bacteria or inhibiting their growth. As 
shown in Figure 15, the target modification comprises: i) the mutation in gene encoding 
the target; ii) the enzymatic modification of the target; and iii) the substitution of the 
classical target. 
During a bacterial infection, a point mutation could compromise the functionality of an 
antibiotic target (see Figure 15A) so generating a strain with a resistance to the antibiotic 
which gives it a proliferative advantage over the strains without the mutation. The bacterial 
ribosome represents a major antibiotic target and the linezolid resistance is an example 
of target alteration. Briefly, the 23S ribosomal ribonucleic acid (rRNA), a linezolid target, 
may undergo a series of mutational events which decrease its affinity binding to the 
linezolid and induce the resistance reducing the efficiency of the antibiotic . However, as 
the genes encoding for the ribosomal target exist in multiple copies, the accumulation of 
mutations is necessary to observe a functional effect 102. Another example of mutational 
alteration is the rifampicin (RIF) resistance due to a single-step point mutation event of 
the DNA-dependent RNA polymerase enzyme which inhibits the ability of RIF to block the 
bacterial transcription permitting this process to continue103.  
The modification of an antimicrobial target may involve not only mutational changes but 
can also be mediated by a chemical alteration of the target  (see Figure 15A). The 
erythromycin ribosomal methylation (erm) gene encodes for an enzyme which catalyses 
the methylation of the 23S rRNA and results in the resistance to macrolide, lincosamine 
and streptogramin B87. The methylation of the target can be also mediated by the 
chloramphenicol-florfenicol resistance methyltrasferase. This enzyme specifically 
methylates the 23S rRNA and prevents its binding to phenicols, lincosamides, 
pleuromutilins and streptogramin A104.  
Another route to inhibit the antimicrobial activity is the replacement of natural targets with 
new molecules having a low affinity for the drug (see Figure 15B). This is the case of the 
Penicillin Binding Protein 2a (PBP2a) which acts as a substitute of the original Penicillin 
Binding Protein (PBP). As shown in Figure 15B, the protein PBP2a is expressed in 
methicillin-resistant Staphylococcus aureus (MRSA) by the acquired foreign gene mecA 
whose induction confers the resistant phenotype. The mecA gene is located in a gene 
cassette and scientific evidences suggest the high mobility rate of the allele. The methicillin 
binds weakly to the PBP2a thus enabling the bacteria to survive despite high levels of 
antibiotics105.  
The vancomycin resistance is another example of target alteration. Vancomycin blocks the 
bacterial cell wall synthesis by binding the terminal residues D-Alanine-D-Alanine (D-Ala-
D-Ala) of peptidoglycan precursors. In vancomycin resistant strains, the D-Ala-D-Ala 
moiety of the growing peptidoglycan is substituted by the D-Lactate-D-Lactate or D-
Serine-D-Serine groups and the affinity of vancomycin to its target is significantly reduced. 
Another mechanism is the destruction of the terminal group D-Ala-D-Ala preventing the 
binding between the antibiotic and its target106. 
 
 
  
 
Figure 15. Mechanisms of antimicrobial resistance. A. A target alteration can be mediated by mutations or enzymatic  
modifications generating a protein (modified target) with reduced or null affinity for the antibiotics (e.g. β-lactamases, 
aminoglycosides, glycopeptides, macrolides, tetracyclines, sulfonamides). B. Substitution of the classical target can occur in β-
lactams resistant bacteria (e.g. methicillin-resistant Staphylococcus aureus (MRSA)) where a resistance gene codifies for an altered 
form of Penicillin Binding Protein (PBP), called Penicillin Binding Protein 2a (PBP2a), which has a reduced affinity for β-lactams 
antibiotics. When PBP2a is expressed, it binds weakly to the antibiotics enabling bacteria to survive.  
 
38 
 39 
 
4.2 Antibiotic resistance in aquatic systems 
Aquatic ecosystems contribute to the ecological productivity and provide many services to 
the society. These services include water for drinking, irrigation, and recreational 
activities. The quality and access to safe water is a matter of great importance. It is indeed 
known that pathogen contamination of water resources has a potential health risk and the 
recent spread of antibiotic resistance bacteria make this risk even more severe107. 
Moreover, antibiotic resistance has developed over time from a single antibiotic resistance 
to a multidrug resistance108. Multidrug resistant bacteria are insensitive to the 
administrated microbial medicines (which have different structures and molecular targets) 
and facilitate the spread of antibiotic resistance because of the failure of the microbial 
responses to standard treatments which can lead to a protracted illness109.  
Water is not only a way to disseminate antibiotic resistance genes (ARG) among human 
and animal populations but also a route by which ARG are introduced in natural 
ecosystems110. The resistant bacteria in the environment can act as an unlimited source 
of resistance genes not yet encountered in human pathogens and these genes can be then 
introduced in clinic, and vice versa9,88. An example of a direct exchange between the 
environmental and clinical resistome (defined as the complete set of resistance genes in 
bacteria) is given by the identification of the quinolone resistance gene qnr110-112. This 
gene was first detected in clinical isolates of Klebsiella pneumoniae in United States (USA) 
and it was more recently found in Shewanella algae (a Gram-negative species widely 
distributed in marine and freshwater) and in Aeromonas spp. in the Seine River 
(France)113-115. 
Resistant bacteria can be induced in the environment under selection pressures of the 
antibiotics and when this pressure disappears, ARG are not readily lost116, meaning that 
ARG can be also detected in waterbodies without antibiotic contamination117,118.  
Several studies have investigated the presence of ARG in wastewater treatment plant 
(WWTP) effluents, where the maximal antibiotic concentrations, according to the data 
collected from the literature (see Table A in the Annex I), are usually between 0.1 µg/L 
and 1 µg/L119. One hundred and twenty-three different plasmid-encoded resistance-gene-
specific amplicons have been detected in bacteria isolated from the effluent of a WWTP in 
Germany. Some of the genes detected are known to confer resistance to β-lactam, 
chloramphenicol, fluoroquinolone, tretracycline and sulfonamide antibiotics120. Another 
study reported the expression of ARG forquinolones, tetracyclines and sulfonamides in 
two WWTP in China and showed that the gene abundance decreased in the WWTP effluents 
respect to the influents121.  
From WWTP, ARG can be spread to different aquatic compartments such as lakes and 
rivers. A study showed that ARG for sulfonamide (sul), tetracycline (tet) and quinolone 
(qnr) antibiotics were widely distributed in selected urban lakes in China122. The abundance 
and diversity of 258 ARG were investigated in a highly polluted urban river in eastern 
China, and a Rijksinstituut voor Volksgezondheid en Milieu (RIVM) report showed high-
levels of ampicillin-, aminoglycoside- and quinolone-resistant bacteria in the rivers Meuse, 
Rhine and New Meuse123,124.  
  
When bacteria adhere to surfaces in aqueous environments, they can form a complex 
matrix known as biofilm. These biofilms may be composed of a single species or, more 
frequently, by a complex community of microorganisms125. Biofilms represent a reservoir 
of ARG but their role in the acquisition and spread of antibiotic resistance has not been 
fully investigated in aquatic systems125. In biofilms, the antibiotic resistance is probably 
due to a combination of factors including a poor antibiotic penetration, the presence of 
slow-growing or stationary phase-cells and an altered microenvironment in which the 
oxygen availability and pH gradients may impact the antibiotic efficacy126. A study reported 
the expression of ARG for β-lactams, tetracyclines and sulfonamides in biofilms samples 
collected in WWTP in Spain and showed a significant increase in the relative abundances 
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of ARG when the samples were collected downstream of the WWTP discharge127. In New 
Zealand, ARG including one which conferred resistance to vancomycin were detected in 
freshwater biofilms collected in Taieri River128. The discovery that ARG are also expressed 
in biofilms in water contributes to a better understanding of the spread and persistence of 
antibiotic resistance in the environment. 
 
4.3 Co-selection of antibiotic resistance  
Non-antibiotic compounds like biocides and heavy metals may promote the antibiotic 
resistance through a phenomenon called co-selection129-134. As shown in Figure 16, co-
selection occurs when a biochemical mechanism induces resistance to different compounds 
(e.g. biocides/metals and/or antibiotics) (cross-resistance), when genes conferring 
resistant phenotyphes are located on the same genetic element (e.g. resistance genes for 
antibiotics and/or metals/biocides) (co-resistance), or when a resistance gene for different 
substances (e.g. biocides/metals and/or antibiotics) is regulated by a single regulatory 
gene (co-regulation). 
Biocides have a broad spectrum of antimicrobial activity and are commonly used as 
disinfectants in hospitals and farms as well as preservatives in pharmaceutical products, 
cosmetics and food135. Heavy metals are also used as antimicrobial agents in hospitals, 
industries and agricultures136. For example, urinary catheter coated with silver (Ag) 
showed a significant reduction of urinary tract infections in hospitalised patients137. 
The exposure of bacteria to environmental pollutants could result in a selection of 
resistance genes to biocides/metals and antibiotics132. 
 
 
Figure 16. Co-selection mechanisms of antibiotic resistance. Antibiotic resistance 
can be co-selected through different mechanisms such as: A. Co-resistance that occurs 
when two or more genes are located on the same genetic element, B. Cross-resistance 
that takes place when one resistance mechanism provides resistance for different 
substances (e.g. antibiotics and/or metals) and C. Co-regulation that occurs when 
resistance genes for different substances (e.g. antibiotics and/or metals) are regulated by 
a single regulatory gene. AntibioticR stands for antibiotic resistance; MetalR stands for 
metal resistance. 
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The co-selection process is mainly caused by co-resistance and cross-resistance (Figure 
16). The co-resistance occurs when two or more genes that codify resistance to different 
agents are located on the same genetic element such as a plasmid (Figure 16A)132. These 
genetic elements can be transferred from one bacterium to another by horizontal gene 
transfer, hence causing the spread of resistance (see section 4.1)138,139. Resistance genes 
can also be carried in integrons, mobile genetic elements that play an important role in 
the worldwide dissemination of antibiotic resistance132,140. Class I integrons are assumed 
to catalyse co-selection because they often contain gene cassets that mediate resistance 
to antibiotics. Although they were originally associated with transposons and/or plasmids, 
they have also been detected on chromosomes141. A study in freshwater biofilms has 
demonstrated a dynamic exchange of gene cassets between different integron classes 
found in environmental, commensal and pathogenic bacteria allowing them to rapidly 
adapt to new environmental conditions142.  
Cross-resistance refers to the presence of a single mechanism that provides resistance to 
more than one substance (Figure 16B)143. It can occur when a single efflux pump can 
provide resistance to different classes of antibiotics and other substances such as 
metals100,144. Cross-resistance can also be mediated by mutations such as those observed 
in the cell membrane of Pseudomonas aeruginosa which confer resistance to different 
antibiotics as a consequence of a lower cell wall permeability and the activation of efflux 
systems145,146.    
The co-regulation mechanism happens when multiple resistance genes that provide 
resistance to different compounds are regulated by a single regulatory gene (Figure 
16C)132. For example, the overexpression of efflux pumps and the simultaneous 
downregulation of porin pathways seem to be an effective mechanism to prevent 
intracellular accumulation of different substances147. 
Bacteria can be found in large proportions in aquatic systems, and their exposure to 
different chemical pollutants has the potential to allow them to develop resistance to 
different compounds, even to ones that they have never been exposed to, so increasing 
the risk of selecting organisms adapted to antibiotic agents131. Considering the levels of 
metal pollution in the environment, of particular concern is the role that these substances 
can play in the maintenance and spread of resistance to antibiotics. 
 
4.3.1 Heavy metals and resistance mechanisms 
Heavy metals are metals with a density above 5 g/cm3 and their distribution in the 
environment is governed by natural and human activities. Potential sources of heavy 
metals include soil erosion, mining, industrial wastes, urban and agricultural runoff, 
insecticides applied to crops, and many others. Heavy metals are persistent in the 
environment where they tend to accumulate causing damages to plants and animals148,149.  
Some heavy metals such as zinc (Zn), nickel (Ni) and copper (Cu) are physiologically 
essential for biological systems while others like mercury (Hg) and cadmium (Cd), have 
no known biological functions133,150.  
Most of the heavy metals are non-toxic for humans at low concentrations, however they 
can become toxic at higher concentrations151,152. They are often used as antimicrobial 
agents and some metals and products containing metals are also used in medicine for 
treatment of various diseases. For example, arsenic (As) has been administered to patients 
with acute promyelocytic leukemia, and bismuth (Bi) has been used for treating infections 
caused by Helicobacter pylori or against gastric lymphoma153. Other metals such as Cu, 
Zn, Cd and As are used in agricultural activities as growth promoters, fungicides and 
herbicides, as well as antifouling in fish farms133,154-157.  
In bacteria, heavy metal toxicity also depends on their concentration even if some metals 
like silver (Ag) and Hg are poisonous at very low concentrations136. In order to avoid 
cellular damage, bacteria have evolved regulatory mechanisms of resistance to metals. 
Metal-resistant bacteria were first detected by Moore and his team in 1960, when Hg 
resistant (HgR) bacteria (Staphylococcus aureus) were isolated from wounds143. Some 
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studies have then showed evidences that heavy metals can induce co-selection of 
antimicrobial resistance in bacteria132,133. In 2016, Lloyd and her team found that bacteria 
with resistance to three or more antibiotics were more common in HgR isolates than in Hg-
sensitive (HgS) isolates158. Figure 17 shows the three main metal resistance mechanisms 
are known in bacteria133,136: A) extracellular sequestration of metals, which minimises the 
concentration of free metal ions in the cell; B) reduction of metal uptake and increased 
elimination of toxic metals by efflux systems; C) inactivation of metals through reduction 
of intracellular ions by enzymes like the Hg reductase (MerA) which reduces Hg ions (Hg2+) 
to the less toxic form, the elemental Hg (Hg0); and D) repair mediated by cellular 
chaperones, enzymes or antioxidants of molecules that are vulnerable to oxidation by 
metals.  
It was also observed that metal resistance shares the common mode of actions which 
confer resistance to antibiotics. These mechanisms are listed in Table 5.  
  
 
 
 
Figure 17. Metal resistance mechanisms in bacteria. A. Sequestration of metals; B. 
Reduction of metal uptake and increase of efflux outside the cell; C. Inactivation of metals 
in a less toxic form (e.g. from Hg2+ to Hg0); D. Repair of molecules vulnerable to oxidation 
by metals which is mediated by cellular chaperones, enzymes or antioxidants. 
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Table 5. List of common resistance mechanisms between heavy metals and 
antibiotics 
 
As: arsenic; Ag: silver; Cd: cadmium; Co: cobalt; Cu: copper; Hg: mercury; Mn: 
manganese; Ni: nickel; Zn: zinc. 
 
 
Antibiotic and metal resistance can be associated with co-selection mechanisms in which 
genes encoding resistance to both metals and antibiotics may reside in the same genetic 
element (co-resistance) or when there is a coregulation of resistance genes expression 
(co-regulation) or again, when a single mechanism is responsible for the induced 
resistances (cross-resistance) (see Figure 16)159.  
Multidrug efflux pumps can extrude a variety of compounds including antibiotics and heavy 
metals mainly through cross-resistance mechanisms100. An example is the multidrug efflux 
pump in Listeria monocytogenes which can export metals and antibiotics160. 
In 2016, Fang and co-authors described that in Escherichia coli strains isolated from 
diseased food-producing animals, genes encoding efflux systems to detoxify Cu, Ag and 
As co-existed with antimicrobial and heavy metal resistance determinants on the same 
plasmids, giving an example of co-resistance138. Co-resistance of Hg-resistant bacteria 
(HgR) to antibiotics has been observed in a study where the Hg exposure in fish increased 
the expression of the Hg reductase gene (merA), providing resistance to Hg and showing 
a higher probability for these bacteria to be resistant to multiple antibiotics compared to 
the Hg-sensitive bacteria158. As an example of co-regulation, a study performed in 
Pseudomonas aeruginosa showed that the expression of an efflux system conferring 
resistance to Zn, Cd and cobalt (Co) was regulated by mechanisms also responsible for 
the resistance to carbapenems147. 
A study in China found a significant positive correlation between antibiotic resistance genes 
(ARG) and metals like Cu, Zn, and Hg in agricultural soil and manure showing the potential 
role of heavy metals in the co-selection of antibiotic resistance. In the same study, the 
correlation between ARG and the corresponding antibiotic concentration was instead much 
weaker161. Similar results were found in Western Australia, where even low concentrations 
of metals could select antibiotic resistance in residential soil underlying the possible 
contribution of metals in the spread of ARG162.  
 
4.3.2 Heavy metals and co-selection in water 
As heavy metals are persistent in the environment, metal contamination may act as a 
long-term selective pressure for antibiotic resistance. Indeed, while most antibiotics are 
readily degraded in water, metals are not and they can accumulate in natural ecosystems, 
including water. A positive correlation between antibiotics and heavy metals 
concentrations has been indeed observed in water samples collected in the final effluents 
of two wastewater treatment plants (WWTP) in China. A significant correlation was in 
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particular found between antibiotic resistance genes (ARG) and the concentration of 
arsenic (As), zinc (Zn), lead (Pb) and mercury (Hg), suggesting that their combined 
presence in WWTP may favour the propagation of ARG121. In another study in China, a 
cluster analyses was used to assess a positive correlation between the expression of ARG 
and the concentration of anthropogenic pollutants (antibiotics and metals) in three artificial 
city park lakes122.   
To address the molecular mechanisms involved in the association between metal exposure 
and the spread of ARG, water samples collected from three different WWTP in Italy were 
analysed for the abundance of ARG and heavy metals. A stric t correlation between the 
expression of the class I Integron gene (int1), the ARG for sulfonamides (sulII), and the 
two genes czcA and arsB, the first encoding resistance for cadmium (Cd), cobalt (Co) and 
Zn, and the second for As was also identified suggesting a mechanism of co-selection 
between ARG and metals in water163. In Colorado, candidates for co-selection were 
identified using the high-throughput DNA sequencing in order to obtain a metagenomic  
profile of ARG and metal resistance genes (MRG) in river waters164. The same 
metagenomic approach was performed in samples derived from influents and effluents of 
Korean WWTP. Also in this case, both ARG and MRG were detected in the microbial 
community165.  
Other studies tried to investigate the relationship between the antibiotic and heavy metal  
resistance but they did not focus on the molecular mechanisms involved in this association. 
A bacterial strain highly resistant to Cd (the Minimal Inhibitory Concentration – MIC, 
intended as the minimal concentration that inhibits the growth of a microorganism, was 
250 mg/L), penicillin and ampicillin was isolated from electronic industry effluents during 
a study aimed at finding novel bacterial strains to be used in bioremediation techniques166. 
A concomitant antibiotic and heavy metal resistance was observed in Hg-resistant bacteria 
isolated from different sampling sites in an Indian river contaminated with heavy metals  
including chromium (Cr), Pb and Hg. Specifically, Hg-resistant bacteria were found to be 
resistant to different metals and in particular to Pb and copper (Cu), suggesting that the 
resistance to both metals and antibiotics may be genetically linked by co-selection. Hg-
resistant bacterial strains checked for the antibiotic resistance pattern showed that the 
isolates were also sensitive to antibiotics like teicoplanin, azithromycin and vancomycin. 
The contamination of water with Hg may therefore act as a driving force for the carriage 
of ARG in water167. Again, in Turkey, samples were collected from seawater and sediment  
in a polluted Bay. Gram-negative bacterial strains were isolated from water samples and 
tested for their susceptibility to different antibiotics. The MIC for metals (Cd, Cu, Pb, Cr 
and manganese (Mg)) was also derived. More specifically, it was found that metal 
resistant-bacteria isolated from seawater also showed the resistance to streptomycin, 
ampicillin and trimethoprim-sulphamethoxazole168. A similar study was performed by the 
same authors and in the same marine environment (in Turkey) but this time it was focused 
only on Aeromonas spp. and Pseudomonas spp. and the authors found strains that were 
resistant to both metals and antibiotics169. The bacterial tolerance to metals and antibiotics 
was also checked in an American study conducted in two streams where the incubation of 
bacteria with different antibiotics and metals showed a positive correlation between the 
antibiotic and metal tolerance values. This evidence supported the hypothesis that metal 
contamination may result in an increased frequency of antibiotic resistance in bacteria170. 
In a microcosm study, freshwater bacteria have been exposed to individual metals and 
antibiotics and it was observed that each pollutant selected for multiresistant  
microorganisms. The antibiotic concentrations used in this study were higher than the 
levels detected in waterbodies, while the metal concentrations applied were in a more 
environmentally realistic ranges, underlying that metals, rather than antibiotics, may 
select for ARG in water171. Additionally, the occurrence of antibiotic and metal resistance 
was investigated in the River Indus, the major river in Pakistan, where the discovery of 
bacteria resistant to both antibiotics and metals suggested a possible concomitant gene 
regulation by these pollutants through co-selection. 
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As described above, most of the studies performed in water did not analyse the 
relationship between metal and antibiotic resistance at molecular level but they 
determined the levels of resistance after exposure of bacteria to these pollutants. More 
studies are therefore needed to better understand the molecular mechanisms involved in 
the association between antibiotics and metals in water and also to assess the presence 
of plasmid-encoded resistance genes.  
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5. Conclusions  
Antibiotic resistance represents a European and global problem which has already reached 
high levels of concern in many parts of the world. Aquatic environments are considered a 
reservoir of antibiotic resistance determinants and the identification of the abundance and 
distribution of antibiotics and antibiotic resistance genes (ABR) in waterbodies can aid in 
establishing how antrophogenic inputs affect their spread and which strategies could be 
developed to combat this worldwide issue. In this technical report, a review of the global 
scientific literature was conducted to analyse the levels of antibiotics in water (e.g. 
wastewater treatment plants (WWTP), surface waters, drinking water). For WWTP, the 
monitoring data collected were related to 45 antibiotics from 13 countries all over the 
world. Most of the data came from Europe (79.2%) and for the antibiotics detected, the 
concentrations were in the range of 0,1-1 µg/L. The antibiotics sulfamethoxazole, 
trimethoprim and ciprofloxacin were the most frequently observed in WWTP effluents. 
Similar concentrations of antibiotics were also reported in surface waters, although a 
reduction in their levels due to the dilutions of these substances from effluents into 
receiving water should have been expected. Complementary to the literature data, 
measured concentrations of antibiotics were also gathered from a European database 
containing more than 16.6 million records for 1390 individual substances monitored for 
the period from 2006 to 2014. Data show that among 35 antibiotics, sulfamethoxazole 
and sulfamethazine were the most frequently monitored in Europe.  
Concerning drinking water, antibiotic residues are unlikely to be considered as a potential 
risk to humans. Indeed, the detected antibiotic concentrations in drinking water (DW) are 
usually low and in the range of ng/L. A particular attention should be instead posed to the 
aquaculture. So far, there is little research available reporting the occurrence of antibiotics 
in this sector. Unless in Europe the use of antibiotics in aquacultures is carefully managed 
and aquaculture products must not contain pharmacologically active substances above an 
established Maximum Residue Limit (MRL) (Commission Regulation (EU) No 37/2010172), 
there is anyway a need to have public data available to be aware of the antibiotic residues 
in aquaculture products. Aquaculture is indeed considered the fastest growing animal food-
producing sector and it is estimated to account for approximately half of the total food-
fish supply. It is therefore necessary to prevent the bacterial diseases in aquaculture 
products and the use of vaccines could limit the use of chemicals and antibiotics in this 
sector.  
There are also evidences suggesting a link between the environmental resistome (defined 
as a collection of naturally-occurring antibiotic resistance genes in water and soil) and 
clinically relevant resistance genes; moreover, a deeper knowledge about how the genes 
are transferred from the environment to the clinic will be useful for the discovery and the 
management of antibiotics and for controlling the dissemination of antibiotic resistance. 
Metals, unlike antibiotics which are usually rapidly degraded in water, are more persistent 
in the environment and bacteria have evolved different mechanisms of resistance to 
tolerate their actions. Literature data show a co-selection between antibiotic resistance 
genes and genes conferring resistance to metals suggesting a role of heavy metals in the 
spreading of antibiotic resistance. However, for the majority of the studies, the antibiotic 
concentrations used to induce resistance were higher than the levels found in the 
environment and until now the potential molecular mechanisms to assess the role of 
metals as a selective force in the spread of the antibiotic resistance genes have been 
investigated in very few studies. Therefore, a clear and detailed understanding of the 
relationships between metals, antibiotics and the dissemination of antibiotic resistance 
need additional investigations, as well as new research should be carried out to define the 
minimal concentration of antibiotics which would induce the resistance. An environmental 
risk assessment for these substances needs to be defined taking into consideration the 
relative effects of the main determinants of antibiotic resistance and to estimate the risk 
of emergence and spread of this event.   
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Annex I 
Table A: Antibiotics in wastewater treatment plant (WWTP) effluents (*) 
Substance Country WWTP effluents / description MEC (µg/L) Reference 
Amoxicillin 
  
  
  
  
  
Italy Different WWTP effluents 0.0018 – 
0.120 
Andreozzi et 
al., 2004173 
Italy WWTP effluents 0.015 – 0.120 Castiglioni et 
al., 200531 
Australia WWTP effluent in Brisbane 0.270 (max) Watkinson et 
al., 200732 
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.258 (max) Gros et al., 
2013174 
Europe 90 WWTP effluents from 18 countries < 0.025 Loos et al., 
2013175 
Germany WWTP effluent in Dresden 0.187 (max) Rossmann et 
al., 2014176 
Ampicillin 
  
Greece WWTP effluent in Volos 0.151 (mean) Papageorgio
u et al., 
2016177 
Greece WWTP effluent in Volos 0.498 (max) Papageorgio
u et al., 
2016177  
Azithromycin 
  
  
  
  
  
  
  
  
  
  
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.085-0.592 Gros et al., 
2013174 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.050 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.22 (max) Golovko et 
al., 2014178 
Germany WWTP effluent in Dresden 0.277 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 0.956 (max) Rossmann et 
al., 2014176 
Slovakia WWTP effluents (n=2) 0.504 (mean) Birošová et 
al., 2014179 
Slovakia WWTP effluents (n=2) 1.2 (max) Birošová et 
al., 2014179 
Spain WWTP effluents in Girona  0.135 (max) Rodriguez-
Mozaz et al., 
201529 
Portugal WWTP effluents (n=15) 0.007 (mean) Pereira et 
al., 201530 
Portugal WWTP effluents (n=15) 0.2 (max) Pereira et 
al., 201530 
England 
(south) 
WWTP effluents (n=4) 0.035 – 0.264 Johnson et 
al.; 2017180 
Cefaclor Australia WWTP effluent in Brisbane 0.800 (max) Watkinson et 
al., 200732 
Cefazolin Spain WWTP effluents in Girona  0.025 (max) Rodriguez-
Mozaz et al., 
201529 
Cefotaxime 
  
Spain WWTP effluents in Girona  0.229 (max) Rodriguez-
Mozaz et al., 
201529 
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Germany WWTP effluent in Dresden 0.217 (max) Rossmann et 
al., 2014176 
Cefuroxime 
  
Germany WWTP effluent in Dresden 0.599 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 2.0 (max) Rossmann et 
al., 2014176 
Cephalexin Australia WWTP effluent in Brisbane 3.9 (max) Watkinson et 
al., 200732 
Chloramphenicol 
  
UK WWTP effluent Coslech (Wales) 0.021 (mean) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent Coslech (Wales) 0.069 (max) Kasprzyk-
Hordern et 
al., 2009181 
Chlorotetracycline Australia WWTP effluent in Brisbane 0.005 (max) Watkinson et 
al., 200732 
Ciprofloxacin 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
USA WWTP effluents (n=2) 0.130 
(median) 
Renew et al., 
200424 
USA WWTP effluents (n=2) 0.370 (max) Renew et al., 
200424 
Italy WWTP effluents 0.027 – 0.514 Castiglioni et 
al., 200531 
USA WWTP effluents (n=3) 5.6 (max) Batt et al., 
200628 
Australia WWTP effluent in Brisbane 0.640 
(median) 
Watkinson et 
al., 200732 
Australia WWTP effluent in Brisbane 6.9 (max) Watkinson et 
al., 200732 
China WWTP effluent 0.037 (mean) Jia et al., 
2012182 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.70 
(median) 
Gracia-Lor et 
al., 2012183 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
1.1 (max) Gracia-Lor et 
al., 2012183 
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
7.4 (max) Gros et al., 
2013174 
Europe 90 WWTP effluents from 18 countries 0.096 
(mean); 
0.264 (max) 
Loos et al., 
2013175 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.065 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.19 (max) Golovko et 
al., 2014178 
Germany WWTP effluent in Dresden 0.146 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 0.920 (max) Rossmann et 
al., 2014176 
Slovakia WWTP effluents (n=2) 0.211 (mean) Birošová et 
al., 2014179 
Slovakia WWTP effluents (n=2) 0.338 (max) Birošová et 
al., 2014179 
Spain WWTP effluents in Girona  0.175 (max) Rodriguez-
Mozaz et al., 
201529 
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Portugal WWTP effluents (n=15) 0.137 (mean) Pereira et 
al., 201530 
Portugal WWTP effluents (n=15) 0.836 (max) Pereira et 
al., 201530 
Greece WWTP effluent in Volos 0.199 (mean) Papageorgio
u et al., 
2016177 
Greece WWTP effluent in Volos 0.591 (max) Papageorgio
u et al., 
2016177 
Portugal WWTP effluent in Beirolas, Lisbon 0.35 
(median) 
de Jesus 
Gaffney et 
al., 201725 
Portugal WWTP effluent in Beirolas, Lisbon 1.4 (max) de Jesus 
Gaffney et 
al., 201725 
Clarithromycin 
  
  
  
  
  
  
  
  
  
  
  
  
Switzerland WWTP effluents (n=3) 0.057-0.328 McArdell et 
al., 2003184 
Italy WWTP effluents 0.008 – 0.059 Castiglioni et 
al., 200531 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.02 
(median) 
Gracia-Lor et 
al., 2012183  
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.06 (max) Gracia-Lor et 
al., 2012183 
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.113-0.973 Gros et al., 
2013174 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.93 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  2.31 (max) Golovko et 
al., 2014178 
Germany WWTP effluent in Dresden 0.366 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 1.8 (max) Rossmann et 
al., 2014176 
Slovakia WWTP effluents (n=2) 1.2 (mean) Birošová et 
al., 2014179 
Slovakia WWTP effluents (n=2) 1.8 (max) Birošová et 
al., 2014179 
Spain WWTP effluents in Girona  0.129 (max) Rodriguez-
Mozaz et al., 
201529 
England 
(south) 
WWTP effluents (n=4) 0.024 – 0.377 Johnson et 
al.; 2017180 
Clindamycin 
  
  
  
  
  
  
  
USA WWTP effluents (n=3) 1.0 (max) Batt et al., 
200628 
Australia WWTP effluent in Brisbane 0.005 
(median) 
Watkinson et 
al., 200732 
Australia WWTP effluent in Brisbane 0.005 (max) Watkinson et 
al., 200732 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.02 
(median) 
Gracia-Lor et 
al., 2012183 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.02 (max) Gracia-Lor et 
al., 2012183 
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Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.018-1.5 Gros et al., 
2013174 
Europe 90 WWTP effluents from 18 countries 0.070 
(mean); 
0.277 (max) 
Loos et al., 
2013175 
Germany WWTP effluent in Dresden 0.151 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 0.882 (max) Rossmann et 
al., 2014176 
Slovakia WWTP effluents (n=2) 0.056 (mean) Birošová et 
al., 2014179 
Slovakia WWTP effluents (n=2) 0.069 (max) Birošová et 
al., 2014179 
Clindamycin 
sulfoxide 
  
Germany WWTP effluent in Dresden 0.423 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 1.3 (max) Rossmann et 
al., 2014176 
Doxycycline 
  
  
  
Australia WWTP effluent in Brisbane 0.040 (max) Watkinson et 
al., 200732 
China WWTP effluent 0.632 (mean) Gao et al., 
2012185 
Germany WWTP effluent in Dresden 1.1 (max) Rossmann et 
al., 2014176 
Slovakia WWTP effluents (n=2) 0.008 (max) Birošová et 
al., 2014179 
Enoxacin Slovakia WWTP effluents (n=2) 0.008 (max) Birošová et 
al., 2014179 
Enrofloxacin 
  
  
  
Australia WWTP effluent in Brisbane 0.010 
(median) 
Watkinson et 
al., 200732 
Australia WWTP effluent in Brisbane 0.020 (max) Watkinson et 
al., 200732 
China WWTP effluent 0.002 (mean) Jia et al., 
2012182 
Slovakia WWTP effluents (n=2) 0.003 (max) Birošová et 
al., 2014179 
Erythromycin 
  
  
  
  
  
  
  
  
  
  
  
  
Switzerland WWTP effluents (n=3) 0.199 (max) McArdell et 
al., 2003184 
Italy WWTP effluents 0.009 – 0.353 Castiglioni et 
al., 200531 
UK WWTP effluent in Cilfynydd (Wales) 1.4 (mean) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent in Cilfynydd (Wales) 2.8 (max) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent Coslech (Wales) 0.696 (mean) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent Coslech (Wales) 2.8 (max) Kasprzyk-
Hordern et 
al., 2009181 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.08 
(median) 
Gracia-Lor et 
al., 2012183 
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  Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.12 (max) Gracia-Lor et 
al., 2012183 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.11 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.35 (max) Golovko et 
al., 2014178 
Slovakia WWTP effluents (n=2) 0.015 (mean) Birošová et 
al., 2014179 
Slovakia WWTP effluents (n=2) 0.020 (max) Birošová et 
al., 2014179 
Portugal WWTP effluent in Beirolas, Lisbon 0.51 
(median) 
de Jesus 
Gaffney et 
al., 201725 
Portugal WWTP effluent in Beirolas, Lisbon 2.8 (max) de Jesus 
Gaffney et 
al., 201725 
Fleroxacin China WWTP effluent 0.005 (mean) Jia et al., 
2012182 
Gatifloxacin China WWTP effluent 0.04 (mean) Jia et al., 
2012182 
Levofloxacin 
  
  
  
  
  
  
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.006 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.018 (max) Golovko et 
al., 2014178 
Germany WWTP effluent in Dresden 0.150 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 0.836 (max) Rossmann et 
al., 2014176 
Slovakia WWTP effluents (n=2) 0.042 (mean) Birošová et 
al., 2014179 
Slovakia WWTP effluents (n=2) 0.058 (max) Birošová et 
al., 2014179 
England 
(south) 
WWTP effluents (n=4) 0.047 (max) Johnson et 
al.; 2017180 
Lincomycin 
  
  
  
  
  
  
Italy WWTP effluents 0.011 – 0.846 Castiglioni et 
al., 200531 
Australia WWTP effluent in Brisbane 0.050 
(median) 
Watkinson et 
al., 200732 
Australia WWTP effluent in Brisbane 0.070 (max) Watkinson et 
al., 200732 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.01 
(median) 
Gracia-Lor et 
al., 2012183 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.16 (max) Gracia-Lor et 
al., 2012183 
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.119 (max) Gros et al., 
2013174 
Europe 90 WWTP effluents from 18 countries 0.031 
(mean); 
0.317 (max) 
Loos et al., 
2013175 
Lomefloxacin China WWTP effluent 0.071 (mean) Jia et al., 
2012182 
Marbofloxacin Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.096 (max) Gros et al., 
2013174 
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Metronidazole 
  
  
  
  
  
  
UK WWTP effluent in Cilfynydd (Wales) 0.265 (mean) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent in Cilfynydd (Wales) 0.421 (max) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent Coslech (Wales) 0.353 (mean) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent Coslech (Wales) 0.561 (max) Kasprzyk-
Hordern et 
al., 2009181 
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.017-0.643 Gros et al., 
2013174 
Spain WWTP effluents in Girona  0.144 (max) Rodriguez-
Mozaz et al., 
201529 
Greece WWTP effluent in Volos 0.035 (max) Papageorgio
u et al., 
2016177 
Monesin Australia WWTP effluent in Brisbane 0.010 (max) Watkinson et 
al., 200732 
Moxifloxacin 
  
  
  
  
China WWTP effluent 0.04 (mean) Jia et al., 
2012182 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.16 
(median) 
Gracia-Lor et 
al., 2012183 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.18 (max) Gracia-Lor et 
al., 2012183 
Greece WWTP effluent in Volos 0.085 (mean) Papageorgio
u et al., 
2016177 
Greece WWTP effluent in Volos 0.298 (max) Papageorgio
u et al., 
2016177 
Nalidixic acid Australia WWTP effluent in Brisbane 0.055 (max) Watkinson et 
al., 200732 
Norfloxacin 
  
  
  
  
  
  
  
  
  
Australia WWTP effluent in Brisbane 0.025 
(median) 
Watkinson et 
al., 200732 
Australia WWTP effluent in Brisbane 0.145 (max) Watkinson et 
al., 200732 
China WWTP effluent 0.256 (mean) Jia et al., 
2012182 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.13 
(median) 
Gracia-Lor et 
al., 2012183 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.15 (max) Gracia-Lor et 
al., 2012183 
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.327 (max) Gros et al., 
2013174 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.083 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.25 (max) Golovko et 
al., 2014178 
Slovakia WWTP effluents (n=2) 0.021 (mean) Birošová et 
al., 2014179 
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Slovakia WWTP effluents (n=2) 0.033 (max) Birošová et 
al., 2014179 
Ofloxacin 
  
  
  
  
  
  
USA WWTP effluents (n=2) 0.255 
(median) 
Renew et al., 
200424 
USA WWTP effluents (n=2) 0.350 (max) Renew et al., 
200424  
Italy WWTP effluents 0.150 – 1.1 Castiglioni et 
al., 200531 
China WWTP effluent 0.528 (mean) Jia et al., 
2012182 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.44 
(median) 
Gracia-Lor et 
al., 2012183 
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.063-10.3 Gros et al., 
2013174 
Spain WWTP effluents in Girona  0.172 (max) Rodriguez-
Mozaz et al., 
201529 
Oxytetracycline 
  
  
Australia WWTP effluent in Brisbane 0.020 (max) Watkinson et 
al., 200732 
China WWTP effluent 0.021 (mean) Gao et al., 
2012185 
England 
(south) 
WWTP effluents (n=4) 0.017 – 0.602 Johnson et 
al.; 2017180 
Penicilline V 
  
  
Australia WWTP effluent in Brisbane 0.030 
(median) 
Watkinson et 
al., 200732 
Australia WWTP effluent in Brisbane 0.080 (max) Watkinson et 
al., 200732 
Europe 90 WWTP effluents from 18 countries 0.029 
(mean); 
0.122 (max) 
Loos et al., 
2013175 
Pipemidic acid 
  
  
China WWTP effluent 0.033 (mean) Jia et al., 
2012182 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.10 
(median) 
Gracia-Lor et 
al., 2012183 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.12 (max) Gracia-Lor et 
al., 2012183 
Piperacillin 
  
Germany WWTP effluent in Dresden 0.274 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 1.2 (max) Rossmann et 
al., 2014176 
Roxithromycin 
  
  
  
Switzerland WWTP effluents (n=3) 0.031 (max) McArdell et 
al., 2003184 
Australia WWTP effluent in Brisbane 0.100 (max) Watkinson et 
al., 200732 
Germany WWTP effluent in Dresden 0.084 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 0.281 (max) Rossmann et 
al., 2014176 
Sparfloxacin China WWTP effluent 0.001 (mean) Jia et al., 
2012182 
Spiramycin Italy WWTP effluents 0.001 – 0.161 Castiglioni et 
al., 200531 
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China WWTP effluent 0.027 (mean) Gao et al., 
2012185 
Europe 90 WWTP effluents from 18 countries 0.004 
(mean); 
0.105 (max) 
Loos et al., 
2013175 
Greece WWTP effluent in Volos 0.194 (max) Papageorgio
u et al., 
2016177 
Sulfamethoxazole 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
USA WWTP effluents (n=2) 0.485 
(median) 
Renew et al., 
200424 
USA WWTP effluents (n=2) 1.6 (max) Renew et al., 
200424 
Italy WWTP effluents 0.046 – 0.317 Castiglioni et 
al., 200531 
USA WWTP effluents (n=3) 6.0 (max) Batt et al., 
200628 
Australia WWTP effluent in Brisbane 0.270 
(median) 
Watkinson et 
al., 200732 
Australia WWTP effluent in Brisbane 0.570 (max) Watkinson et 
al., 200732 
UK WWTP effluent in Cilfynydd (Wales) 0.010 (mean) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent in Cilfynydd (Wales) 0.023 (max) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent Coslech (Wales) 0.019 (mean) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent Coslech (Wales) 0.044 (max) Kasprzyk-
Hordern et 
al., 2009181 
China WWTP effluent 0.192 (mean) Gao et al., 
2012185 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.05 
(median) 
Gracia-Lor et 
al., 2012183 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.06 (max) Gracia-Lor et 
al., 2012183 
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.019-0.198 Gros et al., 
2013174 
Europe 90 WWTP effluents from 18 countries 0.142 
(mean); 1.1 
(max) 
Loos et al., 
2013175 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.090 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.26 (max) Golovko et 
al., 2014178 
Greece WWTP effluents (n=8) 0.481 (max) Kosma et al., 
2014186 
Germany WWTP effluent in Dresden 0.199 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 8.3 (max) Rossmann et 
al., 2014176 
Slovakia WWTP effluents (n=2) 0.049 (mean) Birošová et 
al., 2014179 
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Slovakia WWTP effluents (n=2) 0.108 (max) Birošová et 
al., 2014179 
Spain WWTP effluents in Girona  0.073 (max) Rodriguez-
Mozaz et al., 
201529 
Greece WWTP effluent in Volos 0.020 (mean) Papageorgio
u et al., 
2016177 
Greece WWTP effluent in Volos 0.080 (max) Papageorgio
u et al., 
2016177 
England 
(south) 
WWTP effluents (n=4) 0.227 (max) Johnson et 
al.; 2017180 
Portugal WWTP effluent in Beirolas, Lisbon 0.69 
(median) 
de Jesus 
Gaffney et 
al., 201725 
Portugal WWTP effluent in Beirolas, Lisbon 2.0 (max) de Jesus 
Gaffney et 
al., 201725 
Sulfapyridine 
  
  
  
  
  
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.059 (max) Gros et al., 
2013174 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.055 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.20 (max) Golovko et 
al., 2014178  
Slovakia WWTP effluents (n=2) 0.078 (mean) Birošová et 
al., 2014179 
Slovakia WWTP effluents (n=2) 0.120 (max) Birošová et 
al., 2014179 
Portugal WWTP effluent in Beirolas, Lisbon 0.28 
(median) 
de Jesus 
Gaffney et 
al., 201725 
Portugal WWTP effluent in Beirolas, Lisbon 1.5 (max) de Jesus 
Gaffney et 
al., 201725 
Sulfasalazine 
  
  
  
  
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.050 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.83 (max) Golovko et 
al., 2014178 
Slovakia WWTP effluents (n=2) 0.055 (mean) Birošová et 
al., 2014179 
Slovakia WWTP effluents (n=2) 0.124 (max) Birošová et 
al., 2014179 
Australia WWTP effluent in Brisbane 0.010 (max) Watkinson et 
al., 200732 
Sulfathiazole Australia WWTP effluent in Brisbane 0.005 (max) Watkinson et 
al., 200732 
Tetracycline 
  
  
  
USA WWTP effluents (n=3) 0.56 (max) Batt et al., 
200628 
Australia WWTP effluent in Brisbane 0.030 (max) Watkinson et 
al., 200732 
Slovakia WWTP effluents (n=2) 0.003 (max) Birošová et 
al., 2014179 
England 
(south) 
WWTP effluents (n=4) 0.045 – 0.133 Johnson et 
al.; 2017180 
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Trimethoprim 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
USA WWTP effluents (n=2) 0.373 
(median) 
Renew et al., 
200424 
USA WWTP effluents (n=2) 1.2 (max) Renew et al., 
200424 
USA WWTP effluents (n=3) 0.53 (max) Batt et al., 
200628 
Australia WWTP effluent in Brisbane 0.050 
(median) 
Watkinson et 
al., 200732 
Australia WWTP effluent in Brisbane 0.480 (max) Watkinson et 
al., 200732 
UK WWTP effluent in Cilfynydd (Wales) 1.2 (mean) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent in Cilfynydd (Wales) 3.1 (max) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent Coslech (Wales) 0.876 (mean) Kasprzyk-
Hordern et 
al., 2009181 
UK WWTP effluent Coslech (Wales) 1.2 (max) Kasprzyk-
Hordern et 
al., 2009181 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.09 
(median) 
Gracia-Lor et 
al., 2012183 
Spain WWTP effluents (n=14) in Castellon province 
(Valencia) 
0.1 (max) Gracia-Lor et 
al., 2012183 
Spain Hospital wastewater, and urban WWTP 
effluent in Girona 
0.216 (max) Gros et al., 
2013174 
Europe 90 WWTP effluents from 18 countries 0.229 
(mean); 
0.800 (max) 
Loos et al., 
2013175 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.25 
(median) 
Golovko et 
al., 2014178 
Czech 
Republic 
WWTP effluent in Ceské Budejovice  0.44 (max) Golovko et 
al., 2014178 
Greece WWTP effluents (n=8) 0.533 (max) Kosma et al., 
2014186 
Germany WWTP effluent in Dresden 0.208 
(median) 
Rossmann et 
al., 2014176 
Germany WWTP effluent in Dresden 0.554 (max) Rossmann et 
al., 2014176 
Slovakia WWTP effluents (n=2) 0.087 (mean) Birošová et 
al., 2014179 
Slovakia WWTP effluents (n=2) 0.088 (max) Birošová et 
al., 2014179 
Spain WWTP effluents in Girona  0.125 (max) Rodriguez-
Mozaz et al., 
201529 
Greece WWTP effluent in Volos 0.047 (mean) Papageorgio
u et al., 
2016177 
Greece WWTP effluent in Volos 0.096 (max) Papageorgio
u et al., 
2016177 
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England 
(south) 
WWTP effluents (n=4) 0.087 – 0.455 Johnson et 
al.; 2017180 
Tylosin Australia WWTP effluent in Brisbane 0.065 (max) Watkinson et 
al., 200732 
Vancomycin Germany WWTP effluent in Dresden 0.348 (max) Rossmann et 
al., 2014176 
(*) The name “Europe” indicated in the column “Country” for eight antibiotics (amoxicillin, 
ciprofloxacin, clindamycin, lincomycin, penicilline V, sulfadiazine, sulfamethoxazole and 
trimethoprim) was used for reporting the mean concentration calculated from 90 
measurements from samples collected in wastewater treatment plants (WWTP) effluents 
located in 18 European countries. For sulfamethoxazole, we included in the dataset 
concentrations measured not only in single countries but also mean concentrations calculated 
on: i) totally 6633 samples collected all over the world; ii) measurements performed in 122 
European river samples; iii) data collected from Danube river; and iv) totally 5536 surface 
water samples across Europe and in tributaries of Danube Rivers. For trimethoprim, we 
incorporated to the dataset both the concentrations in different countries and the mean 
concentration calculated on a total of 1899 surface water samples in Europe. 
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Annex II 
Table B: Antibiotics in surface water 
Substance Country River / Lake MEC (µg/L) Reference 
Amoxicillin 
UK (Wales) River Taff  
0.058 (median); 0.245 
(max) 
Kasprzyk-Hordern 
et al., 2007187 
UK River Taff and Ely (Wales) 
0.117 (median); 0.622 
(max) 
Kasprzyk-Hordern 
et al., 2008188  
Australia River water 
0.200 (max) 
Watkinson et al., 
200943  
Italy Surface water, River Arno 
0.006 (mean); 0.010 
(max) 
Zuccato et al., 
2010189  
Canada 
Wascana Creek, Qu'Appelle 
River 
0.080 (max) Waiser et al., 
2010190 
France 
Seine River 
0.068 Tuc Dinh et al., 
2011191 
Greece 
Saronikos Gulf and Elefsis 
Bay in central Aegean Sea 
(WWTP impact from 
Athens) 0.128 (max) 
Alygizakis et al., 
2016192 
Ampicillin 
China 
Sindian, Dahan and 
Gaoping Rivers 
0.100 (max) 
Lin et al., 2009193 
France 
Canche River (urban 
impact) 0.001 Tlili et al., 201679 
Azithromycin 
Spain 
Ebro River (n=7; 
downstream WWTPs) 
0.017 (median); 0.068 
(max) Gros et al., 2007194 
Japan Tone River basin  
0.012 (median); 0.070 
(max) 
Nakada et al., 
2007195 
USA 
Loup River, Big Blue River, 
Wood River, Salt Creek, 
Missouri River 
(downstream WWTPs) 
0.670 (median); 1.5 
(max) Bartelt-Hunt et al., 
2009196 
Serbia 
Danube, Sava and Tamis 
Rivers 
0.055 (median); 0.081 
(max) 
Grujić et al., 
2009197 
Spain Llobregat River 0.072 (max) 
López-Serna et al., 
201047 
Spain Ebro River 0.037 (max) 
López-Serna et al., 
2011198  
Spain 
Jarama, Manzanares, 
Guadarrama, Henares, and 
Tagus Rivers 0.569 (max) 
Valcárcel et al., 
2011199 
Italy 
Receiving water in the Po 
Valley 0.090 (max) 
Al Aukidy et al., 
2012200 
Spain Llobregat River 0.037 (max) 
Osorio et al., 
2012201  
Spain Ebro River and tributaries 0.041 (max) 
López-Serna et al., 
2012202 
Spain Llobregat River 0.018 (max) 
Boleda et al., 
2013203 
Italy 
Receiving water of a large 
WWTP in the Po Valley 0.007 (mean) 
Verlicchi et al., 
2014204 
Spain El Albujón River 16.6 (max) 
Moreno-González 
et al., 2014205 
 59 
 
Spain 
Mar Menor lagoon (SE 
Spain, Murcia) 0.164 (max) 
Moreno-González 
et al., 2015206 
Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.154 (max) 
Osorio et al., 
2016207  
Spain 
Ter River downstream 
WWTP in Girona  
0.115 (max) 
Rodriguez-Mozaz et 
al., 201529 
Cefaclor 
Australia River water 
0.200 (max) 
Watkinson et al., 
200943 
Cefalexin 
Australia River water 
0.100 (max) 
Watkinson et al., 
200943 
Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.001 (max) 
Osorio et al., 
2016207 
Cefazolin 
Spain 
Ter River downstream 
WWTP in Girona  
0.008 (max) 
Rodriguez-Mozaz et 
al., 201529 
Cefotaxime 
Spain 
Ter River downstream 
WWTP in Girona  
0.165 (max) 
Rodriguez-Mozaz et 
al., 201529 
Chloramphenicol 
Germany 
Rhine, Urselbach, Nidda 
and Main Rivers 
0.060 (max) 
Hirsch et al., 
1999208  
China Pearl River at Guangzhou 
0.084 (median); 0.266 
(max) Xu et al., 2007b209 
South Korea 
Han River, North and South 
Han River, Kyung-Ahn 
Stream 
0.031 (median); 0.054 
(max) 
Choi et al., 
2008a210 
UK River Taff and Ely (Wales) 
0.002 (median); 0.040 
(max) 
Kasprzyk-Hordern 
et al., 2008188 
UK River Ely (Wales) 0.005 (mean) 
Kasprzyk-Hordern 
et al., 2009181 
China Huangpu River 0.028 (max) Jiang et al., 2011211 
Spain Llobregat River 0.001 (max) 
Osorio et al., 
2012201 
Romania 
Danube, Olt, Siret, and 
Argeș Rivers 0.013 (max) 
Chitescu et al., 
2015212 
Chlortetracycline 
USA 
Streams and rivers 
(n=139) 
0.69 (max) 
Kolpin et al., 
2002213 
Canada Grand River watershed 
0.192 (max) 
Lissemore et al., 
2006214 
USA Cache La Poudre River 
0.080 (median); 0.210 
(max) 
Sung-Chul et al., 
2007215 
Australia River water 
0.060 (max) 
Watkinson et al., 
200943 
China 
Sindian, Dahan and 
Gaoping Rivers 
0.090 (max) 
Lin et al., 2009193 
China Huangpu River 0.017 (max) Jiang et al., 2011211 
Spain Ebro River 0.059 (max) 
López-Serna et al., 
2011198 
Spain Llobregat River 0.011 (max) 
Osorio et al., 
2012201 
France 
Canche River (urban 
impact) 0.004 Tlili et al., 201679 
South Korea River Han 0.793 (max) Kim et al., 2016216 
Ciprofloxacin 
USA 
Streams and rivers 
(n=139) 
0.030 (max) 
Kolpin et al., 
2002213 
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Italy Po and Lambro River 
0.020 (median); 0.026 
(max) 
Calamari et al., 
2003217 
Italy Po and Lambro Rivers 
0.020 (median); 0.026 
(max) 
Zuccato et al., 
2005218 
USA 
Streams downstream 
WWTPs 
0.170 (median); 0.360 
(max) Batt et al., 200628 
Finland Vantaa River 
0.025 (max) 
Vieno et al., 
2006219 
USA Upper Tennessee River 
0.007 (median); 0.054 
(max) 
Conley et al., 
2008220 
China Pearl River 0.459 (max) Peng et al., 2008221 
China Tonghui River 
0.010 (median); 0.020 
(max) Xiao et al., 2008222 
Australia River water 
1.3 (max) 
Watkinson et al., 
200943 
France Arc River (WWTP impact) 10 (max) 
Feitosa et al., 
2009223 
Italy Surface water, River Po 
0.009 (mean); 0.016 
(max) 
Zuccato et al., 
2010189 
Italy Surface water, River Arno 
0.019 (mean); 0.038 
(max) 
Zuccato et al., 
2010189 
Spain Llobregat River 0.028 (max) 
López-Serna et al., 
201047 
France 
Seine River 
0.017 Tuc Dinh et al., 
2011191 
France 
Charmoise River, upstream 
WWTP 
0.004 Tuc Dinh et al., 
2011191 
France 
Charmoise River, 
downstream WWTP 
0.135 Tuc Dinh et al., 
2011191 
Spain Ebro River 0.115 (max) 
López-Serna et al., 
2011198 
Spain 
Surface water in Castellon 
and Valencia provinces 0.740 (max) 
Gracia-Lor et al., 
2011224  
Spain 
Jarama, Manzanares, 
Guadarrama, Henares, and 
Tagus Rivers 0.224 (max) 
Valcárcel et al., 
2011199 
Italy 
Receiving water in the Po 
Valley 0.100 (max) 
Al Aukidy et al., 
2012200 
Spain Llobregat River 0.271 (max) 
Osorio et al., 
2012201 
Italy 
Receiving water of a large 
WWTP in the Po Valley 0.025 (mean) 
Verlicchi et al., 
2014204 
Poland Gościcina and Reda Rivers 2.7 (max) 
Wagil et al., 
2014225  
China Wenyu River 
0.066 (max) 
Zhang et al., 
2014226 
Romania 
Danube, Olt, Siret, and 
Argeș Rivers 0.006 (max) 
Chitescu et al., 
2015212 
USA 
River in Maryland, 
upstream WWTP 0.01 He et al., 2015227 
USA 
River in Maryland, 
downstream WWTP 0.031 (max) He et al., 2015227 
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Spain 
Ter River downstream 
WWTP in Girona  
0.072 (max) 
Rodriguez-Mozaz et 
al., 201529 
France 
Canche River (urban 
impact) 0.007 Tlili et al., 201679 
Clarithromycin 
Germany 
Rhine, Urselbach, Nidda 
and Main Rivers 
0.260 (max) 
Hirsch et al., 
1999208 
Italy Po and Lambro River 
0.002 (median); 0.020 
(max) 
Calamari et al., 
2003217 
Germany River Elbe 
0.034 (median); 0.040 
(max) 
Weigel et al., 
2004228 
Italy Po and Lambro Rivers 
0.008 (median); 0.020 
(max) 
Zuccato et al., 
2005218 
Japan Tone River basin  
0.026 (median); 0.060 
(max) 
Nakada et al., 
2007195 
Germany River Havel 
0.009 (median); 0.043 
(max) 
Heberer et al., 
2008229 
USA A stream in Ohio 
0.005 (median) 
Spongberg & 
Witter, 2008230 
France Arc River (WWTP impact) 
0.700 (median); 2.3 
(max) 
Feitosa et al., 
2009223  
Italy Surface water, River Po 
0.002 (mean); 0.002 
(max) 
Zuccato et al., 
2010189 
Italy Surface water, River Arno 
0.025 (mean); 0.045 
(max) 
Zuccato et al., 
2010189 
Germany River Leine and Baltic Sea 
0.077 (max) 
Nödler et al., 
2010231 
USA 
Surface water in Colorado 0.005 (max) 
Ferrer et al., 
2010232 
Germany 
Rhine River 
0.013 (median); 0.030 
(max) 
Ter Laak et al., 
2010233 
Spain Llobregat River 0.089 (max) 
López-Serna et al., 
201047 
Spain Ebro River 0.037 (max) 
López-Serna et al., 
2011198 
Spain 
Surface water in Castellon 
and Valencia provinces 0.091 (max) 
Gracia-Lor et al., 
2011224 
Spain Ebro River 0.037 (max) Silva et al., 2011234 
Spain 
Jarama, Manzanares, 
Guadarrama, Henares, and 
Tagus Rivers 1.7 (max) 
Valcárcel et al., 
2011199 
Spain Ebro River and tributaries 0.141 (max) 
López-Serna et al., 
2012202 
Spain Llobregat River 0.232 (max) 
Osorio et al., 
2012201 
Spain 
River water of Pego-Oliva 
Marshlands  0.035 (max) 
Vazquez-Roig et 
al., 2012235 
Italy 
Receiving water in the Po 
Valley 0.100 (max) 
Al Aukidy et al., 
2012200 
Spain Llobregat River 0.054 (max) 
Boleda et al., 
2013203 
Spain El Albujón River 2.4 (max) 
Moreno-González 
et al., 2014205 
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Italy 
Receiving water of a large 
WWTP in the Po Valley 0.006 (mean) 
Verlicchi et al., 
2014204 
Spain 
Ter River downstream 
WWTP in Girona  
0.096 (max) 
Rodriguez-Mozaz et 
al., 201529 
Spain Surface waters in Castellón 0.034 (max) Boix et al., 2015236 
Spain 
Mar Menor lagoon (SE 
Spain, Murcia) 0.010 (max) 
Moreno-González 
et al., 2015206 
Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.066 (max) 
Osorio et al., 
2016207 
Germany Large Rivers 0.070 (max) 
Baumann et al., 
2015237 
Germany Small Rivers 3.6 (max) 
Baumann et al., 
2015237 
Germany 7 Rivers in Bavaria 
0.030 (median); 0.100 
(max) 
Baumann et al., 
2015237 
China 
Yangtze, Huai, Yellow, Hai, 
Liao River 
0.001 (median); 0.012 
(max) Sun et al., 2015238 
Clindamycin 
USA 
Streams downstream 
WWTPs 
0.066 (median); 0.140 
(max) Batt et al., 200628 
Germany River Havel 
0.031 (median); 0.048 
(max) 
Heberer et al., 
2008229 
USA A stream in Ohio 
0.001 (median) 
Spongberg & 
Witter, 2008230 
Australia River water 
0.010 (max) 
Watkinson et al., 
200943 
Canada 
Wascana Creek, Qu'Appelle 
River 
0.300 (max) Waiser et al., 
2010190 
Germany 
Rhine River 
0.016 (median); 0.090 
(max) 
Ter Laak et al., 
2010233 
Netherlands Rhine and Meuse River 
0.005 (mean); 0.016 
(max) 
de Jongh et al., 
2012239 
Danofloxacin 
France Seine, Marne, Oise rivers 
0.019 (max) 
Tamtam et al., 
2008240 
Spain Llobregat River 0.280 (max) 
Osorio et al., 
2012201 
Spain Ebro River 0.207 (max) 
López-Serna et al., 
2011198 
France 
Canche River (urban 
impact) 0.068 Tlili et al., 201679 
Demecolcycline 
USA Cache La Poudre River 
0.030 (median); 0.050 
(max) 
Sung-Chul et al., 
2007215 
Difloxacin 
France 
Canche River (urban 
impact) 0.032 Tlili et al., 201679 
Dimetridazole 
Spain El Albujón River 0.028 (max) 
Moreno-González 
et al., 2014205 
Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.047 (max) 
Osorio et al., 
2016207 
Doxycycline 
Canada Grand River watershed 
0.008 (median); 0.073 
(max) 
Lissemore et al., 
2006214 
USA Cache La Poudre River 
0.020 (median); 0.050 
(max) 
Sung-Chul et al., 
2007215 
Australia River water 
0.400 (max) 
Watkinson et al., 
200943 
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Spain Ebro River 0.048 (max) 
López-Serna et al., 
2011198 
China Huangpu River 0.047 (max) Jiang et al., 2011211 
Spain Llobregat River 0.018 (max) 
Osorio et al., 
2012201 
China Wenyu River 
0.008 (max) 
Zhang et al., 
2014226 
France Allier River 0.002 (max) 
Celle-Jeanton et 
al., 2014241 
France 
Canche River (urban 
impact) 0.004 Tlili et al., 201679 
Enoxacin 
Spain Llobregat River 0.005 (max) 
López-Serna et al., 
201047 
Spain Ebro River 0.140 (max) 
López-Serna et al., 
2011198 
Spain Llobregat River 0.279 (max) 
Osorio et al., 
2012201 
Enrofloxacin 
USA Streams in Iowa 
0.010 (max) 
Kolpin et al., 
2004242 
Australia River water 
0.300 (max) 
Watkinson et al., 
200943 
Spain Llobregat River 0.040 (max) 
López-Serna et al., 
201047 
Spain Ebro River 0.178 (max) 
López-Serna et al., 
2011198 
Spain 
Surface water in Castellon 
and Valencia provinces 0.070 (max) 
Gracia-Lor et al., 
2011224 
Spain Llobregat River 0.313 (max) 
Osorio et al., 
2012201 
Poland Gościcina and Reda Rivers 0.249 (max) 
Wagil et al., 
2014225 
France 
Canche River (urban 
impact) 0.038 Tlili et al., 201679 
South Korea River Han 0.133 (max) Kim et al., 2016216 
Epitetracycline  
China Wenyu River 
0.026 (max) 
Zhang et al., 
2014226 
Erythromycin 
USA 
Streams and rivers 
(n=139) 
1.7 (max) 
Kolpin et al., 
2002213 
Italy Po and Lambro River 
0.004 (median); 0.016 
(max) 
Calamari et al., 
2003217 
UK Rivers 
1.0 (max) 
Ashton et al., 
2004243 
USA Streams in Iowa 
0.220 (max) 
Kolpin et al., 
2004242 
Germany River Elbe 
0.040 (median); 0.070 
(max) 
Weigel et al., 
2004228 
Canada Grand River watershed 
0.006 (median); 0.051 
(max) 
Lissemore et al., 
2006214 
Canada Grand River watershed 
0.007 (median); 0.007 
(max) Hao et al., 2006244 
UK Tyne River 
0.070 (max) 
Roberts and 
Thomas, 2006245 
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USA Cache La Poudre River 
0.120 (median); 0.450 
(max) 
Sung-Chul et al., 
2007215 
South Korea Surface waters 
0.003 (median); 0.005 
(max) Kim et al., 2007246 
UK (Wales) River Taff  0.022 (max) 
Kasprzyk-Hordern 
et al., 2007187 
Spain 
Ebro River (n=7; 
downstream WWTPs) 
0.071 (max) 
Gros et al., 2007194 
China Pearl River Delta  0.489 Xu et al., 2007a247 
China Pearl River at Guangzhou 
0.245 (median); 0.636 
(max) Xu et al., 2007b209 
Canada 
Little River and Upper 
Detroir River 
0.178 (max) 
Hao et al., 2008248 
UK River Taff (Wales) 
0.015 (median); 0.121 
(max) 
Kasprzyk-Hordern 
et al., 2009181 
UK River Ely (Wales) 0.015 (mean) 
Kasprzyk-Hordern 
et al., 2009181 
China 
Sindian, Dahan and 
Gaoping Rivers 
0.078 (median) 
Lin et al., 2009193 
Spain 
Middle and lower Llobregat 
and Anoia Rivers 
0.030 (median); 0.070 
(max) 
Muñoz et al., 
2009249 
Spain 
Llobregat, Cardener and 
Anoia rivers 
0.033 (median); 0.112 
(max) 
López-Roldán et 
al., 2010250 
Italy Surface water, River Po 
0.009 (mean); 0.010 
(max) 
Zuccato et al., 
2010189 
Italy Surface water, River Arno 
0.023 (mean); 0.038 
(max) 
Zuccato et al., 
2010189 
Germany River Leine and Baltic Sea 
0.022 (max) 
Nödler et al., 
2010231  
USA 
Surface water in Colorado 0.052 (max) 
Ferrer et al., 
2010232 
South Korea 5 rivers in Busan 0.072 (median) Sim et al., 2010251 
Germany 
Rhine River 
0.021 (median); 0.110 
(max) 
Ter Laak et al., 
2010233 
Spain Llobregat River 0.119 (max) 
López-Roldán et 
al., 2010250 
Spain Llobregat River 0.175 (max) 
López-Serna et al., 
201047 
France 
Seine River 
0.004 Tuc Dinh et al., 
2011191 
France 
Prédecelle River, 
downstream WWTP 
0.004 Tuc Dinh et al., 
2011191 
France 
Charmoise River, 
downstream WWTP 
0.131 Tuc Dinh et al., 
2011191 
Canada 
Wascana Creek, Qu'Appelle 
River 
0.300 (max) Waiser et al., 
2010190 
Spain Ebro River 0.052 (max) 
López-Serna et al., 
2011198 
Spain 
Surface water in Castellon 
and Valencia provinces 0.078 (max) 
Gracia-Lor et al., 
2011224 
Spain Ebro River 0.042 (max) Silva et al., 2011234 
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Spain 
Jarama, Manzanares, 
Guadarrama, Henares, and 
Tagus Rivers 3.8 (max) 
Valcárcel et al., 
2011199 
Netherlands Rhine and Meuse River 
0.010 (mean); 0.035 
(max) 
de Jongh et al., 
2012239 
Spain Llobregat River 0.362 (max) 
Osorio et al., 
2012201 
Spain Llobregat River 0.040 (max) 
Boleda et al., 
2013203 
Spain El Albujón River 0.065 (max) 
Moreno-González 
et al., 2014205 
Romania 
Prahova, Timis, Danube, 
Siret, Prut, and Jijia Rivers 0.025 (max) 
Chițescu and 
Nicolau, 2014252 
Portugal 
River Tagus and Zezere 
(Lisbon) 0.031 (max) 
de Jesus Gaffney et 
al., 201554 
Spain Surface waters in Castellón 0.010 (max) Boix et al., 2015236 
Spain 
Mar Menor lagoon (SE 
Spain, Murcia) 0.078 (max)  
Moreno-González 
et al., 2015206 
Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.019 (max) 
Osorio et al., 
2016207 
Florfenicol China Huangpu River 0.010 (median) Jiang et al., 2011211  
South Korea River Han 0.340 (max) Kim et al., 2016216 
Flumequine 
France Seine, Marne, Oise rivers 
0.012 (median); 0.032 
(max) 
Tamtam et al., 
2008240 
France 
Seine River 
0.005 Tuc Dinh et al., 
2011191 
Spain 
Surface water in Castellon 
and Valencia provinces 0.020 (max) 
Gracia-Lor et al., 
2011224 
Spain Ebro River 0.030 (max) 
López-Serna et al., 
2011198 
China Wenyu River 
0.154 (max) 
Zhang et al., 
2014226 
Spain Surface waters in Castellón 0.003 (max) Boix et al., 2015236 
Gatifloxacin 
China Tonghui River 
0.030 (median); 0.042 
(max) Xiao et al., 2008222 
China Wenyu River 
0.116 (max) 
Zhang et al., 
2014226 
Josamycin 
Japan Tone River basin  
0.0003 (median); 
0.0004 (max) 
Nakada et al., 
2007195 
Spain Llobregat River 0.002 (max) 
López-Serna et al., 
201047 
Spain Ebro River 0.001 (max) 
López-Serna et al., 
2011198 
Spain Ebro River 0.001 (max) Silva et al., 2011234 
Spain Llobregat River 0.011 (max) 
Osorio et al., 
2012201 
Levofloxacin 
Japan Tone River basin  
0.023 (median); 0.032 
(max) 
Nakada et al., 
2007195 
USA Upper Tennessee River 
0.012 (median); 0.059 
(max) 
Conley et al., 
2008220 
Lincomycin 
USA 
Streams and rivers 
(n=139) 
0.73 (max) 
Kolpin et al., 
2002213 
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Italy Po and Lambro River 
0.028 (median); 0.249 
(max) 
Calamari et al., 
2003217 
USA Streams in Iowa 
0.010 (max) 
Kolpin et al., 
2004242 
Italy Po and Lambro Rivers 
0.033 (median); 0.249 
(max) 
Zuccato et al., 
2005218 
Canada Grand River watershed 
0.012 (median); 0.355 
(max) 
Lissemore et al., 
2006214 
Canada Grand River watershed 
0.026 (median); 0.046 
(max) Hao et al., 2006244 
Canada 
Little River and Upper 
Detroir River 
0.010 (max) 
Hao et al., 2008248 
Australia River water 
0.050 (max) 
Watkinson et al., 
200943 
Italy Surface water, River Po 
0.006 (mean); 0.007 
(max) 
Zuccato et al., 
2010189 
Italy Surface water, River Arno 
0.008 (mean); 0.011 
(max) 
Zuccato et al., 
2010189 
South Korea 5 rivers in Busan 0.034 (median) Sim et al., 2010251 
Spain 
Surface water in Castellon 
and Valencia provinces 0.047 (max) 
Gracia-Lor et al., 
2011224 
Netherlands 
Meuse River 
0.004 (max) Houtman et al., 
2013253 
China 
Yangtze, Huai, Yellow, Hai, 
Liao River 
0.008 (median); 0.012 
(max) Sun et al., 2015238 
Spain Surface waters in Castellón 0.012 (max) Boix et al., 2015236 
Lomefloxacin 
China Tonghui River 
0.003 (median); 0.005 
(max) Xiao et al., 2008222 
China Wenyu River 
0.038 (max) 
Zhang et al., 
2014226 
Marbofloxacin 
Spain 
Surface water in Castellon 
and Valencia provinces 0.205 (max) 
Gracia-Lor et al., 
2011224 
Metronidazole 
UK River Taff and Ely (Wales) 
0.005 (median); 0.024 
(max) 
Kasprzyk-Hordern 
et al., 2008188 
UK River Taff (Wales) 
0.012 (median); 0.024 
(max) 
Kasprzyk-Hordern 
et al., 2009181 
UK River Ely (Wales) 0.012 (mean) 
Kasprzyk-Hordern 
et al., 2009181 
Spain Llobregat River 0.045 (max) 
López-Serna et al., 
201047 
Spain Ebro River 0.030 (max) 
López-Serna et al., 
2011198 
Spain Ebro River 0.030 (max) Silva et al., 2011234 
Spain 
Jarama, Manzanares, 
Guadarrama, Henares, and 
Tagus Rivers 1.8 (max) 
Valcárcel et al., 
2011199 
Italy 
Receiving water in the Po 
Valley 0.011 (max) 
Al Aukidy et al., 
2012200 
Spain Llobregat River 0.049 (max) 
Osorio et al., 
2012201 
Spain 
Ter River downstream 
WWTP in Girona  
0.028 (max) 
Rodriguez-Mozaz et 
al., 201529 
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Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.066 (max) 
Osorio et al., 
2016207 
Greece 
Saronikos Gulf and Elefsis 
Bay in central Aegean Sea 
(WWTP impact from 
Athens) 0.008 (max) 
Alygizakis et al., 
2016192 
Minocycline 
China Wenyu River 
0.006 (max) 
Zhang et al., 
2014226 
Monensin 
Canada Grand River watershed 
0.044 (median); 1.2 
(max) 
Lissemore et al., 
2006214 
Canada Grand River watershed 
0.092 (median); 0.220 
(max) Hao et al., 2006244 
Canada 
Little River and Upper 
Detroir River 
0.022 (max) 
Hao et al., 2008248 
Australia River water 
0.150 (max) 
Watkinson et al., 
200943 
France 
Canche River (urban 
impact) 0.017 Tlili et al., 201679 
Moxifloxacin 
China Tonghui River 
0.009 (median); 0.014 
(max) Xiao et al., 2008222 
China Wenyu River 
0.015 (max) 
Zhang et al., 
2014226 
Nalidixic acid 
Japan Tone River basin  
0.004 (median); 0.009 
(max) 
Nakada et al., 
2007195 
Australia River water 
0.750 (max) 
Watkinson et al., 
200943 
Spain 
Surface water in Castellon 
and Valencia provinces 0.014 (max) 
Gracia-Lor et al., 
2011224 
China Wenyu River 
0.113 (max) 
Zhang et al., 
2014226 
China 
Yangtze, Huai, Yellow, Hai, 
Liao River 
0.0001 (median); 
0.001 (max) Sun et al., 2015238 
Spain Surface waters in Castellón 0.004 (max) Boix et al., 2015236 
Norfloxacin 
USA 
Streams and rivers 
(n=139) 
0.12 (max) 
Kolpin et al., 
2002213 
USA Streams in Iowa 
0.030 (max) 
Kolpin et al., 
2004242 
China Pearl River Delta  0.166 Xu et al., 2007a247 
China Pearl River at Guangzhou 
0.081 (median); 0.251 
(max) Xu et al., 2007b209 
China Tonghui River 
0.030 (median); 0.066 
(max) Xiao et al., 2008222 
France Seine, Marne, Oise rivers 
0.022 (median); 0.163 
(max) 
Tamtam et al., 
2008240 
Australia River water 
1.1 (max) 
Watkinson et al., 
200943 
Spain Llobregat River 0.016 (max) 
López-Serna et al., 
201047 
Spain Ebro River 0.090 (max) 
López-Serna et al., 
2011198 
Spain 
Surface water in Castellon 
and Valencia provinces 0.054 (max) 
Gracia-Lor et al., 
2011224 
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France 
Seine River 
0.037 Tuc Dinh et al., 
2011191 
France 
Prédecelle River, 
downstream WWTP 
0.075 Tuc Dinh et al., 
2011191 
France 
Charmoise River, 
downstream WWTP 
0.017 Tuc Dinh et al., 
2011191 
Spain Llobregat River 0.405 (max) 
Osorio et al., 
2012201 
Spain 
River water of Pego-Oliva 
Marshlands  0.037 (max) 
Vazquez-Roig et 
al., 2012235 
China Wenyu River 
0.512 (max) 
Zhang et al., 
2014226 
Poland Gościcina and Reda Rivers 0.443 (max) 
Wagil et al., 
2014225 
France 
Canche River (urban 
impact) 0.008 Tlili et al., 201679 
Ofloxacin 
Italy Po and Lambro Rivers 
0.037 (median); 0.306 
(max) 
Zuccato et al., 
2005218 
Finland Vantaa River 
0.005 (max) 
Vieno et al., 
2006219 
Spain 
Ebro River (n=7; 
downstream WWTPs) 
0.146 (max) 
Gros et al., 2007194 
China Pearl River Delta  0.074 Xu et al., 2007a247 
China Pearl River at Guangzhou 
0.044 (median); 0.108 
(max) Xu et al., 2007b209 
China Pearl River 0.439 (max) Peng et al., 2008221 
China Tonghui River 
0.300 (median); 0.535 
(max) Xiao et al., 2008222 
France Seine, Marne, Oise rivers 
0.030 (median); 0.055 
(max) 
Tamtam et al., 
2008240 
Spain 
Middle and lower Llobregat 
and Anoia Rivers 
2.1 (median); 8.8 
(max) 
Muñoz et al., 
2009249 
Spain 
Llobregat, Cardener and 
Anoia rivers 
0.285 (median); 1.9 
(max) 
López-Roldán et 
al., 2010250 
Italy Surface water, River Po 
0.011 (mean); 0.018 
(max) 
Zuccato et al., 
2010189 
Italy Surface water, River Arno 
0.005 (mean); 0.011 
(max) 
Zuccato et al., 
2010189 
Spain Llobregat River 1.9 (max) 
López-Roldán et 
al., 2010250 
Spain Llobregat River 0.075 (max) 
López-Serna et al., 
201047 
Canada 
Wascana Creek, Qu'Appelle 
River 
0.020 (max) Waiser et al., 
2010190 
France 
Seine River 
0.018 (max) Tuc Dinh et al., 
2011191 
France 
Prédecelle River, upstream 
WWTP 
0.004 Tuc Dinh et al., 
2011191 
France 
Prédecelle River, 
downstream WWTP 
0.065 Tuc Dinh et al., 
2011191 
France 
Charmoise River, upstream 
WWTP 
0.004 Tuc Dinh et al., 
2011191 
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France 
Charmoise River, 
downstream WWTP 
0.231 Tuc Dinh et al., 
2011191 
Spain Ebro River 0.105 (max) 
López-Serna et al., 
2011198 
Spain 
Surface water in Castellon 
and Valencia provinces 0.400 (max) 
Gracia-Lor et al., 
2011224 
Spain 
Jarama, Manzanares, 
Guadarrama, Henares, and 
Tagus Rivers 0.552 (max) 
Valcárcel et al., 
2011199 
Spain Llobregat River 0.488 (max) 
Osorio et al., 
2012201 
Spain 
River water of Pego-Oliva 
Marshlands  0.050 (max) 
Vazquez-Roig et 
al., 2012235 
Spain Ebro River and tributaries 0.080 (max) 
López-Serna et al., 
2012202 
China Wenyu River 
1.1 (max) 
Zhang et al., 
2014226 
USA 
River in Maryland, 
upstream WWTP 0.009 He et al., 2015227 
Spain 
Ter River downstream 
WWTP in Girona  
0.137 (max) 
Rodriguez-Mozaz et 
al., 201529 
USA 
River in Maryland, 
downstream WWTP 0.039 (max) He et al., 2015227 
France 
Canche River (urban 
impact) 0.008 Tlili et al., 201679 
Oleandomycin 
Italy Po and Lambro River 
0.003 (max) 
Calamari et al., 
2003217 
Australia River water 
0.020 (max) 
Watkinson et al., 
200943 
Orbifloxacin 
France 
Canche River (urban 
impact) 0.03 Tlili et al., 201679 
Ornidazole 
France Seine, Marne, Oise rivers 
0.022 (median); 0.058 
(max) 
Tamtam et al., 
2008240 
Oxolinic acid 
France Seine, Marne, Oise rivers 
0.013 (median); 0.019 
(max) 
Tamtam et al., 
2008240 
France 
Seine River 
0.023 Tuc Dinh et al., 
2011191 
Spain 
Surface water in Castellon 
and Valencia provinces 0.023 (max) 
Gracia-Lor et al., 
2011224 
China Wenyu River 
0.013 (max) 
Zhang et al., 
2014226 
Spain Surface waters in Castellón 0.005 (max) Boix et al., 2015236 
Oxytetracycline 
USA 
Streams and rivers 
(n=139) 
0.34 (max) 
Kolpin et al., 
2002213 
Italy Po and Lambro River 
0.009 (median); 0.019 
(max) 
Calamari et al., 
2003217 
USA Cache La Poudre River 
0.180 (median); 1.2 
(max) 
Sung-Chul et al., 
2007215 
China Tonghui River 0.002 (median) Jia et al., 2009254 
France Arc River (WWTP impact) 
0.200 (median); 0.68 
(max) 
Feitosa et al., 
2009223 
Luxembourg Alzette River 
0.007 (max) 
Pailler et al., 
2009255 
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Italy Surface water, River Po 
0.001 (mean); 0.002 
(max) 
Zuccato et al., 
2010189 
Spain Ebro River 0.037 (max) 
López-Serna et al., 
2011198 
China Huangpu River 0.021 (median) Jiang et al., 2011211 
Spain Llobregat River 0.081 (max) 
Osorio et al., 
2012201 
China Wenyu River 
0.214 (max) 
Zhang et al., 
2014226 
South Korea River Han 1.2 (max) Kim et al., 2016216 
France 
Canche River (urban 
impact) 0.001 Tlili et al., 201679 
Pefloxacin 
Spain 
Surface water in Castellon 
and Valencia provinces 0.064 (max) 
Gracia-Lor et al., 
2011224 
China Wenyu River 
0.022 (max) 
Zhang et al., 
2014226 
Penicillin G 
Australia River water 
0.250 (max) 
Watkinson et al., 
200943 
Penicillin V 
Australia River water 
0.010 (max) 
Watkinson et al., 
200943 
Pipemidic acid 
China Tonghui River 
0.010 (median); 0.013 
(max) Xiao et al., 2008222 
Spain 
Surface water in Castellon 
and Valencia provinces 0.245 (max) 
Gracia-Lor et al., 
2011224 
China Wenyu River 
0.020 (max) 
Zhang et al., 
2014226 
Piromidic acid  
China Wenyu River 
0.129 (max) 
Zhang et al., 
2014226 
Ronidazole 
Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.008 (max) 
Osorio et al., 
2016207 
Roxithromycin 
Germany 
Rhine, Urselbach, Nidda 
and Main Rivers 
0.560 (max) 
Hirsch et al., 
1999208 
USA 
Streams and rivers 
(n=139) 
0.18 (max) 
Kolpin et al., 
2002213 
Germany River Elbe 
0.033 (median); 0.040 
(max) 
Weigel et al., 
2004228 
Canada Grand River watershed 
0.002 (max) 
Lissemore et al., 
2006214 
China Pearl River Delta  0.07 Xu et al., 2007a247 
China Pearl River at Guangzhou 
0.041 (median); 0.169 
(max) Xu et al., 2007b209 
South Korea 
Han River, North and South 
Han River, Kyung-Ahn 
Stream 
0.031 (median); 0.054 
(max) 
Choi et al., 
2008a210 
Germany River Havel 
0.011 (median); 0.069 
(max) 
Heberer et al., 
2008229 
Australia River water 
0.350 (max) 
Watkinson et al., 
200943 
Germany River Leine and Baltic Sea 
0.016 (max) 
Nödler et al., 
2010231 
Germany 
Rhine River 
0.014 (median); 0.018 
(max) 
Ter Laak et al., 
2010233 
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China Huangpu River 0.002 (median) Jiang et al., 2011211 
Spain 
Surface water in Castellon 
and Valencia provinces 0.012 (max) 
Gracia-Lor et al., 
2011224 
Spain Llobregat River 0.008 (max) 
Osorio et al., 
2012201 
China 
Yangtze, Huai, Yellow, Hai, 
Liao River 
0.001 (median); 0.008 
(max) Sun et al., 2015238 
Salinomycin 
Australia River water 
0.150 (max) 
Watkinson et al., 
200943 
Sarafloxacin 
Spain 
Surface water in Castellon 
and Valencia provinces 0.055 (max) 
Gracia-Lor et al., 
2011224 
Spiramycin 
Italy Po and Lambro River 
0.044 (median); 0.074 
(max) 
Calamari et al., 
2003217 
Italy Po and Lambro Rivers 
0.044 (median); 0.074 
(max) 
Zuccato et al., 
2005218 
Italy Surface water, River Po 
0.001 (mean); 0.002 
(max) 
Zuccato et al., 
2010189 
Italy Surface water, River Arno 
0.008 (mean); 0.018 
(max) 
Zuccato et al., 
2010189 
Spain Llobregat River 0.068 (max) 
López-Serna et al., 
201047 
Spain Ebro River 0.488 (max) 
López-Serna et al., 
2011198 
Spain Llobregat River 0.152 (max) 
Osorio et al., 
2012201 
Sulfabenzamide 
Spain Ebro River 0.002 (max) 
García-Galán et al., 
201056 
Spain 
Ebro River 
0.008 (median) García-Galán et al., 
2011256  
Spain Ebro River 0.015 (max) 
García-Galán et al., 
2011256 
Sulfachloro-
pyridazine Canada Grand River watershed 
0.004 (median); 0.007 
(max) 
Lissemore et al., 
2006214 
Canada Grand River watershed 0.020 (max) Hao et al., 2006244 
USA Cache La Poudre River 
0.030 (max) 
Sung-Chul et al., 
2007215 
USA 
Loup River, Big Blue River, 
Wood River, Salt Creek, 
Missouri River 
(downstream WWTPs) 
0.002 (max) 
Bartelt-Hunt et al., 
2009196 
China Huangpu River 0.006 (median) Jiang et al., 2011211 
China Wenyu River 
0.010 (max) 
Zhang et al., 
2014226 
South Korea River Han 0.060 (max) Kim et al., 2016216 
Sulfadiazine 
China Pearl River at Guangzhou 
0.124 (median); 0.336 
(max) Xu et al., 2007b209 
Japan Koyama River 
0.00005 (max) 
Chang et al., 
2008257 
Spain 
Llobregat, Segre and Anoia 
River 
0.119 (median); 2.3 
(max) 
Diaz-Cruz et al., 
2008258 
Spain 
Llobregat, Cardener and 
Anoia Rivers 
0.008 (median); 0.013 
(max) 
García-Galán et al., 
201056 
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Spain Llobregat River 0.013 (max) 
López-Serna et al., 
201047 
Spain Llobregat and Anoia Rivers 5.0 (max) 
García-Galán, et 
al., 201056 
China Huangpu River 0.013 (median) Jiang et al., 2011211 
Spain 
Ebro River 
0.002 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.023 (max) 
López-Serna et al., 
2011198 
Spain Ebro River and tributaries 0.136 (max) 
López-Serna et al., 
2012202 
Spain Ebro River 0.006 (max) 
García-Galán et al., 
2011256 
Spain Llobregat River 0.107 (max) 
Osorio et al., 
2012201 
China Wenyu River 
0.321 (max) 
Zhang et al., 
2014226 
Portugal 
River Tagus and Zezere 
(Lisbon) 0.026 (max) 
de Jesus Gaffney et 
al., 201554 
Greece 
Saronikos Gulf and Elefsis 
Bay in central Aegean Sea 
(WWTP impact from 
Athens) 0.002 (max) 
Alygizakis et al., 
2016192 
France 
Canche River (urban 
impact) 0.022 Tlili et al., 201679 
Sulfadimethoxine 
USA 
Streams and rivers 
(n=139) 
0.060 (max) 
Kolpin et al., 
2002213 
Canada Grand River watershed 
0.001 (median); 0.056 
(max) 
Lissemore et al., 
2006214  
USA Cache La Poudre River 
0.020 (median); 0.040 
(max) 
Sung-Chul et al., 
2007215 
Japan Tone River basin  
0.002 (median); 0.003 
(max) 
Nakada et al., 
2007195 
Japan Koyama River 
0.0002 (max) 
Chang et al., 
2008257 
South Korea 
Han River 
0.011 (median); 0.013 
(max) 
Choi et al., 
2008b259 
Spain 
Llobregat, Segre and Anoia 
River 
0.012 (median); 0.182 
(max) 
Diaz-Cruz et al., 
2008258 
USA 
Loup River, Big Blue River, 
Wood River, Salt Creek, 
Missouri River 
(downstream WWTPs) 
0.003 (median); 4.0 
(max) Bartelt-Hunt et al., 
2009196 
China 
Sindian, Dahan and 
Gaoping Rivers 
0.020 (max) 
Lin et al., 2009193 
Spain 
Llobregat, Cardener and 
Anoia Rivers 
0.005 (median); 0.136 
(max) 
García-Galán et al., 
201056 
Spain 
Henares-Jarama-Tajo river 
system (Madrid) 
0.001 (median) 
Fernandez et al., 
2010260 
Spain Ebro River 0.018 (max) 
García-Galán et al., 
201056 
Spain Llobregat and Anoia Rivers 0.136 (max) 
García-Galán et al., 
201056 
 73 
 
Spain 
Ebro River 
0.002 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.023 (max) 
García-Galán et al., 
2011256 
Spain Llobregat River 0.043 (max) 
Boleda et al., 
2013203 
South Korea River Han 0.080 (max) Kim et al., 2016216 
France 
Canche River (urban 
impact) 0.022 Tlili et al., 201679 
Sulfadimidine 
China Pearl River at Guangzhou 
0.126 (median); 0.323 
(max) Xu et al., 2007b209 
Japan Koyama River 
0.0001 (max) 
Chang et al., 
2008257 
Sulfadoxine 
Spain Ebro River 0.020 (max) 
García-Galán et al., 
201056 
Spain 
Ebro River 
0.013 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.043 (max) 
García-Galán et al., 
2011256 
Sulfaguanidine  
China Wenyu River 
0.003 (max) 
Zhang et al., 
2014226 
Sulfamerazine 
USA Cache La Poudre River 
0.020 (median); 0.060 
(max) 
Sung-Chul et al., 
2007215 
Spain Ebro River 0.016 (max) 
García-Galán et al., 
201056 
Spain 
Ebro River 
0.021 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.042 (max) 
García-Galán et al., 
2011256 
France 
Canche River (urban 
impact) 0.011 Tlili et al., 201679 
Sulfameter  
China Wenyu River 
0.010 (max) 
Zhang et al., 
2014226 
Sulfamethazine 
USA 
Streams and rivers 
(n=139) 
0.22 (max) 
Kolpin et al., 
2002213 
Canada Grand River watershed 
0.003 (median); 0.408 
(max) 
Lissemore et al., 
2006214 
Canada Grand River watershed 
0.002 (median); 0.038 
(max) Hao et al., 2006244 
USA Cache La Poudre River 
0.020 (max) 
Sung-Chul et al.,  
2007215 
Spain 
Llobregat, Segre and Anoia 
River 
0.674 (median); 6.2 
(max) 
Diaz-Cruz et al., 
2008258 
USA 
Loup River, Big Blue River, 
Wood River, Salt Creek, 
Missouri River 
(downstream WWTPs) 
0.005 (median); 0.427 
(max) Bartelt-Hunt et al., 
2009196 
China 
Sindian, Dahan and 
Gaoping Rivers 
0.020 (max) 
Lin et al., 2009193 
Spain 
Llobregat, Cardener and 
Anoia Rivers 
0.023 (median); 2.5 
(max) 
García-Galán et al., 
201056  
Spain Llobregat River 0.112 (max) 
López-Serna et al., 
201047 
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Spain Ebro River 0.020 (max) 
García-Galán et al., 
201056 
Spain Llobregat and Anoia Rivers 5.0 (max) 
García-Galán et al., 
201056 
China Huangpu River 0.159 (median) Jiang et al., 2011211 
Spain 
Ebro River 
0.010 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.065 (max) 
García-Galán et al., 
2011256 
Spain Llobregat River 0.281 (max) 
Osorio et al., 
2012201 
Spain Ebro River and tributaries 0.641 (max) 
López-Serna et al., 
2012202 
Spain Llobregat River 0.113 (max) 
Boleda et al., 
2013203 
China Wenyu River 
0.267 (max) 
Zhang et al., 
2014226 
Portugal 
River Tagus and Zezere 
(Lisbon) 0.001 (max) 
de Jesus Gaffney et 
al., 201554 
South Korea River Han 0.067 (max) Kim et al., 2016216 
Sulfamethizole 
USA 
Streams and rivers 
(n=139) 
0.13 (max) 
Kolpin et al., 
2002213 
Japan Koyama River 
0.0001 (max) 
Chang et al., 
2008257 
Spain 
Llobregat, Segre and Anoia 
River 
0.004 (median); 0.007 
(max) 
Diaz-Cruz et al., 
2008258 
USA 
Loup River, Big Blue River, 
Wood River, Salt Creek, 
Missouri River 
(downstream WWTPs) 
0.141 (median); 0.343 
(max) Bartelt-Hunt et al., 
2009196 
Spain 
Llobregat, Cardener and 
Anoia Rivers 
0.002 (median); 0.010 
(max) 
García-Galán et al., 
201056 
Spain Ebro River 0.003 (max) 
García-Galán et al., 
201056 
Spain Llobregat and Anoia Rivers 0.010 (max) 
García-Galán et al., 
201056 
Spain 
Ebro River 
0.002 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.005 (max) 
García-Galán et al., 
2011256 
Sulfamethoxazole 
Germany 
Rhine, Urselbach, Nidda 
and Main Rivers 
0.030 (median); 0.480 
(max) 
Hirsch et al., 
1999208 
USA 
Streams and rivers 
(n=139) 
1.9 (max) 
Kolpin et al., 
2002213 
Germany River Elbe 
0.047 (median); 0.070 
(max) 
Weigel et al., 
2004228 
Sweden Hoje River  
0.015 (median); 0.050 
(max) 
Bendz et al., 
2005261 
USA Rio Grande River 
0.300 (max) 
Brown et al., 
2006262 
Canada Grand River watershed 
0.003 (median); 0.009 
(max) 
Lissemore et al., 
2006214 
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USA Colorado River 
0.672 (max) 
Vanderford & 
Snyder, 2006263 
USA Cache La Poudre River 
0.110 (median); 0.320 
(max) 
Sung-Chul et al., 
2007215 
South Korea Surface waters 
0.020 (median); 0.036 
(max) Kim et al., 2007246 
Poland River Warta 
0.060 (max) 
Kasprzyk-Hordern 
et al., 2007187 
Spain 
Ebro River (n=7; 
downstream WWTPs) 
0.169 (max) 
Gros et al., 2007194 
Japan Tone River basin  
0.039 (median); 0.160 
(max) 
Nakada et al., 
2007195 
China Pearl River Delta  0.143 Xu et al., 2007a247 
China Pearl River at Guangzhou 
0.086 (median); 0.193 
(max) Xu et al., 2007b209 
Japan Koyama River 
0.0005 (max) 
Chang et al., 
2008257 
South Korea 
Han River 
0.026 (mean) 
Choi et al., 
2008b259 
USA Upper Tennessee River 
0.008 (median); 0.010 
(max) 
Conley et al., 
2008220 
Spain 
Llobregat, Segre and Anoia 
River 
0.145 (median); 1.5 
(max) 
Diaz-Cruz et al., 
2008258 
China Pearl River 0.510 (max) Peng et al., 2008221 
Germany River Havel 
0.151 (median); 0.326 
(max) 
Heberer et al., 
2008229 
France Seine, Marne, Oise rivers 
0.044 (median); 0.544 
(max) 
Tamtam et al., 
2008240 
Canada 
Little River and Upper 
Detroir River 
0.381 (max) 
Hao et al., 2008248 
UK River Taff (Wales) 0.002 (mean) 
Kasprzyk-Hordern 
et al., 2009181 
UK River Ely (Wales) 0.001 (mean) 
Kasprzyk-Hordern 
et al., 2009181 
Europe 122 river water samples 
0.015 (median); 4.1 
(max) Loos et al., 2009264 
Australia River water 
2.0 (max) 
Watkinson et al., 
200943 
China 
Sindian, Dahan and 
Gaoping Rivers 
0.054 (median); 0.300 
(max) Lin et al., 2009193 
Spain 
Middle and lower Llobregat 
and Anoia Rivers 
1.1 (median); 11.9 
(max) 
Muñoz et al., 
2009249 
Europe European rivers 
0.015 (median); 4.1 
(max) Loos et al., 2009264 
Luxembourg Alzette River 
0.005 (max) 
Pailler et al., 
2009255 
UK River Ouse 0.010 (max) Zhou et al., 2009265 
Spain Guadiamar River 
0.010 (max) 
Camacho-Munoz et 
al., 2010266 
Spain 
Llobregat, Cardener and 
Anoia Rivers 
0.008 (median); 4.3 
(max) 
García-Galán et al., 
201056 
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Europe Danube River 
0.016 (median); 0.028 
(max) 
Loos et al., 
2010a267 
Europe (East) Danube Tributary Rivers 
0.021 (median); 0.204 
(max) 
Loos et al., 
2010a267 
Spain 
Llobregat, Cardener and 
Anoia rivers 
0.024 (median); 0.119 
(max) 
López-Roldán et 
al., 2010250 
Italy Surface water, River Po 
0.002 (mean); 0.002 
(max) 
Zuccato et al., 
2010189  
Italy Surface water, River Arno 
0.005 (mean); 0.011 
(max) 
Zuccato et al., 
2010189 
Spain 
Henares-Jarama-Tajo river 
system (Madrid) 
0.007 (median) 
Fernandez et al., 
2010260 
Germany River Leine and Baltic Sea 
0.093 (max) 
Nödler et al., 
2010231 
Portugal Douro River estuary 
0.053 (max) 
Madureira et al., 
2010268 
USA 
Surface water in Colorado 0.210 (max) 
Ferrer et al., 
2010232 
South Korea Han River 
0.061 (median); 0.190 
(max) Yoon et al., 2010269 
Spain Ebro River 0.032 (max) 
García-Galán et al., 
201056 
Spain Llobregat and Anoia Rivers 0.653 (max) 
García-Galán, et 
al., 201056 
Spain Llobregat River 0.119 (max) 
López-Roldán et 
al., 2010250 
Spain Llobregat River 0.078 (max) 
López-Serna et al., 
201047 
Germany 
Rhine River 
0.030 (median); 0.110 
(max) 
Ter Laak et al., 
2010233 
Spain 
Ebro River 
0.060 (median) García-Galán et al., 
2011256 
China Huangpu River 0.018 (median) Jiang et al., 2011211 
France 
Seine River 
0.018 (max) Tuc Dinh et al., 
2011191 
France 
Prédecelle River, 
downstream WWTP 
0.025 Tuc Dinh et al., 
2011191 
France 
Charmoise River, upstream 
WWTP 
0.006 Tuc Dinh et al., 
2011191 
France 
Charmoise River, 
downstream WWTP 
1.4 Tuc Dinh et al., 
2011191 
Spain Ebro River 0.036 (max) 
García-Galán et al., 
2011256 
Spain Ebro River 0.055 (max) 
López-Serna et al., 
2011198 
Spain 
Surface water in Castellon 
and Valencia provinces 0.033 (max) 
Gracia-Lor et al., 
2011224 
Spain 
Jarama, Manzanares, 
Guadarrama, Henares, and 
Tagus Rivers 0.952 (max) 
Valcárcel et al., 
2011199 
Spain Llobregat River 1.5 (max) 
Osorio et al., 
2012201 
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Spain 
River water of Pego-Oliva 
Marshlands  0.016 (max) 
Vazquez-Roig et 
al., 2012235 
Spain Ebro River and tributaries 0.017 (max) 
López-Serna et al., 
2012202 
Italy 
Receiving water in the Po 
Valley 0.005 (max) 
Al Aukidy et al., 
2012200 
Spain Llobregat River 0.149 (max) 
Boleda et al., 
2013203 
Netherlands 
Meuse River 
0.033 (max) Houtman et al., 
2013253 
Spain Miño River, Galicia 0.064 (max) 
Iglesias et al., 
2013270 
Romania 
Prahova, Timis, Danube, 
Siret, Prut, and Jijia Rivers 0.030 (max) 
Chițescu and 
Nicolau, 2014252 
Spain El Albujón River 0.065 (max) 
Moreno-González 
et al., 2014205 
China Wenyu River 
0.443 (max) 
Zhang et al., 
2014226 
Spain Surface waters in Castellón 0.025 (max) Boix et al., 2015236 
Spain 
Mar Menor lagoon (SE 
Spain, Murcia) 0.094 (max) 
Moreno-González 
et al., 2015206 
Portugal 
River Tagus and Zezere 
(Lisbon) 0.022 (max) 
de Jesus Gaffney et 
al., 201554 
Romania 
Danube, Olt, Siret, and 
Argeș Rivers 0.030 (max) 
Chitescu et al., 
2015212 
Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.042 (max) 
Osorio et al., 
2016207 
Spain 
Ter River downstream 
WWTP in Girona  
0.072 (max) 
Rodriguez-Mozaz et 
al., 201529 
South Korea River Han 0.270 (max) Kim et al., 2016216 
Europe 
5536 surface water 
samples 
0.052 (median) 
Straub, 2015271 
World 
6633 surface water 
samples 
0.049 (median) 
Straub, 2015271 
France 
Canche River (urban 
impact) 0.014 Tlili et al., 201679 
Greece 
Saronikos Gulf and Elefsis 
Bay in central Aegean Sea 
(WWTP impact from 
Athens) 0.006 (max) 
Alygizakis et al., 
2016192 
Sulfamethoxy-
pyridazine Spain 
Llobregat, Segre and Anoia 
River 
0.032 (median); 3.7 
(max) 
Diaz-Cruz et al., 
2008258 
Spain 
Llobregat, Cardener and 
Anoia Rivers 
0.096 (median); 0.165 
(max) 
García-Galán et al., 
201056 
Spain Ebro River 0.015 (max) 
García-Galán et al., 
201056 
Spain Llobregat and Anoia Rivers 5.0 (max) 
García-Galán, et 
al., 201056 
Spain 
Ebro River 
0.007 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.018 (max) 
García-Galán et al., 
2011256 
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Spain Miño River, Galicia 0.011 (max) 
Iglesias et al., 
2013270 
Sulfamono-
methoxine Japan Tone River basin  
0.040 (median); 0.130 
(max) 
Nakada et al., 
2007195 
China 
Sindian, Dahan and 
Gaoping Rivers 
0.006 (max) 
Lin et al., 2009193 
China Wenyu River 
0.012 (max) 
Zhang et al., 
2014226 
China 
Yangtze, Huai, Yellow, Hai, 
Liao River 
0.007 (median); 0.013 
(max) Sun et al., 2015238 
Sulfanilamide  
China Wenyu River 
0.003 (max) 
Zhang et al., 
2014226 
Sulfanitran  
Spain 
Ebro River 
0.004 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.127 (max) 
García-Galán et al., 
2011256 
Sulfapyridine 
UK (Wales) River Taff  0.010 (max) 
Kasprzyk-Hordern 
et al., 2007187 
Poland River Warta 
0.039 (max) 
Kasprzyk-Hordern 
et al., 2007187 
Japan Koyama River 
0.003 (max) 
Chang et al., 
2008257 
Spain 
Llobregat, Segre and Anoia 
River 
0.012 (median); 12.0 
(max) 
Diaz-Cruz et al., 
2008258 
UK River Taff and Ely (Wales) 
0.015 (median); 0.142 
(max) 
Kasprzyk-Hordern 
et al., 2008188 
UK River Ely (Wales) 
0.019 (median); 0.060 
(max) 
Kasprzyk-Hordern 
et al., 2009181 
Spain Ebro River 0.011 (max) 
García-Galán et al., 
201056 
Spain Llobregat and Anoia Rivers 5.0 (max) 
García-Galán, et 
al., 201056 
Spain 
Llobregat, Cardener and 
Anoia Rivers 
0.010 (median); 0.092 
(max) 
García-Galán et al., 
201056 
China Huangpu River 0.010 (median) Jiang et al., 2011211 
Spain 
Ebro River 
0.004 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.043 (max) 
García-Galán et al., 
2011256 
China Wenyu River 
0.091 (max) 
Zhang et al., 
2014226 
Portugal 
River Tagus and Zezere 
(Lisbon) 0.002 (max) 
de Jesus Gaffney et 
al., 201554 
Sulfaquinoxaline 
Japan Koyama River 
0.009 (max) 
Chang et al., 
2008257 
Spain Ebro River 0.021 (max) 
García-Galán et al., 
201056 
Spain 
Ebro River 
0.043 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.040 (max) 
García-Galán et al., 
2011256 
China Wenyu River 
0.002 (max) 
Zhang et al., 
2014226 
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Sulfasalazine 
UK River Taff and Ely (Wales) 
0.018 (median); 0.168 
(max) 
Kasprzyk-Hordern 
et al., 2008188 
UK River Ely (Wales) 
0.030 (median); 0.168 
(max) 
Kasprzyk-Hordern 
et al., 2009181 
Australia River water 
0.150 (max) 
Watkinson et al., 
200943 
Sulfathiazole 
Canada Grand River watershed 
0.001 (median); 0.016 
(max) 
Lissemore et al., 
2006214 
USA Cache La Poudre River 
0.010 (median); 0.030 
(max) 
Sung-Chul et al., 
2007215 
Japan Koyama River 
0.007 (max) 
Chang et al., 
2008257 
Spain 
Llobregat, Segre and Anoia 
River 
0.016 (median); 0.332 
(max) 
Diaz-Cruz et al., 
2008258 
USA 
Loup River, Big Blue River, 
Wood River, Salt Creek, 
Missouri River 
(downstream WWTPs) 
0.005 (median); 0.007 
(max) Bartelt-Hunt et al., 
2009196 
Australia River water 
0.040 (max) 
Watkinson et al., 
200943 
Luxembourg Alzette River 
0.002 (max) 
Pailler et al., 
2009255 
Spain Ebro River 0.014 (max) 
García-Galán et al., 
201056 
Spain Llobregat and Anoia Rivers 0.960 (max) 
García-Galán et al., 
201056 
Spain 
Llobregat, Cardener and 
Anoia Rivers 
0.002 (median); 0.960 
(max) 
García-Galán et al., 
201056  
Spain 
Ebro River 
0.007 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.010 (max) 
García-Galán et al., 
2011256 
China Wenyu River 
0.002 (max) 
Zhang et al., 
2014226 
South Korea River Han 0.056 (max) Kim et al., 2016216 
France 
Canche River (urban 
impact) 0.009 Tlili et al., 201679 
Sulfisomidine 
Japan Koyama River 
0.0005 (max) 
Chang et al., 
2008257 
Spain 
Ebro River 
0.006 (median) García-Galán et al., 
2011256 
Spain Ebro River 0.040 (max) 
García-Galán et al., 
2011256 
Sulfisoxazole 
Spain 
Llobregat, Segre and Anoia 
River 
0.001 (median); 0.003 
(max) 
Diaz-Cruz et al., 
2008258 
Spain Ebro River 0.013 (max) 
García-Galán et al., 
201056 
Spain Llobregat and Anoia Rivers 0.025 (max) 
García-Galán et al., 
201056 
Spain 
Llobregat, Cardener and 
Anoia Rivers 
0.025 (max) 
García-Galán et al., 
201056 
Spain 
Ebro River 
0.008 (median) García-Galán et al., 
2011256 
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Spain Ebro River 0.013 (max) 
García-Galán et al., 
2011256 
Tetracycline 
USA 
Streams and rivers 
(n=139) 
0.11 (max) 
Kolpin et al., 
2002213 
USA Cache La Poudre River 
0.020 (median); 0.030 
(max) 
Sung-Chul et al., 
2007215 
Canada 
Little River and Upper 
Detroir River 
0.073 (max) 
Hao et al., 2008248 
Australia River water 
0.080 (max) 
Watkinson et al., 
200943 
China 
Sindian, Dahan and 
Gaoping Rivers 
0.022 (max) 
Lin et al., 2009193 
China Tonghui River 0.002 (median) Jia et al., 2009254 
Luxembourg Alzette River 
0.007 (max) 
Pailler et al., 
2009255 
China Huangpu River 0.114 (max) Jiang et al., 2011211 
Spain Ebro River 0.228 (max) 
López-Serna et al., 
2011198 
France 
Prédecelle River, 
downstream WWTP 
0.007 Tuc Dinh et al., 
2011191 
Spain Llobregat River 0.712 (max) 
Osorio et al., 
2012201 
China Wenyu River 
0.091 (max) 
Zhang et al., 
2014226 
Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.027 (max) 
Osorio et al., 
2016207 
South Korea River Han 2.1 (max) Kim et al., 2016216 
France 
Canche River (urban 
impact) 0.013 Tlili et al., 201679 
Thiamphenicol China Huangpu River 0.014 (median) Jiang et al., 2011211 
Tilmicosin 
Italy Po and Lambro River 
0.0004 (median) 
Calamari et al., 
2003217 
Italy Surface water, River Po 
0.003 (mean); 0.009 
(max) 
Zuccato et al., 
2010189 
Italy Surface water, River Arno 
0.002 (mean); 0.009 
(max) 
Zuccato et al., 
2010189 
Spain Ebro River 0.227 (max) 
López-Serna et al., 
2011198 
Spain Llobregat River 0.096 (max) 
Osorio et al., 
2012201  
Trimethoprim 
Germany 
Rhine, Urselbach, Nidda 
and Main Rivers 
0.200 (max) 
Hirsch et al., 
1999208 
USA 
Streams and rivers 
(n=139) 
0.71 (max) 
Kolpin et al., 
2002213 
UK Rivers 
0.036 (max) 
Ashton et al., 
2004243 
Germany River Elbe 
0.035 (median); 0.040 
(max) 
Weigel et al., 
2004228 
Sweden Hoje River  
0.030 (median); 0.040 
(max) 
Bendz et al., 
2005261  
Canada Grand River watershed 
0.003 (median); 0.015 
(max) 
Lissemore et al., 
2006214 
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USA Colorado River 
0.080 (max) 
Vanderford & 
Snyder, 2006263 
Canada Grand River watershed 
0.001 (median); 0.002 
(max) Hao et al., 2006244 
UK Tyne River 
0.019 (max) 
Roberts and 
Thomas, 2006245 
South Korea Surface waters 
0.004 (median); 0.005 
(max) Kim et al., 2007246 
Poland River Warta 
0.027 (max) 
Kasprzyk-Hordern 
et al., 2007187 
Spain 
Ebro River (n=7; 
downstream WWTPs) 
0.069 (max) 
Gros et al., 2007194 
Japan Koyama River 
0.0003 (max) 
Chang et al., 
2008257 
South Korea 
Han River, North and South 
Han River, Kyung-Ahn 
Stream 
0.031 (median); 0.054 
(max) 
Choi et al., 
2008a210 
South Korea 
Han River 
0.011 (mean) 
Choi et al., 
2008b259 
USA Upper Tennessee River 
0.003(median); 0.007 
(max) 
Conley et al., 
2008220 
UK River Taff and Ely (Wales) 
0.044 (median); 0.183 
(max) 
Kasprzyk-Hordern 
et al., 2008188 
Germany River Havel 
0.012 (median); 0.049 
(max) 
Heberer et al., 
2008229 
France Seine, Marne, Oise rivers 
0.018 (median); 0.045 
(max) 
Tamtam et al., 
2008240 
Canada 
Little River and Upper 
Detroir River 
0.346 (max) 
Hao et al., 2008248 
UK River Taff (Wales) 
0.040 (median); 0.089 
(max) 
Kasprzyk-Hordern 
et al., 2009181 
UK River Ely (Wales) 0.062 (mean) 
Kasprzyk-Hordern 
et al., 2009181 
Serbia 
Danube, Sava and Tamis 
Rivers 
0.025 (median); 0.174 
(max) 
Grujić et al., 
2009197 
Australia River water 
0.150 (max) 
Watkinson et al., 
200943 
Spain 
Middle and lower Llobregat 
and Anoia Rivers 
0.140 (median); 0.470 
(max) 
Muñoz et al., 
2009249 
Spain Guadiamar River 
0.075 (max) 
Camacho-Munoz et 
al., 2010266 
Spain 
Llobregat, Cardener and 
Anoia rivers 
0.038 (median); 0.252 
(max) 
López-Roldán et 
al., 2010250  
Spain 
Henares-Jarama-Tajo river 
system (Madrid) 
0.012 (median) 
Fernandez et al., 
2010260 
Germany River Leine and Baltic Sea 
0.095 (max) 
Nödler et al., 
2010231 
Portugal Douro River estuary 
0.016 (max) 
Madureira et al., 
2010268 
Spain Llobregat River 0.252 (max) 
López-Roldán et 
al., 2010250 
USA 
Surface water in Colorado 0.105 (max) 
Ferrer et al., 
2010232 
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South Korea Han River 
0.041 (median); 0.080 
(max) Yoon et al., 2010269 
Spain Llobregat River 0.034 (max) 
López-Serna et al., 
201047 
Germany 
Rhine River 
0.007 (median); 0.020 
(max) 
Ter Laak et al., 
2010233 
Spain 
Surface water in Castellon 
and Valencia provinces 0.151 (max) 
Gracia-Lor et al., 
2011224 
Spain Ebro River 0.030 (max) Silva et al., 2011234 
Spain 
Jarama, Manzanares, 
Guadarrama, Henares, and 
Tagus Rivers 0.690 (max) 
Valcárcel et al., 
2011199 
Spain Ebro River 0.030 (max) 
López-Serna et al., 
2011198 
France 
Prédecelle River, 
downstream WWTP 
0.008 Tuc Dinh et al., 
2011191 
France 
Charmoise River, 
downstream WWTP 
0.254 Tuc Dinh et al., 
2011191 
Spain Llobregat River 0.036 (max) 
Osorio et al., 
2012201 
Spain 
River water of Pego-Oliva 
Marshlands  0.003 (max) 
Vazquez-Roig et 
al., 2012235 
Italy 
Receiving water in the Po 
Valley 0.015 (max) 
Al Aukidy et al., 
2012200 
Spain Ebro River and tributaries 0.060 (max) 
López-Serna et al., 
2012202 
Netherlands 
Meuse River 
0.013 (max) Houtman et al., 
2013253 
Europe 
1899 surface water 
samples 
0.012 (median) 
Straub, 2013272 
Spain Llobregat River 0.081 (max) 
Boleda et al., 
2013203 
Spain Miño River, Galicia 0.085 (max) 
Iglesias et al., 
2013270 
China Wenyu River 
0.165 (max) 
Zhang et al., 
2014226 
Ireland Marine surface waters 0.870 (max) 
McEneff et al., 
2014273 
Romania 
Prahova, Timis, Danube, 
Siret, Prut, and Jijia Rivers 0.020 (max) 
Chițescu and 
Nicolau, 2014252 
Spain El Albujón River 0.025 (max) 
Moreno-González 
et al., 2014205 
Italy 
Receiving water of a large 
WWTP in the Po Valley 0.002 (mean) 
Verlicchi et al., 
2014204 
Romania 
Danube, Olt, Siret, and 
Argeș Rivers 0.012 (max) 
Chitescu et al., 
2015212 
Spain 
Ter River downstream 
WWTP in Girona  
0.093 (max) 
Rodriguez-Mozaz et 
al., 201529 
Spain Surface waters in Castellón 0.005 (max) Boix et al., 2015236 
Spain 
Mar Menor lagoon (SE 
Spain, Murcia) 0.002 (max) 
Moreno-González 
et al., 2015206 
Spain 
Llobregat, Ebro, Júcar, and 
Guadalquivir Rivers 0.150 (max) 
Osorio et al., 
2016207 
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South Korea River Han 0.587 (max) Kim et al., 2016216 
France 
Canche River (urban 
impact) 0.027 Tlili et al., 201679 
Greece 
Saronikos Gulf and Elefsis 
Bay in central Aegean Sea 
(WWTP impact from 
Athens) 0.003 (max) 
Alygizakis et al., 
2016192 
Tylosin 
USA 
Streams and rivers 
(n=139) 
0.28 (max) 
Kolpin et al., 
2002213 
Italy Po and Lambro River 
0.003 (max) 
Calamari et al., 
2003217 
USA Cache La Poudre River 
0.050 (max) 
Sung-Chul et al., 
2007215 
Canada 
Little River and Upper 
Detroir River 
0.024 (max) 
Hao et al., 2008248 
Australia River water 
0.060 (max) 
Watkinson et al., 
200943 
China 
Sindian, Dahan and 
Gaoping Rivers 
0.010 (max) 
Lin et al., 2009193 
Spain Ebro River 0.001 (max) 
López-Serna et al., 
2011198 
China Huangpu River 0.0002 (median) Jiang et al., 2011211 
France 
Seine River 
0.003 Tuc Dinh et al., 
2011191 
Spain Llobregat River 0.030 (max) 
Osorio et al., 
2012201 
Romania 
Danube, Olt, Siret, and 
Argeș Rivers 0.039 (max) 
Chitescu et al., 
2015212 
Greece 
Saronikos Gulf and Elefsis 
Bay in central Aegean Sea 
(WWTP impact from 
Athens) 0.002 (max) 
Alygizakis et al., 
2016192 
Vancomycin 
Italy Surface water, River Po 
0.005 (mean); 0.012 
(max) 
Zuccato et al., 
2010189 
Italy Surface water, River Arno 
0.003 (mean); 0.012 
(max) 
Zuccato et al., 
2010189 
France 
Charmoise River, 
downstream WWTP 
0.09 Tuc Dinh et al., 
2011191 
Virginiamycin South Korea River Han 0.187 (max) Kim et al., 2016216 
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List of abbreviations and definitions  
 
ABC ATP-binding Cassette Superfamily  
ABR Antibiotic Resistance 
ADP Adenosine Diphosphate  
Ag Silver 
AgR Silver resistance 
Ag+ Silver Ion 
AME Aminogycoside Modifying Enzymes 
AMP Adenosine Monophosphate 
AMR Antimicrobial Resistance 
AntibioticR Antibiotic Resistance 
ARG Antibiotic Resistance Gene 
As Arsenic 
ATP Adenosine Triphosphate 
Bi Bismuth  
CAT Chloramphenicol Acetyltransferase  
Cd Cadmium  
cfr Chloramphenicol-Florfenicol Resistance 
CFU Colony Forming Unit  
Co Cobalt  
CoA Coenzyme A 
Cr Chromium  
CTX-M Cefotaximase M  
Cu Copper  
CuR Copper resistance  
D-Ala-D-Ala D-Alanine-D-Alanine  
DHF Dihydrofolic Acid 
DNA Deoxyribonucleic Acid 
DW Drinking Water  
DWD Dirking Water Directive  
DWTP Drinking Water Treatment Plants 
EC European Commission  
ECDC European Centre for Disease Prevention and Control  
EFSA European Food Safety Authority 
EMA European Medicines Agency  
erm Erythromycin Ribosomal Methylation  
ESBL Extended Spectrum β-Lactamases 
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EU European Union  
GW Ground Water  
Hg Mercury  
HgR Mercury Resistant 
HgS Mercury Sensitive  
Hg0 Elemental Mercury 
Hg2+ Mercuric ions 
IMP Imipenemase Metallo β-Lactamase 
KPC Klebsiella pneumoniae Carbapenemase 
MATE multidrug and Toxic Compounds Extrusion Family  
MDR Multidrug Resistance  
MetalR Metal Resistance 
MFS Major Facilitator Superfamily  
MGE Mobile Genetic Element 
MIC Minimal Inhibitory Concentration  
Mg Manganese 
merA Mercury Reductase 
MRG Metal Resistance Genes 
MRL Maximum Residue Limit 
MRSA methicillin-resistant Staphylococcus aureus 
MS Member States 
NDM-1 New Delhi Metallo-β-Lactamase 1 
NH2 Amino Radical 
Ni Nickel  
OH Hydroxide 
OXA Oxacillin Hydrolysing Enzymes 
PABA Para-aminobenzoic Acid 
Pb Lead 
PBP Penicillin Binding Proteins  
PBP2a Penicillin Binding Protein 2a 
qnr Quinolone resistance gene 
RIF Rifampicin 
RIVM Rijksinstituut voor Volksgezondheid en Milieu 
RNA Ribonucleic Acid 
RND Resistance-Nodulation-Cell Division Family  
rRNA Ribosomal Ribonucleic Acid 
SHV Sulfhydryl Variable Enzymes 
SMR Small Multidrug Resistance Family  
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Sul Sulfonamide 
Tet Tetracycline 
THF Tetrahydrofolic Acid 
UK United Kingdom  
USA United States of America 
UV Ultraviolet light 
VIM Verona Integron Metallo β-Lactamase 
WFD Water Framework Directive 
WHO World Health Organization 
WL Watch List  
WWTP Wastewater Treatment Plant 
Zn Zinc  
Zn2+ Zinc cation  
  
 87 
 
List of figures  
 
Figure 1. Mode of action of antibiotics………………………………………………………………………………….7 
Figure 2. Classes of antibiotics used in human and veterinary medicine in Europe………….9 
Figure 3. Schematic representation of the environmental routes for antibiotics from human 
and veterinary uses…………………………………………………………………………………………………………….10 
Figure 4. Number of collected samples for antibiotics in wastewater treatment plants 
(WWTP) effluents all over the world (literature data)…………………………………………………………13 
Figure 5. Antibiotics’ concentrations in wastewater treatment plants (WWTP) effluents all 
over the world (literature data)………………………………………………………………………………………….14 
Figure 6. Number of collected samples for antibiotics in inland surface water all over the 
world (literature data)…………………………………………………………………………………………………………16 
Figure 7. Antibiotics’ concentrations in inland surface water all over the world (literature 
data)……………………………………………………………………………………………………………………………………17 
Figure 8. Number of collected samples for antibiotics in inland surface water in Europe… .19 
Figure 9. Antibiotics’ concentration in European inland surface water………………………………20 
Figure 10. Mechanism of vertical and horizontal transmission in bacteria…………………………30 
Figure 11. Mechanisms of antimicrobial resistance: inactivation of antibiotics…………………32 
Figure 12. Mechanisms of antimicrobial resistance: decreasing antibiotic penetration…….34 
Figure 13. Mechanisms of antimicrobial resistance: pumping of antibiotics out of 
bacteria……………………………………………………………………………………………………………………………….35 
Figure 14. Porins and efflux pumps…………………………………………………………………………………….36 
Figure 15. Mechanisms of antimicrobial resistance……………………………………………………………38 
Figure 16. Co-selection mechanisms of antibiotic resistance…………………………………………….40 
Figure 17. Metal resistance mechanisms in bacteria………………………………………………………….42  
 88 
 
List of tables 
 
Table 1. List of Antibiotics……………………………………………………………………………………………………8 
Table 2. Antibiotics in drinking water (DW) or sources of DW……………………………………………21 
Table 3. Antibiotics in agricultural runoff……………………………………………………………………………27 
Table 4. Ambler classification of β- lactamases…………………………………………………………………..33 
Table 5. List of common resistance mechanisms between heavy metals and antibiotics…43 
Table A. (Annex I) Antibiotics in wastewater treatment plant (WWTP) effluents………………47
Table B. (Annex II) Antibiotics in surface water……………………………………………………………….58
 89 
 
 References  
 
 
1 Ventola, C. L. The Antibiotic Resistance Crisis: Part 1: Causes and Threats. 
Pharmacy and Therapeutics 40, 277-283 (2015). 
2 Conly, J. M. & Johnston, B. L. Where are all the new antibiotics? The new 
antibiotic paradox. The Canadian Journal of Infectious Diseases & Medical 
Microbiology 16, 159-160 (2005). 
3 O’Neill, J. Tackling drug-resistant infections globally: final report and 
recommendations (HM Government, 2016). 
4 European Commission. COMMUNICATION FROM THE COMMISSION TO THE 
EUROPEAN PARLIAMENT AND THE COUNCIL. Action plan against the rising threats 
from Antimicrobial Resistance. Brussels, 15.11.2011 COM (2011) 748 final  (2011). 
5 European Commission. COMMUNICATION FROM THE COMMISSION TO THE 
COUNCIL AND THE EUROPEAN PARLIAMENT. A European One Health Action Plan 
against Antimicrobial Resistance (AMR). Brussels, COM(2017) 339 final.  (2017).  
6 European Commission. A European One Health Action Plan against Antimicrobial 
Resistance (AMR).  (2017). 
7 European Commission. COMMISSION IMPLEMENTING DECISION (EU) 2015/495 
of 20 March 2015 establishing a watch list of substances for Union-wide monitoring 
in the field of water policy pursuant to Directive 2008/105/EC of the European 
Parliament and of the Council.  (2015). 
8 European Commission. COMMISSION IMPLEMENTING DECISION (EU) 2018/840 
of 5 June 2018 establishing a  watch list  of  substances  for  Union-wide monitoring  
in  the  field  of  water policy pursuant to Directive 2008/105/EC of  the European 
Parliament and of  the Council and repealing Commission Implementing Decision (EU) 
2015/495 (2018). 
9 Larsson, D. G. J. Antibiotics in the environment. Upsala Journal of Medical 
Sciences 119, 108-112, doi:10.3109/03009734.2014.896438 (2014). 
10 Wilson, G. S. & Miles, A. A. Topley and Wilson's principles of bacteriology, virology 
and immunity. 5th ed. Edward Arnold, London, United Kingdom edn,  (1964). 
11 Kapoor, G., Saigal, S. & Elongavan, A. Action and resistance mechanisms of 
antibiotics: A guide for clinicians. J Anaesthesiol Clin Pharmacol 33, 300-305, 
doi:10.4103/joacp.JOACP_349_15 (2017). 
12 Carvalho, I. T. & Santos, L. Antibiotics in the aquatic environments: A review of 
the European scenario. Environment International 94, 736-757, 
doi:https://doi.org/10.1016/j.envint.2016.06.025 (2016). 
13 Berkner, S., Konradi, S. & Schönfeld, J. Antibiotic resistance and the 
environment—there and back again. EMBO Reports 15, 740-744, 
doi:10.15252/embr.201438978 (2014). 
14 Kümmerer, K. Resistance in the environment. Journal of Antimicrobial 
Chemotherapy 54, 311-320, doi:10.1093/jac/dkh325 (2004). 
15 Anadón, A. et al. Pharmacokinetics and residues of ciprofloxacin and its 
metabolites in broiler chickens. Research in Veterinary Science 71, 101-109, 
doi:https://doi.org/10.1053/rvsc.2001.0494 (2001). 
16 Homem, V. & Santos, L. Degradation and removal methods of antibiotics from 
aqueous matrices – A review. Journal of Environmental Management  92, 2304-2347, 
doi:https://doi.org/10.1016/j.jenvman.2011.05.023 (2011). 
17 Kümmerer, K. Antibiotics in the aquatic environment – A review – Part I. 
Chemosphere 75, 417-434, 
doi:https://doi.org/10.1016/j.chemosphere.2008.11.086 (2009). 
X
X
-N
A
-x
x
x
x
x
-E
N
-C
 
 90 
 
18 Manzetti, S. & Ghisi, R. The environmental release and fate of antibiotics. Marine 
Pollution Bulletin 79, 7-15, doi:https://doi.org/10.1016/j.marpolbul.2014.01.005 
(2014). 
19 Thomas, K. V., Dye, C., Schlabach, M. & Langford, K. H. Source to sink tracking 
of selected human pharmaceuticals from two Oslo city hospitals and a wastewater 
treatment works. Journal of Environmental Monitoring 9, 1410-1418, 
doi:10.1039/B709745J (2007). 
20 Sengelov, G., Halling-Sorensen, B. & Aarestrup, F. M. Susceptibility of 
Escherichia coli and Enterococcus faecium isolated from pigs and broiler chickens to 
tetracycline degradation products and distribution of tetracycline resistance 
determinants in E. coli from food animals. Vet Microbiol 95, 91-101 (2003). 
21 Ramírez Castillo, F. et al. Antimicrobial resistance: the role of aquatic 
environments. Vol. 2 (2014). 
22 Ye, Q. & Weinberg, H. S. Occurrence of Antibiotics in Drinking Water Department 
of Environmental Sciences and Engineering. The University of North Carolina at 
Chapel Hill (2004). 
23 Sui, Q. et al. Occurrence, sources and fate of pharmaceuticals and personal care 
products in the groundwater: A review. Emerging Contaminants 1, 14-24, 
doi:https://doi.org/10.1016/j.emcon.2015.07.001 (2015). 
24 Renew, J. E. & Huang, C.-H. Simultaneous determination of fluoroquinolone, 
sulfonamide, and trimethoprim antibiotics in wastewater using tandem solid phase 
extraction and liquid chromatography–electrospray mass spectrometry. Journal of 
Chromatography A 1042, 113-121, 
doi:https://doi.org/10.1016/j.chroma.2004.05.056 (2004). 
25 de Jesus Gaffney, V. et al. Occurrence and behaviour of pharmaceutical 
compounds in a Portuguese wastewater treatment plant: Removal efficiency through 
conventional treatment processes. Environ Sci Pollut Res Int 24, 14717-14734, 
doi:10.1007/s11356-017-9012-7 (2017). 
26 Hughes, S. R., Kay, P. & Brown, L. E. Global Synthesis and Critical Evaluation of 
Pharmaceutical Data Sets Collected from River Systems. Environmental Science & 
Technology 47, 661-677, doi:10.1021/es3030148 (2013). 
27 Golet, E. M., Xifra, I., Siegrist, H., Alder, A. C. & Giger, W. Environmental 
Exposure Assessment of Fluoroquinolone Antibacterial Agents from Sewage to Soil. 
Environmental Science & Technology 37, 3243-3249, doi:10.1021/es0264448 
(2003). 
28 Batt, A. L., Bruce, I. B. & Aga, D. S. Evaluating the vulnerability of surface waters 
to antibiotic contamination from varying wastewater treatment plant discharges. 
Environ Pollut 142, 295-302, doi:10.1016/j.envpol.2005.10.010 (2006). 
29 Rodriguez-Mozaz, S. et al. Occurrence of antibiotics and antibiotic resistance 
genes in hospital and urban wastewaters and their impact on the receiving river. 
Water Research 69, 234-242, doi:https://doi.org/10.1016/j.watres.2014.11.021 
(2015). 
30 Pereira, A. M. P. T., Silva, L. J. G., Meisel, L. M., Lino, C. M. & Pena, A. 
Environmental impact of pharmaceuticals from Portuguese wastewaters: 
geographical and seasonal occurrence, removal and risk assessment. Environmental 
Research 136, 108-119, doi:https://doi.org/10.1016/j.envres.2014.09.041 (2015). 
31 Castiglioni, S., Bagnati, R., Calamari, D., Fanelli, R. & Zuccato, E. A multiresidue 
analytical method using solid-phase extraction and high-pressure liquid 
chromatography tandem mass spectrometry to measure pharmaceuticals of different  
therapeutic classes in urban wastewaters. Journal of Chromatography A 1092, 206-
215, doi:https://doi.org/10.1016/j.chroma.2005.07.012 (2005). 
32 Watkinson, A. J., Murby, E. J. & Costanzo, S. D. Removal of antibiotics in 
conventional and advanced wastewater treatment: implications for environmental 
discharge and wastewater recycling. Water Res 41, 4164-4176, 
doi:10.1016/j.watres.2007.04.005 (2007). 
 91 
 
33 Pruden, A. et al. Management options for reducing the release of antibiotics and 
antibiotic resistance genes to the environment. Environ Health Perspect 121, 878-
885, doi:10.1289/ehp.1206446 (2013). 
34 Deo, R. & Halden, R. Pharmaceuticals in the Built and Natural Water Environment  
of the United States. Water 5, 1346-1365, doi:10.3390/w5031346 (2013). 
35 Carvalho, R. et al. European Commission. JRC Science for Policy Report. 
Monitoring-based Exercise: Second Review of the Priority Substances List under the 
Water Framework Directive.  (2016). 
36 European Commission. COMMISSION DIRECTIVE (EU) 2015/1787 of 6 October 
2015 amending Annexes II and III to Council Directive 98/83/EC on the quality of 
water intended for human consumption.  (2015). 
37 European Commission. COUNCIL DIRECTIVE 98/83/EC of 3 November 1998 on 
the quality of water intended for human consumption. (1998). 
38 Gullberg, E. et al. Selection of Resistant Bacteria at Very Low Antibiotic 
Concentrations. PLOS Pathogens 7, e1002158, doi:10.1371/journal.ppat.1002158 
(2011). 
39 Zuccato, E., Calamari, D., Natangelo, M. & Fanelli, R. Presence of therapeutic 
drugs in the environment. Lancet 355, 1789-1790, doi:10.1016/S0140-
6736(00)02270-4 (2000). 
40 Ye, Z., Weinberg, H. S. & Meyer, M. T. Trace analysis of trimethoprim and 
sulfonamide, macrolide, quinolone, and tetracycline antibiotics in chlorinated drinking 
water using liquid chromatography electrospray tandem mass spectrometry. Anal 
Chem 79, 1135-1144, doi:10.1021/ac060972a (2007). 
41 Li, N., Ho, K. W. K., Ying, G. G. & Deng, W. J. Veterinary antibiotics in food, 
drinking water, and the urine of preschool children in Hong Kong. Environ Int 108, 
246-252, doi:10.1016/j.envint.2017.08.014 (2017). 
42 Wang, H. et al. Antibiotics in Drinking Water in Shanghai and Their Contribution 
to Antibiotic Exposure of School Children. Environmental Science & Technology 50, 
2692-2699, doi:10.1021/acs.est.5b05749 (2016). 
43 Watkinson, A. J., Murby, E. J., Kolpin, D. W. & Costanzo, S. D. The occurrence of 
antibiotics in an urban watershed: from wastewater to drinking water. Sci Total 
Environ 407, 2711-2723, doi:10.1016/j.scitotenv.2008.11.059 (2009). 
44 Stackelberg, P. E. et al. Persistence of pharmaceutical compounds and other 
organic wastewater contaminants in a conventional drinking-water-treatment plant. 
Sci Total Environ 329, 99-113, doi:10.1016/j.scitotenv.2004.03.015 (2004). 
45 World Health Organization. Pharmaceuticals in drinking-water. Technical Report. 
ISBN: 978 9241502085.  (2012). 
46 Focazio, M. J. et al. A national reconnaissance for pharmaceuticals and other 
organic wastewater contaminants in the United States — II) Untreated drinking water 
sources. Science of The Total Environment  402, 201-216, 
doi:https://doi.org/10.1016/j.scitotenv.2008.02.021 (2008). 
47 López-Serna, R., Pérez, S., Ginebreda, A., Petrović, M. & Barceló, D. Fully 
automated determination of 74 pharmaceuticals in environmental and waste waters 
by online solid phase extraction–liquid chromatography-electrospray–tandem mass 
spectrometry. Talanta 83, 410-424, 
doi:https://doi.org/10.1016/j.talanta.2010.09.046 (2010). 
48 Simazaki, D. et al. Occurrence of selected pharmaceuticals at drinking water 
purification plants in Japan and implications for human health. Water Research 76, 
187-200, doi:https://doi.org/10.1016/j.watres.2015.02.059 (2015). 
49 Vieno, N. M., Härkki, H., Tuhkanen, T. & Kronberg, L. Occurrence of 
Pharmaceuticals in River Water and Their Elimination in a Pilot -Scale Drinking Water 
Treatment Plant. Environmental Science & Technology 41, 5077-5084, 
doi:10.1021/es062720x (2007). 
 92 
 
50 Morasch, B. et al. Occurrence and fate of micropollutants in the Vidy Bay of Lake 
Geneva, Switzerland. Part II: Micropollutant removal between wastewater and raw 
drinking water. Environmental Toxicology and Chemistry 29, 1658-1668, 
doi:10.1002/etc.222 (2010). 
51 Yiruhan et al. Determination of four fluoroquinolone antibiotics in tap water in 
Guangzhou and Macao. Environ Pollut 158, 2350-2358, 
doi:10.1016/j.envpol.2010.03.019 (2010). 
52 Cabeza, Y., Candela, L., Ronen, D. & Teijon, G. Monitoring the occurrence of 
emerging contaminants in treated wastewater and groundwater between 2008 and 
2010. The Baix Llobregat (Barcelona, Spain). J Hazard Mater 239-240, 32-39, 
doi:10.1016/j.jhazmat.2012.07.032 (2012). 
53 Huntscha, S., Singer, H. P., McArdell, C. S., Frank, C. E. & Hollender, J. 
Multiresidue analysis of 88 polar organic micropollutants in ground, surface and 
wastewater using online mixed-bed multilayer solid-phase extraction coupled to high 
performance liquid chromatography–tandem mass spectrometry. Journal of 
Chromatography A 1268, 74-83, doi:https://doi.org/10.1016/j.chroma.2012.10.032 
(2012). 
54 de Jesus Gaffney, V. et al. Occurrence of pharmaceuticals in a water supply 
system and related human health risk assessment. Water Research 72, 199-208, 
doi:https://doi.org/10.1016/j.watres.2014.10.027 (2015). 
55 Houtman, C. J., Kroesbergen, J., Lekkerkerker-Teunissen, K. & van der Hoek, J. 
P. Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking 
water and its sources based on frequent monitoring data. Science of The Total 
Environment 496, 54-62, doi:https://doi.org/10.1016/j.scitotenv.2014.07.022 
(2014). 
56 García-Galán, M. J., Villagrasa, M., Díaz-Cruz, M. S. & Barceló, D. LC-QqLIT MS 
analysis of nine sulfonamides and one of their acetylated metabolites in the Llobregat  
River basin. Quantitative determination and qualitative evaluation by IDA 
experiments. Analytical and Bioanalytical Chemistry 397, 1325-1334, 
doi:10.1007/s00216-010-3630-y (2010). 
57 Benotti, M. J. et al. Pharmaceuticals and Endocrine Disrupting Compounds in U.S. 
Drinking Water. Environmental Science & Technology 43, 597-603, 
doi:10.1021/es801845a (2009). 
58 Loos, R. et al. Pan-European survey on the occurrence of selected polar organic  
persistent pollutants in ground water. Water Research 44, 4115-4126, 
doi:https://doi.org/10.1016/j.watres.2010.05.032 (2010). 
59 Glassmeyer, S. T. et al. Nationwide reconnaissance of contaminants of emerging 
concern in source and treated drinking waters of the United States. Science of The 
Total Environment 581-582, 909-922, 
doi:https://doi.org/10.1016/j.scitotenv.2016.12.004 (2017). 
60 Stackelberg, P. E. et al. Efficiency of conventional drinking-water-treatment  
processes in removal of pharmaceuticals and other organic compounds. Science of 
The Total Environment 377, 255-272, 
doi:https://doi.org/10.1016/j.scitotenv.2007.01.095 (2007). 
61 Diana, J. S. et al. Responsible aquaculture in 2050: valuing local conditions and 
human innovations will be key to success. Bioscience 63, 255-262 (2013). 
62 European Commission, E. C. Commission staff working paper. Impact  
assessment. Accompanying commission proposal for a regulation of the European 
Parliament and of the Council on the Common Fisheries Policy [repealing Regulation 
(EC) N° 2371/2002]. (2011). 
63 European Commission. Report on the implementation of national residue 
monitoring plans in the Member States in 2015 (Council 
Directive 96/23/EC).  (2015). 
64 Dhar, A. K., Manna, S. K. & Thomas Allnutt, F. C. Viral vaccines for farmed finfish. 
Virusdisease 25, 1-17, doi:10.1007/s13337-013-0186-4 (2014). 
 93 
 
65 Gudding, R. & Van Muiswinkel, W. B. A history of fish vaccination: science-based 
disease prevention in aquaculture. Fish Shellfish Immunol 35, 1683-1688, 
doi:10.1016/j.fsi.2013.09.031 (2013). 
66 Brudeseth, B. E. et al. Status and future perspectives of vaccines for 
industrialised fin-fish farming. Fish Shellfish Immunol 35, 1759-1768, 
doi:10.1016/j.fsi.2013.05.029 (2013). 
67 Niewold, T. A. The nonantibiotic anti-inflammatory effect of antimicrobial growth 
promoters, the real mode of action? A hypothesis. Poult Sci 86, 605-609 (2007). 
68 Casewell, M., Friis, C., Marco, E., McMullin, P. & Phillips, I. The European ban on 
growth-promoting antibiotics and emerging consequences for human and animal 
health. J Antimicrob Chemother 52, 159-161, doi:10.1093/jac/dkg313 (2003). 
69 Administration, U. S. F. a. D. FDA's Strategy on Antimicrobial Resistance - 
Questions and Answers. 
https://www.fda.gov/AnimalVeterinary/GuidanceComplianceEnforcement/Guidancef
orIndustry/ucm216939.htm (2017). 
70 European Commission. Communication from the commission to the European 
Parliament and the council. Action plan against the rising threats from Antimicrobial 
Resistance. COM (2011) 748 (2011). 
71 Murphy, D. et al. EMA and EFSA Joint Scientific Opinion on measures to reduce 
the need to use antimicrobial agents in animal husbandry in the European Union, and 
the resulting impacts on food safety (RONAFA). EFSA Journal 15, 
doi:10.2903/j.efsa.2017.4666 (2017). 
72 Ghidini, S., Zanardi, E., Varisco, G. & Chizzolini, R. Annuali della Facoltà di 
Medicina Veterinaria di Parma . Prevalence of molecules of ß-lactam antibiotics in 
bovine milk in Lombardia and Emilia Romagna (Italy).  XXII, 245-252 (2002). 
73 European Commission. COUNCIL REGULATION (EEC) No 2377/90 of 26 June 
1990 laying down a Community  procedure for the  establishment of maximum  
residue limits of veterinary medicinal products in foodstuffs of animal origin (1990).  
74 European Food Safety Authority (EFSA). Report for 2015 on the results from the 
monitoring of veterinary medicinal product residues and other substances in live 
animals and animal products. Technical Report. . doi:10.2903/sp.efsa.2017. (2017).  
75 Martinez-Carballo, E., Gonzalez-Barreiro, C., Scharf, S. & Gans, O. Environmental 
monitoring study of selected veterinary antibiotics in animal manure and soils in 
Austria. Environ Pollut 148, 570-579, doi:10.1016/j.envpol.2006.11.035 (2007). 
76 Zhao, L., Dong, Y. H. & Wang, H. Residues of veterinary antibiotics in manures 
from feedlot livestock in eight provinces of China. Sci Total Environ 408, 1069-1075, 
doi:10.1016/j.scitotenv.2009.11.014 (2010). 
77 Pan, M. & Chu, L. M. Transfer of antibiotics from wastewater or animal manure 
to soil and edible crops. Environ Pollut 231, 829-836, 
doi:10.1016/j.envpol.2017.08.051 (2017). 
78 Sarmah, A. K., Meyer, M. T. & Boxall, A. B. A global perspective on the use, sales, 
exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the 
environment. Chemosphere 65, 725-759, doi:10.1016/j.chemosphere.2006.03.026 
(2006). 
79 Tlili, I. et al. Simultaneous detection of antibiotics and other drug residues in the 
dissolved and particulate phases of water by an off-line SPE combined with on-line 
SPE-LC-MS/MS: Method development and application. Science of The Total 
Environment 563-564, 424-433, 
doi:https://doi.org/10.1016/j.scitotenv.2016.04.101 (2016). 
80 Wu, C., Witter, J. D., Spongberg, A. L. & Czajkowski, K. P. Occurrence of selected 
pharmaceuticals in an agricultural landscape, western Lake Erie basin. Water 
Research 43, 3407-3416, doi:https://doi.org/10.1016/j.watres.2009.05.014 (2009). 
81 Gbylik-Sikorska, M., Posyniak, A., Sniegocki, T. & Zmudzki, J. Liquid 
chromatography–tandem mass spectrometry multiclass method for the 
determination of antibiotics residues in water samples from water supply systems in 
 94 
 
food-producing animal farms. Chemosphere 119, 8-15, 
doi:https://doi.org/10.1016/j.chemosphere.2014.04.105 (2015). 
82 Fernandes, M. M. et al. Nanotransformation of Vancomycin Overcomes the 
Intrinsic Resistance of Gram-Negative Bacteria. ACS Appl Mater Interfaces 9, 15022-
15030, doi:10.1021/acsami.7b00217 (2017). 
83 Yoneyama, H. & Katsumata, R. Antibiotic resistance in bacteria and its future for 
novel antibiotic development. Biosci Biotechnol Biochem 70, 1060-1075, 
doi:10.1271/bbb.70.1060 (2006). 
84 Melnyk, A. H., Wong, A. & Kassen, R. The fitness costs of antibiotic resistance 
mutations. Evol Appl 8, 273-283, doi:10.1111/eva.12196 (2015). 
85 European Centre for Disease Prevention and Control (ECDC),European Food 
Safety Authority (EFSA) and European Medicines Agency (EMA). ECDC/EFSA/EMA 
second joint report on the integrated analysis of the consumption of antimicrobial 
agents and occurrence of antimicrobial resistance in bacteria from humans and food-
producing animals. Joint Interagency Antimicrobial Consumption and Resistance 
Analysis (JIACRA) Report. doi:10.2903/j.efsa.2017.4872 (2017). 
86 Toma, A. & Deyno, S. Overview on mechanisms of antibacterial resistance. 
International Journal of Research in Pharmacy and Biosciences 2, 27-36 (2015). 
87 Munita, J. M. & Arias, C. A. Mechanisms of Antibiotic Resistance. Microbiology 
spectrum 4, 10.1128/microbiolspec.VMBF-0016-2015, 
doi:10.1128/microbiolspec.VMBF-0016-2015 (2016). 
88 Lupo, A., Coyne, S. & Berendonk, T. U. Origin and evolution of antibiotic 
resistance: the common mechanisms of emergence and spread in water bodies. Front 
Microbiol 3, 18, doi:10.3389/fmicb.2012.00018 (2012). 
89 Marti, E., Variatza, E. & Balcázar, J. L. Bacteriophages as a reservoir of extended-
spectrum β -lactamase and fluoroquinolone resistance genes in the environment . 
Clinical Microbiology and Infection 20, O456-O459, 
doi:https://doi.org/10.1111/1469-0691.12446 (2014). 
90 Colomer-Lluch, M., Jofre, J. & Muniesa, M. Antibiotic Resistance Genes in the 
Bacteriophage DNA Fraction of Environmental Samples. PLoS ONE 6, e17549, 
doi:10.1371/journal.pone.0017549 (2011). 
91 Jończyk, E., Kłak, M., Międzybrodzki, R. & Górski, A. The influence of external 
factors on bacteriophages — review. Folia Microbiologica 56, 191-200, 
doi:10.1007/s12223-011-0039-8 (2011). 
92 Azucena, E. & Mobashery, S. Aminoglycoside-modifying enzymes: mechanisms 
of catalytic processes and inhibition. Drug Resist Updat 4, 106-117, 
doi:10.1054/drup.2001.0197 (2001). 
93 Santajit, S. & Indrawattana, N. Mechanisms of Antimicrobial Resistance in 
ESKAPE Pathogens. BioMed Research International 2016, 8, 
doi:10.1155/2016/2475067 (2016). 
94 Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O. & Piddock, L. J. V. 
Molecular mechanisms of antibiotic resistance. Nat Rev Micro 13, 42-51, 
doi:10.1038/nrmicro3380 (2015). 
95 Fernandes, R., Amador, P. & Prudêncio, C. β-Lactams: chemical structure, mode 
of action and mechanisms of resistance. Reviews in Medical Microbiology 24, 7-17, 
doi:10.1097/MRM.0b013e3283587727 (2013). 
96 Li, H., Luo, Y.-F., Williams, B. J., Blackwell, T. S. & Xie, C.-M. Structure and 
function of OprD protein in Pseudomonas aeruginosa: From antibiotic resistance to 
novel therapies. International journal of medical microbiology : IJMM 302, 
10.1016/j.ijmm.2011.1010.1001, doi:10.1016/j.ijmm.2011.10.001 (2012). 
97 Keith, P. Outer Membranes and Efflux: The Path to Multidrug Resistance in Gram-  
Negative Bacteria. Current Pharmaceutical Biotechnology 3, 77-98, 
doi:http://dx.doi.org/10.2174/1389201023378454 (2002). 
 95 
 
98 Alvarez-Ortega, C., Olivares, J. & Martínez, J. L. RND multidrug efflux pumps: 
what are they good for? Frontiers in Microbiology 4, 7, 
doi:10.3389/fmicb.2013.00007 (2013). 
99 Poole, K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas 
aeruginosa and related organisms. J Mol Microbiol Biotechnol 3, 255-264 (2001). 
100 Blanco, P. et al. Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic 
Resistance Determinants. Microorganisms 4, 14, 
doi:10.3390/microorganisms4010014 (2016). 
101 Fernández, L. & Hancock, R. E. W. Adaptive and mutational resistance: role of 
porins and efflux pumps in drug resistance. Clinical microbiology reviews 25, 661-
681, doi:10.1128/CMR.00043-12 (2012). 
102 Long, K. S. & Vester, B. Resistance to linezolid caused by modifications at its 
binding site on the ribosome. Antimicrob Agents Chemother 56, 603-612, 
doi:10.1128/AAC.05702-11 (2012). 
103 Hartmann, G., Honikel, K. O., Knusel, F. & Nuesch, J. The specific inhibition of 
the DNA-directed RNA synthesis by rifamycin. Biochim Biophys Acta 145, 843-844 
(1967). 
104 Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S. & Vester, B. The Cfr 
rRNA methyltransferase confers resistance to Phenicols, Lincosamides, 
Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics. Antimicrobial agents 
and chemotherapy 50, 2500-2505, doi:10.1128/AAC.00131-06 (2006). 
105 Zervosen, A., Sauvage, E., Frere, J. M., Charlier, P. & Luxen, A. Development of 
new drugs for an old target: the penicillin binding proteins. Molecules 17, 12478-
12505, doi:10.3390/molecules171112478 (2012). 
106 Nikolaidis, I., Favini-Stabile, S. & Dessen, A. Resistance to antibiotics targeted to 
the bacterial cell wall. Protein science : a publication of the Protein Society 23, 243-
259, doi:10.1002/pro.2414 (2014). 
107 Pandey, P. K., Kass, P. H., Soupir, M. L., Biswas, S. & Singh, V. P. Contamination 
of water resources by pathogenic bacteria. AMB Express 4, 51, doi:10.1186/s13568-
014-0051-x (2014). 
108 Walsh, F. Investigating antibiotic resistance in non-clinical environments. 
Frontiers in Microbiology 4, 19, doi:10.3389/fmicb.2013.00019 (2013). 
109 Tanwar, J., Das, S., Fatima, Z. & Hameed, S. Multidrug Resistance: An Emerging 
Crisis. Interdisciplinary Perspectives on Infectious Diseases (2014). 
110 Baquero, F., Martínez, J.-L. & Cantón, R. Antibiotics and antibiotic resistance in 
water environments. Current Opinion in Biotechnology 19, 260-265, 
doi:10.1016/j.copbio.2008.05.006 (2008). 
111 Poirel, L., Liard, A., Rodriguez-Martinez, J. M. & Nordmann, P. Vibrionaceae as a 
possible source of Qnr-like quinolone resistance determinants. J Antimicrob 
Chemother 56, 1118-1121, doi:10.1093/jac/dki371 (2005). 
112 Perry, J. A. & Wright, G. D. The antibiotic resistance “mobilome”: searching for 
the link between environment and clinic. Frontiers in Microbiology 4, 138, 
doi:10.3389/fmicb.2013.00138 (2013). 
113 Nordmann, P. & Poirel, L. Emergence of plasmid-mediated resistance to 
quinolones in Enterobacteriaceae. J Antimicrob Chemother 56, 463-469, 
doi:10.1093/jac/dki245 (2005). 
114 Cattoir, V., Poirel, L., Aubert, C., Soussy, C.-J. & Nordmann, P. Unexpected 
Occurrence of Plasmid-Mediated Quinolone Resistance Determinants in 
Environmental Aeromonas spp. Emerging Infectious Diseases 14, 231-237, 
doi:10.3201/eid1402.070677 (2008). 
115 Martínez-Martínez, L., Pascual, A. & Jacoby, G. A. Quinolone resistance from a 
transferable plasmid. The Lancet 351, 797-799, doi:https://doi.org/10.1016/S0140-
6736(97)07322-4 (1998). 
 96 
 
116 Salyers, A. A. & Amábile-Cuevas, C. F. Why are antibiotic resistance genes so 
resistant to elimination? Antimicrobial Agents and Chemotherapy 41, 2321-2325 
(1997). 
117 Hatha, A. A. M. et al. Relatively high antibiotic resistance among heterotrophic  
bacteria from arctic fjord sediments than water – Evidence towards better selection 
pressure in the fjord sediments. Polar Science 9, 382-388, 
doi:https://doi.org/10.1016/j.polar.2015.10.002 (2015). 
118 Pruden, A., Arabi, M. & Storteboom, H. N. Correlation between upstream human 
activities and riverine antibiotic resistance genes. Environ Sci Technol 46, 11541-
11549, doi:10.1021/es302657r (2012). 
119 Karkman, A., Do, T. T., Walsh, F. & Virta, M. P. J. Ant ibiotic-Resistance Genes in 
Waste Water. Trends Microbiol 26, 220-228, doi:10.1016/j.tim.2017.09.005 (2018).  
120 Szczepanowski, R. et al. Detection of 140 clinically relevant antibiotic -resistance 
genes in the plasmid metagenome of wastewater treatment plant bacteria showing 
reduced susceptibility to selected antibiotics. Microbiology 155, 2306-2319, 
doi:doi:10.1099/mic.0.028233-0 (2009). 
121 Mao, D. et al. Prevalence and proliferation of antibiotic resistance genes in two 
municipal wastewater treatment plants. Water Research 85, 458-466, 
doi:https://doi.org/10.1016/j.watres.2015.09.010 (2015). 
122 Yang, Y., Xu, C., Cao, X., Lin, H. & Wang, J. Antibiotic resistance genes in surface 
water of eutrophic urban lakes are related to heavy metals, antibiotics, lake 
morphology and anthropic impact. Ecotoxicology 26, 831-840, doi:10.1007/s10646-
017-1814-3 (2017). 
123 Zhou, Z. C. et al. Antibiotic resistance genes in an urban river as impacted by 
bacterial community and physicochemical parameters. Environ Sci Pollut Res Int 24, 
23753-23762, doi:10.1007/s11356-017-0032-0 (2017). 
124 Blaak, H. et al. RIVM report 703719071/2011. Prevalence of antibiotic resistant 
bacteria in the rivers Meuse, Rhine, and New Meuse.  (2011). 
125 Balcázar, J. L., Subirats, J. & Borrego, C. M. The role of biofilms as environmental 
reservoirs of antibiotic resistance. Frontiers in Microbiology 6, 1216-1216, 
doi:10.3389/fmicb.2015.01216 (2015). 
126 Stewart, P. S. Mechanisms of antibiotic resistance in bacterial biofilms. 
International Journal of Medical Microbiology 292, 107-113, 
doi:https://doi.org/10.1078/1438-4221-00196 (2002). 
127 Marti, E., Jofre, J. & Balcazar, J. L. Prevalence of Antibiotic Resistance Genes and 
Bacterial Community Composition in a River Influenced by a Wastewater Treatment  
Plant. PLoS ONE 8, e78906, doi:10.1371/journal.pone.0078906 (2013). 
128 Winkworth, C. L. Antibiotic resistance genes in freshwater biofilms along a whole 
river. J Water Health 11, 186-198, doi:10.2166/wh.2013.223 (2013). 
129 Pal, C., Bengtsson-Palme, J., Kristiansson, E. & Larsson, D. G. J. Co-occurrence 
of resistance genes to antibiotics, biocides and metals reveals novel insights into their 
co-selection potential. BMC Genomics 16, 964-964, doi:10.1186/s12864-015-2153-
5 (2015). 
130 Enne, V. I., Bennett, P. M., Livermore, D. M. & Hall, L. M. C. Enhancement of 
host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure. 
Journal of Antimicrobial Chemotherapy 53, 958-963 (2004). 
131 Wales, A. D. & Davies, R. H. Co-Selection of Resistance to Antibiotics, Biocides 
and Heavy Metals, and Its Relevance to Foodborne Pathogens. Antibiotics 4, 567-
604, doi:10.3390/antibiotics4040567 (2015). 
132 Baker-Austin, C., Wright, M. S., Stepanauskas, R. & McArthur, J. V. Co-selection 
of antibiotic and metal resistance. Trends in Microbiology 14, 176-182, 
doi:https://doi.org/10.1016/j.tim.2006.02.006 (2006). 
133 Seiler, C. & Berendonk, T. U. Heavy metal driven co-selection of antibiotic 
resistance in soil and water bodies impacted by agric ulture and aquaculture. Frontiers 
in Microbiology 3, 399, doi:10.3389/fmicb.2012.00399 (2012). 
 97 
 
134 Singer, A. C., Shaw, H., Rhodes, V. & Hart, A. Review of Antimicrobial Resistance 
in the Environment and Its Relevance to Environmental Regulators. Frontiers in 
Microbiology 7, 1728, doi:10.3389/fmicb.2016.01728 (2016). 
135 SCENIHR . Assessment of the Antibiotic Resistance Effects of Biocides. Scientific 
Committee on Emerging and Newly Identified Health Risks, European Commission; 
Brussels, Belgium. 1-87 (2009). 
136 Lemire, J. A., Harrison, J. J. & Turner, R. J. Antimicrobial activity of metals: 
mechanisms, molecular targets and applications. Nature Reviews Microbiology 11, 
371, doi:10.1038/nrmicro3028 
          https://www.nature.com/articles/nrmicro3028#supplementary-information 
(2013). 
137 Rupp, M. E. et al. Effect of silver-coated urinary catheters: Efficacy, cost-
effectiveness, and antimicrobial resistance. American Journal of Infection Control 32, 
445-450, doi:https://doi.org/10.1016/j.ajic.2004.05.002 (2004). 
138 Fang, L. et al. Co-spread of metal and antibiotic resistance within ST3-IncHI2 
plasmids from E. coli isolates of food-producing animals. Scientific Reports 6, 25312-
25312, doi:10.1038/srep25312 (2016). 
139 von Wintersdorff, C. J. H. et al. Dissemination of Antimicrobial Resistance in 
Microbial Ecosystems through Horizontal Gene Transfer. Frontiers in Microbiology 7, 
doi:10.3389/fmicb.2016.00173 (2016). 
140 Gillings, M. et al. The Evolution of Class 1 Integrons and the Rise of Antibiotic 
Resistance. Journal of Bacteriology 190, 5095-5100, doi:10.1128/JB.00152-08 
(2008). 
141 Cantón, R. & Ruiz-Garbajosa, P. Co-resistance: an opportunity for the bacteria 
and resistance genes. Current Opinion in Pharmacology 11, 477-485, 
doi:https://doi.org/10.1016/j.coph.2011.07.007 (2011). 
142 Gillings, M. R., Holley, M. P. & Stokes, H. W. Evidence for dynamic exchange of 
qac gene cassettes between class 1 integrons and other integrons in freshwater 
biofilms. FEMS Microbiology Letters 296, 282-288 (2009). 
143 Pal, C. et al. in Advances in Microbial Physiology Vol. 70  (ed Robert K. Poole)  
261-313 (Academic Press, 2017). 
144 Cheng, J., Hicks, D. B. & Krulwich, T. A. The purified Bacillus subtilis tetracycline 
efflux protein TetA(L) reconstitutes both tetracycline–cobalt/H(+) and 
Na(+)(K(+))/H(+) exchange. Proceedings of the National Academy of Sciences of the 
United States of America 93, 14446-14451 (1996). 
145 Chuanchuen, R. et al. Cross-Resistance between Triclosan and Antibiotics 
in<em>Pseudomonas aeruginosa</em> Is Mediated by Multidrug Efflux Pumps: 
Exposure of a Susceptible Mutant Strain to Triclosan Selects <em>nfxB</em> 
Mutants Overexpressing MexCD-OprJ. Antimicrobial Agents and Chemotherapy 45, 
428-432, doi:10.1128/aac.45.2.428-432.2001 (2001). 
146 Masuda, N. & Ohya, S. Cross-resistance to meropenem, cephems, and quinolones 
in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 36, 1847-
1851, doi:10.1128/aac.36.9.1847 (1992). 
147 Perron, K. et al. CzcR-CzcS, a Two-component System Involved in Heavy Metal 
and Carbapenem Resistance in Pseudomonas aeruginosa. Journal of Biologic al 
Chemistry 279, 8761-8768, doi:10.1074/jbc.M312080200 (2004). 
148 Han, F. X. et al. Industrial age anthropogenic inputs of heavy metals into the 
pedosphere. Naturwissenschaften 89, 497-504, doi:10.1007/s00114-002-0373-4 
(2002). 
149 Burridge, L., Weis, J. S., Cabello, F., Pizarro, J. & Bostick, K. Chemical use in 
salmon aquaculture: A review of current practices and possible environmental effects. 
Aquaculture 306, 7-23, doi:10.1016/j.aquaculture.2010.05.020 (2010). 
150 Canli, M. & Atli, G. The relationships between heavy metal (Cd, Cr, Cu, Fe, Pb, 
Zn) levels and the size of six Mediterranean fish species. Environmental Pollution 
121, 129-137 (2003). 
 98 
 
151 Jaishankar, M., Tseten, T., Anbalagan, N., Mathew, B. B. & Beeregowda, K. N. 
Toxicity, mechanism and health effects of some heavy metals. Interdisciplinary 
Toxicology 7, 60-72, doi:10.2478/intox-2014-0009 (2014). 
152 Nies, D. H. Microbial heavy-metal resistance. Applied Microbiology and 
Biotechnology 51, 730-750, doi:10.1007/s002530051457 (1999). 
153 Desoize, B. Metals and Metal Compounds in Cancer Treatment. Anticancer 
Research 24, 1529-1544 (2004). 
154 LÓPez-Alonso, M. et al. The Effect of Pig Farming on Copper and Zinc 
Accumulation in Cattle in Galicia (North-Western Spain). The Veterinary Journal 160, 
259-266, doi:https://doi.org/10.1053/tvjl.2000.0503 (2000). 
155 Han, F. X., Kingery, W. L., Selim, H. M. & Gerard, P. D. Accumulation of heavy 
metals in a long-term poultry waste-amended soil. Soil Science 165, 
doi:10.1097/00010694-200003000-00008 (2000). 
156 Nikolaou, M., Neofitou, N., Skordas, K., Castritsi-Catharios, J. & L, T. Fish 
Farming and Antifouling Paints: A Potential Source of Cu and Zn in Farmed Fish. Vol. 
5 (2014). 
157 Defarge, N., Spiroux de Vendômois, J. & Séralini, G. E. Toxicity of formulants and 
heavy metals in glyphosate-based herbicides and other pesticides. Toxicology Reports 
5, 156-163, doi:https://doi.org/10.1016/j.toxrep.2017.12.025 (2018). 
158 Lloyd, N. A., Janssen, S. E., Reinfelder, J. R. & Barkay, T. Co-selection of Mercury 
and Multiple Antibiotic Resistances in Bacteria Exposed to Mercury in the Fundulus 
heteroclitus Gut Microbiome. Current Microbiology 73, 834-842, 
doi:10.1007/s00284-016-1133-6 (2016). 
159 Di Cesare, A., Eckert, E. & Corno, G. Co-selection of antibiotic and heavy metal 
resistance in freshwater bacteria. Journal of Limnology; Vol. 75, No. 2s (2016): Lake 
Orta: a new lease on life (2016). 
160 Mata, M. T., Baquero, F. & Perez-Diaz, J. C. A multidrug efflux transporter in 
Listeria monocytogenes. FEMS Microbiol Lett 187, 185-188 (2000). 
161 Ji, X. et al. Antibiotic resistance gene abundances associated with antibiotics and 
heavy metals in animal manures and agricultural soils adjacent to feedlots in 
Shanghai; China. Journal of Hazardous Materials 235-236, 178-185, 
doi:https://doi.org/10.1016/j.jhazmat.2012.07.040 (2012). 
162 Knapp, C. W. et al. Relationship between antibiotic resistance genes and metals 
in residential soil samples from Western Australia. Environmental Science and 
Pollution Research International 24, 2484-2494, doi:10.1007/s11356-016-7997-y 
(2017). 
163 Di Cesare, A. et al. Co-occurrence of integrase 1, antibiotic and heavy metal 
resistance genes in municipal wastewater treatment plants. Water Research 94, 208-
214, doi:https://doi.org/10.1016/j.watres.2016.02.049 (2016). 
164 Garner, E. et al. Metagenomic profiling of historic Colorado Front Range flood 
impact on distribution of riverine antibiotic resistance genes. Scientific Reports 6, 
38432, doi:10.1038/srep38432 
https://www.nature.com/articles/srep38432#supplementary-information (2016). 
165 Gupta, S. K., Shin, H., Han, D., Hur, H.-G. & Unno, T. Metagenomic analysis 
reveals the prevalence and persistence of antibiotic - and heavy metal-resistance 
genes in wastewater treatment plant. Journal of Microbiology 56, 408-415, 
doi:10.1007/s12275-018-8195-z (2018). 
166 Manasi, Rajesh, V., Santhana Krishna Kumar, A. & Rajesh, N. Biosorption of 
cadmium using a novel bacterium isolated from an electronic industry effluent. 
Chemical Engineering Journal 235, 176-185, 
doi:https://doi.org/10.1016/j.cej.2013.09.016 (2014). 
167 Rahman, Z. & Singh, V. P. Assessment of heavy metal contamination and Hg-
resistant bacteria in surface water from different regions of Delhi, India. Saudi Journal 
of Biological Sciences, doi:https://doi.org/10.1016/j.sjbs.2016.09.018 (2016). 
 99 
 
168 Matyar, F., Kaya, A. & Dinçer, S. Antibacterial agents and heavy metal resistance 
in Gram-negative bacteria isolated from seawater, shrimp and sediment in 
Iskenderun Bay, Turkey. Science of The Total Environment  407, 279-285, 
doi:https://doi.org/10.1016/j.scitotenv.2008.08.014 (2008). 
169 Matyar, F., Akkan, T., Uçak, Y. & Eraslan, B. Aeromonas and Pseudomonas: 
antibiotic and heavy metal resistance species from Iskenderun Bay, Turkey 
(northeast Mediterranean Sea). Environmental Monitoring and Assessment  167, 309-
320, doi:10.1007/s10661-009-1051-1 (2010). 
170 Wright, M. S., Peltier, G. L., Stepanauskas, R. & McArthur, J. V. Bacterial 
tolerances to metals and antibiotics in metal-contaminated and reference streams. 
FEMS Microbiology Ecology 58, 293-302, doi:10.1111/j.1574-6941.2006.00154. x 
(2006). 
171 Stepanauskas, R. et al. Coselection for microbial resistance to metals and 
antibiotics in freshwater microcosms. Environmental Microbiology 8, 1510-1514, 
doi:10.1111/j.1462-2920.2006.01091.x (2006). 
172 European Commission. COMMISSION REGULATION (EU) No 37/2010of 22 
December 2009on  pharmacologically  active  substances and  their  classification  
regarding  maximum residue limits in foodstuffs of animal origin.  (2010). 
173 Andreozzi, R. et al. Antibiotics in the Environment:  Occurrence in Italian STPs, 
Fate, and Preliminary Assessment on Algal Toxicity of Amoxicillin. Environmental 
Science & Technology 38, 6832-6838, doi:10.1021/es049509a (2004). 
174 Gros, M., Rodríguez-Mozaz, S. & Barceló, D. Rapid analysis of multiclass antibiotic 
residues and some of their metabolites in hospital, urban wastewater and river water 
by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion 
trap tandem mass spectrometry. Journal of Chromatography A 1292, 173-188, 
doi:https://doi.org/10.1016/j.chroma.2012.12.072 (2013). 
175 Loos, R. et al. EU-wide monitoring survey on emerging polar organic  
contaminants in wastewater treatment plant effluents. Water Research 47, 6475-
6487, doi:https://doi.org/10.1016/j.watres.2013.08.024 (2013). 
176 Rossmann, J., Schubert, S., Gurke, R., Oertel, R. & Kirch, W. Simultaneous 
determination of most prescribed antibiotics in multiple urban wastewater by SPE-
LC–MS/MS. Journal of Chromatography B 969, 162-170, 
doi:https://doi.org/10.1016/j.jchromb.2014.08.008 (2014). 
177 Papageorgiou, M., Kosma, C. & Lambropoulou, D. Seasonal occurrence, removal, 
mass loading and environmental risk assessment of 55 pharmaceuticals and personal 
care products in a municipal wastewater treatment plant in Central Greece. Science 
of The Total Environment 543, 547-569, 
doi:https://doi.org/10.1016/j.scitotenv.2015.11.047 (2016). 
178 Golovko, O., Kumar, V., Fedorova, G., Randak, T. & Grabic, R. Seasonal changes 
in antibiotics, antidepressants/psychiatric drugs, antihistamines and lipid regulators 
in a wastewater treatment plant. Chemosphere 111, 418-426, 
doi:https://doi.org/10.1016/j.chemosphere.2014.03.132 (2014). 
179 Birošová, L. et al. Pilot study of seasonal occurrence and distribution of antibiotics 
and drug resistant bacteria in wastewater treatment plants in Slovakia. Science of 
The Total Environment 490, 440-444, 
doi:https://doi.org/10.1016/j.scitotenv.2014.05.030 (2014). 
180 Johnson, A. C. et al. Linking changes in antibiotic effluent concentrations to flow, 
removal and consumption in four different UK sewage treatment plants over four 
years. Environmental Pollution 220, 919-926, 
doi:https://doi.org/10.1016/j.envpol.2016.10.077 (2017). 
181 Kasprzyk-Hordern, B., Dinsdale, R. M. & Guwy, A. J. The removal of 
pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during 
wastewater treatment and its impact on the quality of receiving waters. Water 
Research 43, 363-380, doi:https://doi.org/10.1016/j.watres.2008.10.047 (2009). 
 100 
 
182 Jia, A., Wan, Y., Xiao, Y. & Hu, J. Occurrence and fate of quinolone and 
fluoroquinolone antibiotics in a municipal sewage treatment plant. Water Research 
46, 387-394, doi:https://doi.org/10.1016/j.watres.2011.10.055 (2012). 
183 Gracia-Lor, E., Sancho, J. V., Serrano, R. & Hernández, F. Occurrence and 
removal of pharmaceuticals in wastewater treatment plants at the Spanish 
Mediterranean area of Valencia. Chemosphere 87, 453-462, 
doi:https://doi.org/10.1016/j.chemosphere.2011.12.025 (2012). 
184 McArdell, C. S., Molnar, E., Suter, M. J. F. & Giger, W. Occurrence and Fate of 
Macrolide Antibiotics in Wastewater Treatment Plants and in the Glatt Valley 
Watershed, Switzerland. Environmental Science & Technology 37, 5479-5486, 
doi:10.1021/es034368i (2003). 
185 Gao, P., Munir, M. & Xagoraraki, I. Correlation of tetracycline and sulfonamide 
antibiotics with corresponding resistance genes and resistant bacteria in a 
conventional municipal wastewater treatment plant. Science of The Total 
Environment 421-422, 173-183, 
doi:https://doi.org/10.1016/j.scitotenv.2012.01.061 (2012). 
186 Kosma, C. I., Lambropoulou, D. A. & Albanis, T. A. Investigation of PPCPs in 
wastewater treatment plants in Greece: Occurrence, removal and environmental risk 
assessment. Science of The Total Environment  466-467, 421-438, 
doi:https://doi.org/10.1016/j.scitotenv.2013.07.044 (2014). 
187 Kasprzyk-Hordern, B., Dinsdale, R. M. & Guwy, A. J. Multi-residue method for the 
determination of basic/neutral pharmaceuticals and illicit drugs in surface water by 
solid-phase extraction and ultra performance liquid chromatography–posit ive 
electrospray ionisation tandem mass spectrometry. Journal of Chromatography A 
1161, 132-145, doi:https://doi.org/10.1016/j.chroma.2007.05.074 (2007). 
188 Kasprzyk-Hordern, B., Dinsdale, R. M. & Guwy, A. J. The occurrence of 
pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in 
surface water in South Wales, UK. Water Research 42, 3498-3518, 
doi:10.1016/j.watres.2008.04.026 (2008). 
189 Zuccato, E., Castiglioni, S., Bagnati, R., Melis, M. & Fanelli, R. Source, occurrence 
and fate of antibiotics in the Italian aquatic environment. Journal of Hazardous 
Materials 179, 1042-1048, doi:https://doi.org/10.1016/j.jhazmat.2010.03.110 
(2010). 
190 Waiser, M. J., Humphries, D., Tumber, V. & Holm, J. Effluent-dominated streams. 
Part 2: Presence and possible effects of pharmaceuticals and personal care products 
in Wascana Creek, Saskatchewan, Canada. Environmental Toxicology and Chemistry 
30, 508-519, doi:10.1002/etc.398 (2010). 
191 Tuc Dinh, Q. et al. Measurement of trace levels of antibiotics in river water using 
on-line enrichment and triple-quadrupole LC–MS/MS. Talanta 85, 1238-1245, 
doi:https://doi.org/10.1016/j.talanta.2011.05.013 (2011). 
192 Alygizakis, N. A. et al. Occurrence and spatial distribution of 158 
pharmaceuticals, drugs of abuse and related metabolites in offshore seawater. 
Science of The Total Environment  541, 1097-1105, 
doi:https://doi.org/10.1016/j.scitotenv.2015.09.145 (2016). 
193 Lin, A. Y.-C. & Tsai, Y.-T. Occurrence of pharmaceuticals in Taiwan's surface 
waters: Impact of waste streams from hospitals and pharmaceutical production 
facilities. Science of The Total Environment  407, 3793-3802, 
doi:https://doi.org/10.1016/j.scitotenv.2009.03.009 (2009). 
194 Gros, M., Petrović, M. & Barceló, D. Wastewater treatment plants as a pathway 
for aquatic contamination by pharmaceuticals in the Ebro river basin (Northeast  
Spain. Environmental Toxicology and Chemistry 26, 1553-1562, doi:10.1897/06-
495R.1 (2007). 
195 Nakada, N. et al. Occurrence of 70 pharmaceutical and personal care products in 
Tone River basin in Japan. Water Science and Technology 56, 133-140, 
doi:10.2166/wst.2007.801 (2007). 
 101 
 
196 Bartelt-Hunt, S. L., Snow, D. D., Damon, T., Shockley, J. & Hoagland, K. The 
occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and 
surface waters in Nebraska. Environmental Pollution 157, 786-791, 
doi:https://doi.org/10.1016/j.envpol.2008.11.025 (2009). 
197 Grujić, S., Vasiljević, T. & Laušević, M. Determination of multiple pharmaceutical 
classes in surface and ground waters by liquid chromatography–ion trap–tandem 
mass spectrometry. Journal of Chromatography A 1216, 4989-5000, 
doi:https://doi.org/10.1016/j.chroma.2009.04.059 (2009). 
198 López-Serna, R., Petrović, M. & Barceló, D. Development  of a fast instrumental 
method for the analysis of pharmaceuticals in environmental and wastewaters based 
on ultra high performance liquid chromatography (UHPLC)–tandem mass 
spectrometry (MS/MS). Chemosphere 85, 1390-1399, 
doi:https://doi.org/10.1016/j.chemosphere.2011.07.071 (2011). 
199 Valcárcel, Y., González Alonso, S., Rodríguez-Gil, J. L., Gil, A. & Catalá, M. 
Detection of pharmaceutically active compounds in the rivers and tap water of the 
Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 84, 1336-
1348, doi:https://doi.org/10.1016/j.chemosphere.2011.05.014 (2011). 
200 Al Aukidy, M., Verlicchi, P., Jelic, A., Petrovic, M. & Barcelò, D. Monitoring release 
of pharmaceutical compounds: Occurrence and environmental risk assessment of two 
WWTP effluents and their receiving bodies in the Po Valley, Italy. Science of The Total 
Environment 438, 15-25, doi:https://doi.org/10.1016/j.scitotenv.2012.08.061 
(2012). 
201 Osorio, V. et al. Occurrence and modeling of pharmaceuticals on a sewage-
impacted Mediterranean river and their dynamics under different hydrologic al 
conditions. Science of The Total Environment  440, 3-13, 
doi:https://doi.org/10.1016/j.scitotenv.2012.08.040 (2012). 
202 López-Serna, R., Petrović, M. & Barceló, D. Occurrence and distribution of multi-
class pharmaceuticals and their active metabolites and transformation products in the 
Ebro River basin (NE Spain). Science of The Total Environment  440, 280-289, 
doi:https://doi.org/10.1016/j.scitotenv.2012.06.027 (2012). 
203 Boleda, M. R., Galceran, M. T. & Ventura, F. Validation and uncertainty estimation 
of a multiresidue method for pharmaceuticals in surface and treated waters by liquid 
chromatography–tandem mass spectrometry. Journal of Chromatography A 1286, 
146-158, doi:https://doi.org/10.1016/j.chroma.2013.02.077 (2013). 
204 Verlicchi, P., Al Aukidy, M., Jelic, A., Petrović, M. & Barceló, D. Comparison of 
measured and predicted concentrations of selected pharmaceuticals in wastewater 
and surface water: A case study of a catchment area in the Po Valley (Italy). Science 
of The Total Environment 470-471, 844-854, 
doi:https://doi.org/10.1016/j.scitotenv.2013.10.026 (2014). 
205 Moreno-González, R. et al. Input of pharmaceuticals through coastal surface 
watercourses into a Mediterranean lagoon (Mar Menor, SE Spain): Sources and 
seasonal variations. Science of The Total Environment  490, 59-72, 
doi:https://doi.org/10.1016/j.scitotenv.2014.04.097 (2014). 
206 Moreno-González, R., Rodriguez-Mozaz, S., Gros, M., Barceló, D. & León, V. M. 
Seasonal distribution of pharmaceuticals in marine water and sediment from a 
mediterranean coastal lagoon (SE Spain). Environmental Research 138, 326-344, 
doi:https://doi.org/10.1016/j.envres.2015.02.016 (2015). 
207 Osorio, V., Larrañaga, A., Aceña, J., Pérez, S. & Barceló, D. Concentration and 
risk of pharmaceuticals in freshwater systems are related to the population density 
and the livestock units in Iberian Rivers. Science of The Total Environment  540, 267-
277, doi:https://doi.org/10.1016/j.scitotenv.2015.06.143 (2016). 
208 Hirsch, R., Ternes, T., Haberer, K. & Kratz, K.-L. Occurrence of antibiotics in the 
aquatic environment. Science of The Total Environment  225, 109-118, 
doi:https://doi.org/10.1016/S0048-9697(98)00337-4 (1999). 
209 Xu, W.-h., Zhang, G., Zou, S.-c., Li, X.-d. & Liu, Y.-c. Determination of selected 
antibiotics in the Victoria Harbour and the Pearl River, South China using high-
performance liquid chromatography-electrospray ionization tandem mass 
 102 
 
spectrometry. Environmental Pollution 145, 672-679, 
doi:https://doi.org/10.1016/j.envpol.2006.05.038 (2007). 
210 Choi, K. et al. Occurrences and ecological risks of roxithromycin, trimethoprim, 
and chloramphenicol in the Han River, Korea. Environmental Toxicology and 
Chemistry 27, 711-719, doi:10.1897/07-143.1 (2008). 
211 Jiang, L., Hu, X., Yin, D., Zhang, H. & Yu, Z. Occurrence, distribution and seasonal 
variation of antibiotics in the Huangpu River, Shanghai, China. Chemosphere 82, 822-
828, doi:https://doi.org/10.1016/j.chemosphere.2010.11.028 (2011). 
212 Chitescu, C. L., Kaklamanos, G., Nicolau, A. I. & Stolker, A. A. M. High sensitive 
multiresidue analysis of pharmaceuticals and antifungals in surface water using U-
HPLC-Q-Exactive Orbitrap HRMS. Application to the Danube river basin on the 
Romanian territory. Science of The Total Environment  532, 501-511, 
doi:https://doi.org/10.1016/j.scitotenv.2015.06.010 (2015). 
213 Kolpin, D. et al. Pharmaceuticals, Hormones, and Other Organic Wastewater 
Contaminants in U.S. Streams, 1999-2000: a Naional Reconnaissance. Environmental 
Science & Technology 36, 1202-1202, doi:10.1021/es011055j (2002). 
214 Lissemore, L. et al. An exposure assessment for selected pharmaceuticals within 
a watershed in Southern Ontario. Chemosphere 64, 717-729, 
doi:10.1016/j.chemosphere.2005.11.015 (2006). 
215 Sung-Chul, K. & Carlson, K. Temporal and Spatial Trends in the Occurrence of 
Human and Veterinary Antibiotics in Aqueous and River Sediment Matrices. 
Environmental Science & Technology 41, 50-57, doi:10.1021/es060737+ (2007). 
216 Kim, Y., Lee, K.-B. & Choi, K. Effect of runoff discharge on the environmental 
levels of 13 veterinary antibiotics: A case study of Han River and Kyungahn Stream, 
South Korea. Marine Pollution Bulletin 107, 347-354, 
doi:https://doi.org/10.1016/j.marpolbul.2016.03.011 (2016). 
217 Calamari, D., Zuccato, E., Castiglioni, S., Bagnati, R. & Fanelli, R. Strategic 
Survey of Therapeutic Drugs in the Rivers Po and Lambro in Northern Italy. 
Environmental Science & Technology 37, 1241-1248, doi:10.1021/es020158e 
(2003). 
218 Zuccato, E., Castiglioni, S. & Fanelli, R. Identification of the pharmaceuticals for 
human use contaminating the Italian aquatic environment. Journal of Hazardous 
Materials 122, 205-209, doi:10.1016/j.jhazmat.2005.03.001 (2005). 
219 Vieno, N. M., Tuhkanen, T. & Kronberg, L. Analysis of neutral and basic 
pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase 
extraction and liquid chromatography–tandem mass spectrometry detection. Journal 
of Chromatography A 1134, 101-111, doi:10.1016/j.chroma.2006.08.077 (2006). 
220 Conley, J. M., Symes, S. J., Kindelberger, S. A. & Richards, S. M. Rapid liquid 
chromatography–tandem mass spectrometry method for the determination of a 
broad mixture of pharmaceuticals in surface water. Journal of Chromatography A 
1185, 206-215, doi:10.1016/j.chroma.2008.01.064 (2008). 
221 Peng, X. et al. Occurrence of steroid estrogens, endocrine-disrupting phenols, 
and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, 
South China. Science of the Total Environment 397, 158-166, 
doi:10.1016/j.scitotenv.2008.02.059 (2008). 
222 Xiao, Y., Chang, H., Jia, A. & Hu, J. Trace analysis of quinolone and 
fluoroquinolone antibiotics from wastewaters by liquid chromatography–electrospray 
tandem mass spectrometry. Journal of Chromatography A 1214, 100-108, 
doi:10.1016/j.chroma.2008.10.090 (2008). 
223 Feitosa-Felizzola, J. & Chiron, S. Occurrence and distribution of selected 
antibiotics in a small Mediterranean stream (Arc River, Southern France). Journal of 
Hydrology 364, 50-57, doi:10.1016/j.jhydrol.2008.10.006 (2009). 
224 Gracia-Lor, E., Sancho, J. V. & Hernández, F. Multi-class determination of around 
50 pharmaceuticals, including 26 antibiotics, in environmental and wastewater 
samples by ultra-high performance liquid chromatography–tandem mass 
 103 
 
spectrometry. Journal of Chromatography A 1218, 2264-2275, 
doi:10.1016/j.chroma.2011.02.026 (2011). 
225 Wagil, M. et al. Development of sensitive and reliable LC-MS/MS methods for the 
determination of three fluoroquinolones in water and fish tissue samples and 
preliminary environmental risk assessment of their presence in two rivers in northern 
Poland. Science of the Total Environment  493, 1006-1013, 
doi:10.1016/j.scitotenv.2014.06.082 (2014). 
226 Zhang, Q. et al. Occurrences of Three Classes of Antibiotics in a Natural River 
Basin: Association with Antibiotic -Resistant Escherichia coli. Environmental Science & 
Technology 48, 14317-14325, doi:10.1021/es503700j (2014). 
227 He, K. et al. Detection of a wide variety of human and veterinary fluoroquinolone 
antibiotics in municipal wastewater and wastewater-impacted surface water. Journal 
of Pharmaceutical and Biomedical Analysis 106, 136-143, 
doi:10.1016/j.jpba.2014.11.020 (2015). 
228 Weigel, S., Kallenborn, R. & Hühnerfuss, H. Simultaneous solid-phase extraction 
of acidic, neutral and basic pharmaceuticals from aqueous samples at ambient  
(neutral) pH and their determination by gas chromatography–mass spectrometry. 
Journal of Chromatography A 1023, 183-195, doi:10.1016/j.chroma.2003.10.036 
(2004). 
229 Heberer, T., Massmann, G., Fanck, B., Taute, T. & Dünnbier, U. Behaviour and 
redox sensitivity of antimicrobial residues during bank filtration. Chemosphere 73, 
451-460, doi:10.1016/j.chemosphere.2008.06.056 (2008). 
230 Spongberg, A. L. & Witter, J. D. Pharmaceutical compounds in the wastewater 
process stream in Northwest Ohio. Science of the Total Environment  397, 148-157, 
doi:10.1016/j.scitotenv.2008.02.042 (2008). 
231 Nödler, K., Licha, T., Bester, K. & Sauter, M. Development of a multi-residue 
analytical method, based on liquid chromatography–tandem mass spectrometry, for 
the simultaneous determination of 46 micro-contaminants in aqueous samples. 
Journal of Chromatography A 1217, 6511-6521, 
doi:https://doi.org/10.1016/j.chroma.2010.08.048 (2010). 
232 Ferrer, I., Zweigenbaum, J. A. & Thurman, E. M. Analysis of 70 Environmental 
Protection Agency priority pharmaceuticals in water by EPA Method 1694. Journal of 
Chromatography A 1217, 5674-5686, 
doi:https://doi.org/10.1016/j.chroma.2010.07.002 (2010). 
233 ter Laak, T. L., van der Aa, M., Houtman, C. J., Stoks, P. G. & van Wezel, A. P. 
Relating environmental concentrations of pharmaceuticals to consumption: A mass 
balance approach for the river Rhine. Environment International 36, 403-409, 
doi:https://doi.org/10.1016/j.envint.2010.02.009 (2010). 
234 Silva, B. F. D. et al. Occurrence and distribution of pharmaceuticals in surface 
water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere  
85, 1331-1339, doi:10.1016/j.chemosphere.2011.07.051 (2011). 
235 Vazquez-Roig, P., Andreu, V., Blasco, C. & Picó, Y. Risk assessment on the 
presence of pharmaceuticals in sediments, soils and waters of the Pego–Oliva 
Marshlands (Valencia, eastern Spain). Science of The Total Environment  440, 24-32, 
doi:https://doi.org/10.1016/j.scitotenv.2012.08.036 (2012). 
236 Boix, C. et al. Fast determination of 40 drugs in water using large volume direct 
injection liquid chromatography–tandem mass spectrometry. Talanta 131, 719-727, 
doi:https://doi.org/10.1016/j.talanta.2014.08.005 (2015). 
237 Baumann, M. et al. Aquatic toxicity of the macrolide antibiotic clarithromycin and 
its metabolites. Chemosphere 120, 192-198, 
doi:10.1016/j.chemosphere.2014.05.089 (2015). 
238 Sun, J., Luo, Q., Wang, D. & Wang, Z. Occurrences of pharmaceuticals in drinking 
water sources of major river watersheds, China. Ecotoxicology and Environmental 
Safety 117, 132-140, doi:https://doi.org/10.1016/j.ecoenv.2015.03.032 (2015). 
239 de Jongh, C. M., Kooij, P. J. F., de Voogt, P. & Ter Laak, T. L. Screening and 
human health risk assessment of pharmaceuticals and their transformation products 
 104 
 
in Dutch surface waters and drinking water. Science of the Total Environment  427-
428, 70-77, doi:10.1016/j.scitotenv.2012.04.010 (2012). 
240 Tamtam, F. et al. Occurrence and fate of antibiotics in the Seine River in various 
hydrological conditions. Science of the Total Environment  393, 84-95, 
doi:10.1016/j.scitotenv.2007.12.009 (2008). 
241 Celle-Jeanton, H. et al. Evaluation of pharmaceuticals in surface water: Reliabilit y  
of PECs compared to MECs. Environment International 73, 10-21, 
doi:10.1016/j.envint.2014.06.015 (2014). 
242 Kolpin, D. W., Skopec, M., Meyer, M. T., Furlong, E. T. & Zaugg, S. D. Urban 
contribution of pharmaceuticals and other organic wastewater contaminants to 
streams during differing flow conditions. Science of the Total Environment  328, 119-
130, doi:10.1016/j.scitotenv.2004.01.015 (2004). 
243 Ashton, D., Hilton, M. & Thomas, K. V. Investigating the environmental transport 
of human pharmaceuticals to streams in the United Kingdom. Science of the Total 
Environment 333, 167-184, doi:10.1016/j.scitotenv.2004.04.062 (2004). 
244 Hao, C. et al. Determination of pharmaceuticals in environmental waters by liquid 
chromatography/electrospray ionization/tandem mass spectrometry. Analytical and 
Bioanalytical Chemistry 384, 505-513, doi:10.1007/s00216-005-0199-y (2006). 
245 Roberts, P. H. & Thomas, K. V. The occurrence of selected pharmaceuticals in 
wastewater effluent and surface waters of the lower Tyne catchment. Science of the 
Total Environment 356, 143-153, doi:10.1016/j.scitotenv.2005.04.031 (2006). 
246 Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J. & Snyder, S. A. Occurrence and 
removal of pharmaceuticals and endocrine disruptors in South Korean surface, 
drinking, and waste waters. Water Research 41, 1013-1021, 
doi:https://doi.org/10.1016/j.watres.2006.06.034 (2007). 
247 Xu, W. et al. Occurrence and elimination of antibiotics at four sewage treatment  
plants in the Pearl River Delta (PRD), South China. Water Research 41, 4526-4534, 
doi:10.1016/j.watres.2007.06.023 (2007). 
248 Hao, C., Zhao, X., Tabe, S. & Yang, P. Optimization of a multiresidual method for 
the determination of waterborne emerging organic pollutants using solid-phase 
extraction and liquid chromatography/tandem mass spectrometry and isotope 
dilution mass spectrometry. Environmental science & technology 42, 4068, 
doi:10.1021/es7026125 (2008). 
249 Muñoz, I. et al. Bridging levels of pharmaceuticals in river water with biological 
community structure in the llobregat river basin (northeast spain. Environmental 
Toxicology and Chemistry 28, 2706-2714, doi:10.1897/08-486.1 (2009). 
250 López-Roldán, R. et al. Advanced monitoring of pharmaceuticals and estrogens 
in the Llobregat River basin (Spain) by liquid chromatography–triple quadrupole-
tandem mass spectrometry in combination with ultra performance liquid 
chromatography–time of flight-mass spectrometry. Chemosphere 80, 1337-1344, 
doi:https://doi.org/10.1016/j.chemosphere.2010.06.042 (2010). 
251 Sim, W.-J., Lee, J.-W. & Oh, J.-E. Occurrence and fate of pharmaceuticals in 
wastewater treatment plants and rivers in Korea. Environmental Pollution 158, 1938-
1947, doi:10.1016/j.envpol.2009.10.036 (2010). 
252 Chițescu, C. L. & Nicolau, A. I. Preliminary survey of pharmaceutical residues in 
some important Romanian rivers. Toxicological & Environmental Chemistry 96, 1333-
1345, doi:10.1080/02772248.2015.1005092 (2014). 
253 Houtman, C. J., ten Broek, R., de Jong, K., Pieterse, B. & Kroesbergen, J. A 
multicomponent snapshot of pharmaceuticals and pesticides in the river Meuse basin. 
Environmental Toxicology and Chemistry 32, 2449-2459, doi:10.1002/etc.2351 
(2013). 
254 Jia, A., Xiao, Y., Hu, J., Asami, M. & Kunikane, S. Simultaneous determination of 
tetracyclines and their degradation products in environmental waters by liquid 
chromatography–electrospray tandem mass spectrometry. Journal of 
Chromatography A 1216, 4655-4662, 
doi:https://doi.org/10.1016/j.chroma.2009.03.073 (2009). 
 105 
 
255 Pailler, J. Y., Krein, A., Pfister, L., Hoffmann, L. & Guignard, C. Solid phase 
extraction coupled to liquid chromatography-tandem mass spectrometry analysis of 
sulfonamides, tetracyclines, analgesics and hormones in surface water and 
wastewater in Luxembourg. Science of The Total Environment  407, 4736-4743, 
doi:https://doi.org/10.1016/j.scitotenv.2009.04.042 (2009). 
256 García-Galán, M. J., Díaz-Cruz, M. S. & Barceló, D. Occurrence of sulfonamide 
residues along the Ebro river basin: Removal in wastewater treatment plants and 
environmental impact assessment. Environment International 37, 462-473, 
doi:https://doi.org/10.1016/j.envint.2010.11.011 (2011). 
257 Chang, H., Hu, J., Asami, M. & Kunikane, S. Simultaneous analysis of 16 
sulfonamide and trimethoprim antibiotics in environmental waters by liquid 
chromatography–electrospray tandem mass spectrometry. Journal of 
Chromatography A 1190, 390-393, 
doi:https://doi.org/10.1016/j.chroma.2008.03.057 (2008). 
258 Díaz-Cruz, M. S., García-Galán, M. J. & Barceló, D. Highly sensitive simultaneous 
determination of sulfonamide antibiotics and one metabolite in environmental waters 
by liquid chromatography–quadrupole linear ion trap–mass spectrometry. Journal of 
Chromatography A 1193, 50-59, doi:https://doi.org/10.1016/j.chroma.2008.03.029 
(2008). 
259 Choi, K. et al. Seasonal variations of several pharmaceutical residues in surface 
water and sewage treatment plants of Han River, Korea. Science of The Total 
Environment 405, 120-128, doi:https://doi.org/10.1016/j.scitotenv.2008.06.038 
(2008). 
260 Fernández, C., González-Doncel, M., Pro, J., Carbonell, G. & Tarazona, J. V. 
Occurrence of pharmaceutically active compounds in surface waters of the henares-
jarama-tajo river system (madrid, spain) and a potential risk characterization. 
Science of The Total Environment  408, 543-551, 
doi:https://doi.org/10.1016/j.scitotenv.2009.10.009 (2010). 
261 Bendz, D., Paxéus, N. A., Ginn, T. R. & Loge, F. J. Occurrence and fate of 
pharmaceutically active compounds in the environment, a case study: Höje River in 
Sweden. Journal of Hazardous Materials 122, 195-204, 
doi:https://doi.org/10.1016/j.jhazmat.2005.03.012 (2005). 
262 Brown, K. D., Kulis, J., Thomson, B., Chapman, T. H. & Mawhinney, D. B. 
Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal 
wastewater, and the Rio Grande in New Mexico. Science of The Total Environment  
366, 772-783, doi:https://doi.org/10.1016/j.scitotenv.2005.10.007 (2006). 
263 Vanderford, B. J. & Snyder, S. A. Analysis of Pharmaceuticals in Water by Isotope 
Dilution Liquid Chromatography/Tandem Mass Spectrometry. Environmental Science 
& Technology 40, 7312-7320, doi:10.1021/es0613198 (2006). 
264 Loos, R. et al. EU-wide survey of polar organic persistent pollutants in European 
river waters. Environmental Pollution 157, 561-568, 
doi:https://doi.org/10.1016/j.envpol.2008.09.020 (2009). 
265 Zhou, J. L., Zhang, Z. L., Banks, E., Grover, D. & Jiang, J. Q. Pharmaceutical 
residues in wastewater treatment works effluents and their impact on receiving river 
water. Journal of Hazardous Materials 166, 655-661, 
doi:https://doi.org/10.1016/j.jhazmat.2008.11.070 (2009). 
266 Camacho-Muñoz, D., Martín, J., Santos, J. L., Aparicio, I. & Alonso, E. 
Occurrence, temporal evolution and risk assessment of pharmaceutically active 
compounds in Doñana Park (Spain). Journal of Hazardous Materials 183, 602-608, 
doi:https://doi.org/10.1016/j.jhazmat.2010.07.067 (2010). 
267 Loos, R., Locoro, G. & Contini, S. Occurrence of polar organic contaminants in 
the dissolved water phase of the Danube River and its major tributaries using SPE-
LC-MS2 analysis. Water Research 44, 2325-2335, 
doi:https://doi.org/10.1016/j.watres.2009.12.035 (2010). 
268 Madureira, T. V. et al. Spatiotemporal distribution of pharmaceuticals in the 
Douro River estuary (Portugal). Science of The Total Environment  408, 5513-5520, 
doi:https://doi.org/10.1016/j.scitotenv.2010.07.069 (2010). 
 106 
 
269 Yoon, Y., Ryu, J., Oh, J., Choi, B.-G. & Snyder, S. A. Occurrence of endocrine 
disrupting compounds, pharmaceuticals, and personal care products in the Han River 
(Seoul, South Korea). Science of The Total Environment  408, 636-643, 
doi:https://doi.org/10.1016/j.scitotenv.2009.10.049 (2010). 
270 Iglesias, A. et al. Determination of the Presence of Three Antimicrobials in 
Surface Water Collected from Urban and Rural Areas. Antibiotics (Basel, Switzerland)  
2, 46-57, doi:10.3390/antibiotics2010046 (2013). 
271 Straub, J. O. Aquatic environmental risk assessment for human use of the old 
antibiotic sulfamethoxazole in Europe. Environmental Toxicology and Chemistry 35, 
767-779, doi:10.1002/etc.2945 (2015). 
272 Straub, J. O. An Environmental Risk Assessment for Human-Use Trimethoprim in 
European Surface Waters. Antibiotics (Basel, Switzerland) 2, 115-162, 
doi:10.3390/antibiotics2010115 (2013). 
273 McEneff, G., Barron, L., Kelleher, B., Paull, B. & Quinn, B. A year-long study of 
the spatial occurrence and relative distribution of pharmaceutical residues in sewage 
effluent, receiving marine waters and marine bivalves. Science of The Total 
Environment 476-477, 317-326, 
doi:https://doi.org/10.1016/j.scitotenv.2013.12.123 (2014). 
 
 107 
 
 
GETTING IN TOUCH WITH THE EU 
In person 
All over the European Union there are hundreds of Europe Direct information centres. You can find the 
address of the centre nearest you at: https://europa.eu/european-union/contact_en 
On the phone or by email 
Europe Direct is a service that answers your questions about the European Union. You can contact this 
service: 
- by freephone: 00 800 6 7 8 9 10 11 (certain operators may charge for these calls), 
- at the following standard number: +32 22999696, or 
- by electronic mail via: https://europa.eu/european-union/contact_en 
FINDING INFORMATION ABOUT THE EU 
Online 
Information about the European Union in all the official languages of the EU is available on the Europa 
website at: https://europa.eu/european-union/index_en 
EU publications 
You can download or order free and priced EU publications from EU Bookshop at: 
https://publications.europa.eu/en/publications. Multiple copies of free publications may be obtained by 
contacting Europe Direct or your local information centre (see https://europa.eu/european- 
union/contact_en). 
 108 
 
doi:10.2760/771124  
ISBN 978-92-79-98478-5 
K
J
-N
A
-2
9
5
9
2
-E
N
-N
 
